Welcome to Arctom, sign up to enjoy up to 20% OFF

Search in Small Molecules Search in Biologics

Structure Search

Cart - 0 item(s)
$0.00

Your shopping cart is empty!

Chemistry
Bioactive Molecules
Natural Products
ADCs
Antibodies
- Primary Antibodies
- Secondary Antibodies
Multiplex IHC
Material Science
Others

[CAS NO. 75607-67-9] Fludarabinephosphate

Ships within

Stock

Price

Qty

Total

SDS

COA

Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.

Catalog:	HY-B0028
Brand:	MCE
CAS:	75607-67-9

Overview

MDL	MFCD00866418
Molecular Weight	365.21
Molecular Formula	C10H13FN5O7P
SMILES	NC1=C2C(N([C@H]3[C@@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O3)C=N2)=NC(F)=N1

For research use only. We do not sell to patients.

3 Publications Citing Use of MCE

[1]J Mol Med (Berl). 2019 Aug;97(8):1183-1193.
[2]Antivir Res. 2020 Jun;178:104786.
[3]Research Square Print. 2022 Aug.

Summary

Fludarabine (phosphate) is an analogue of adenosine and deoxyadenosine, which is able to compete with dATP for incorporation into DNA and inhibit DNA synthesis.

In Vitro

Fludarabine phosphate significantly reduces the cell viability in a dose-dependent manner. Fludarabine phosphate exhibits no effect in all tested concentrations when combined with either PBS or control vector, ACE-GFP. Fludarabine phosphate causes a significant decrease in cell viability for 24 h after exposure to ACE-PNP when compared to PBS and ACE-GFP at concentrations of 2.5, 5 and 10 μg/mL ^[2] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

F-araAMP (100 mg/kg given 15 times, 167 mg/kg given 9 times, or 250 mg/kg given 3 times, i.p.) leads to complete regressions of all tumors and cures of all mice. Parental D54 tumors (i.e. without E. coli PNP) are not sensitive to treatment with F-araAMP. Intratumoral injection of Ad/PNP followed by IT F-araAMP can elicit a substantial regressive effect on otherwise refractory solid tumors in a fashion substantially superior to viral PNP transduction followed by systemic prodrug administration ^[1] . The comparison of ACE-GFP/fludarabine phosphate with ACE-GFP/PBS demonstrats that fludarabine phosphate alone has no growth inhibitory activity on KU-19-19 tumors ^[2] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Clinical Trial

NCT Number	Sponsor	Condition	Start Date	Phase
NCT02024308	Changhai Hospital	Acute Myeloid Leukemia\|AML1-ETO Fusion Protein Expression	November 2010	Phase 4
NCT04083170	Fred Hutchinson Cancer Center\|National Heart, Lung, and Blood Institute (NHLBI)	Acute Erythroid Leukemia\|Acute Lymphoblastic Leukemia\|Acute Megakaryoblastic Leukemia\|Acute Myeloid Leukemia\|Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Hematopoietic and Lymphoid Cell Neoplasm\|HIV Infection\|Myelodysplastic Syndrome\|Myelodysplastic Syndrome With Excess Blasts\|Non-Hodgkin Lymphoma\|Refractory Anemia	October 6, 2022	Phase 2
NCT03449108	M.D. Anderson Cancer Center\|Iovance Biotherapeutics, Inc.\|National Cancer Institute (NCI)	Bone Sarcoma\|Dedifferentiated Chondrosarcoma\|Giant Cell Tumor of Bone\|Malignancy in Giant Cell Tumor of Bone\|Malignant Solid Neoplasm\|Ovarian Carcinosarcoma\|Platinum-Resistant Ovarian Carcinoma\|Poorly Differentiated Thyroid Gland Carcinoma\|Recurrent Osteosarcoma\|Recurrent Ovarian Carcinoma\|Refractory Osteosarcoma\|Soft Tissue Sarcoma\|Thyroid Gland Anaplastic Carcinoma\|Thyroid Gland Squamous Cell Carcinoma\|Undifferentiated High Grade Pleomorphic Sarcoma of Bone\|Triple Negative Breast Cancer	April 27, 2018	Phase 2
NCT00719849	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Diseases	November 2005	Phase 2
NCT05578378	The First Affiliated Hospital of Soochow University\|The First People´s Hospital of Changzhou\|Zhongda Hospital\|Suzhou Municipal Hospital	Acute Lymphoblastic Leukemia	January 1, 2022	Phase 2\|Phase 3
NCT02774291	Albert Einstein College of Medicine\|National Cancer Institute (NCI)	HLA-A2 Positive Cells Present\|Metastatic Malignant Neoplasm\|Metastatic Malignant Neoplasm in the Brain	August 2016	Early Phase 1
NCT01289457	M.D. Anderson Cancer Center	Leukemia	February 2, 2011	Phase 1\|Phase 2
NCT00086775	Bayer\|National Cancer Institute (NCI)	Leukemia	July 2003	Phase 2
NCT04151706	Stanford University\|National Institutes of Health (NIH)\|National Cancer Institute (NCI)	Acute Myeloid Leukemia\|Acute Lymphoblastic Leukemia\|Myelodysplastic Syndromes\|Acute Leukemia\|Chronic Myeloid Leukemia	February 27, 2020	Phase 2
NCT00305682	Masonic Cancer Center, University of Minnesota	Myeloproliferative Disorders\|Leukemia\|Lymphoma\|Myelodysplastic Syndromes	June 2005	Phase 2
NCT02627573	St. Petersburg State Pavlov Medical University	Leukemia, Chronic Myeloid\|Myelodysplastic Syndromes\|Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	July 2015	Phase 2
NCT03480360	Dartmouth-Hitchcock Medical Center	Acute Myeloid Leukemia\|Chronic Lymphocytic Leukemia\|Chronic Myeloid Leukemia\|Myelodysplasia\|Myeloproliferative Disorder\|Myelofibrosis\|Lymphoma\|Lymphoma, Non-Hodgkin\|Plasma Cell Disorder	March 28, 2018	Phase 3
NCT00014508	Eastern Cooperative Oncology Group\|National Cancer Institute (NCI)	Multiple Myeloma and Plasma Cell Neoplasm	April 2001	Phase 2
NCT04217278	University of Birmingham	Acute Myeloid Leukaemia\|Myelodysplasia	January 27, 2020	Phase 3
NCT02791919	National Cancer Institute (NCI)	CNS 2a\|CNS 2b\|CNS 2c\|CNS1\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Childhood Acute Myeloid Leukemia	May 25, 2017	Phase 1
NCT01455506	Hackensack Meridian Health	Acute Myeloid Leukemia\|Myelodysplastic Syndrome	May 2009	Phase 1
NCT00003204	National Cancer Institute (NCI)	Stage III Grade 1 Follicular Lymphoma\|Stage III Grade 2 Follicular Lymphoma\|Stage III Grade 3 Follicular Lymphoma\|Stage III Small Lymphocytic Lymphoma\|Stage IV Grade 1 Follicular Lymphoma\|Stage IV Grade 2 Follicular Lymphoma\|Stage IV Grade 3 Follicular Lymphoma\|Stage IV Small Lymphocytic Lymphoma	March 1998	Phase 3
NCT03016806	University of Rochester	Acute Leukemia\|Immune Deficiency Disorder\|Congenital Hematological Disorder\|Metabolism Disorder\|Aplastic Anemia\|Myelodysplastic Syndromes\|Chronic Leukemia\|Lymphoma\|Multiple Myeloma\|Solid Tumor	June 2015	Phase 1
NCT04708054	M.D. Anderson Cancer Center	Acute Myeloid Leukemia\|Chronic Myelomonocytic Leukemia\|Myelodysplastic Syndrome	October 21, 2021	Phase 2
NCT00089453	University of Arkansas	Multiple Myeloma	September 2003	Phase 1
NCT04637763	Caribou Biosciences, Inc.	Lymphoma, Non-Hodgkin\|Relapsed Non Hodgkin Lymphoma\|Refractory B-Cell Non-Hodgkin Lymphoma\|Non Hodgkin Lymphoma\|Lymphoma\|B Cell Lymphoma\|B Cell Non-Hodgkin´s Lymphoma	May 26, 2021	Phase 1
NCT03926624	Delta-Fly Pharma, Inc.	Leukemia, Myeloid, Acute	November 22, 2019	Phase 3
NCT04220684	Sumithira Vasu\|Ohio State University Comprehensive Cancer Center	Allogeneic Stem Cell Transplant Recipient\|Blasts 10 Percent or More of Bone Marrow Nucleated Cells\|Recurrent Acute Myeloid Leukemia\|Refractory Acute Myeloid Leukemia	June 1, 2020	Phase 1
NCT02274506	M.D. Anderson Cancer Center	Blood And Marrow Transplantation\|Leukemia\|Lymphoma	October 20, 2014	Phase 1
NCT03814447	Shanghai 6th People´s Hospital\|Hrain Biotechnology Co., Ltd.	Ovarian Cancer	August 16, 2019	Early Phase 1
NCT03696537	Naoyuki G. Saito, M.D., Ph.D.\|Indiana University	Acute Myeloid Leukemia\|Chronic Myeloid Leukemia\|Acute Lymphocytic Leukemia\|Myelodysplastic Syndromes	August 29, 2018	Phase 1
NCT04323657	TCR2 Therapeutics	Non Hodgkin Lymphoma\|Acute Lymphoblastic Leukemia\|Diffuse Large B Cell Lymphoma\|Primary Mediastinal Large B Cell Lymphoma\|Mantle Cell Lymphoma\|Follicular Lymphoma	March 27, 2020	Phase 1\|Phase 2
NCT02251548	Dana-Farber Cancer Institute\|Pharmacyclics LLC.\|The Leukemia and Lymphoma Society\|Blood Cancer Research Partnership	Chronic Lymphocytic Leukemia\|Leukemia	October 2014	Phase 2
NCT03338972	Fred Hutchinson Cancer Center\|Juno Therapeutics, Inc.\|National Cancer Institute (NCI)	Recurrent Plasma Cell Myeloma\|Refractory Plasma Cell Myeloma	November 29, 2017	Phase 1
NCT04160195	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Lymphoma, B-Cell\|Lymphoma, Non-hodgkins\|Chronic Lymphocytic Leukemia\|B-Cell Chronic Lymphocytic Leukemia	December 20, 2019	Phase 1
NCT04370301	Fred Hutchinson Cancer Center	Primary Myelofibrosis\|Secondary Myelofibrosis	February 9, 2021	Phase 2
NCT03399773	Fred Hutchinson Cancer Center\|Nohla Therapeutics, Inc.\|National Cancer Institute (NCI)\|National Heart, Lung, and Blood Institute (NHLBI)	Acute Biphenotypic Leukemia\|Acute Lymphoblastic Leukemia\|Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Hematopoietic and Lymphoid Cell Neoplasm\|Myelodysplastic Syndrome\|Myelodysplastic Syndrome With Excess Blasts	May 10, 2022	Phase 2
NCT05020392	Wuhan Union Hospital, China\|Wuhan Si´an Medical Technology Co., Ltd	Diffuse Large B Cell Lymphoma\|Mantle Cell Lymphoma\|Chronic Lymphocytic Leukemia\|Follicular Lymphoma\|Burkitt Lymphoma	September 14, 2021	Phase 3
NCT01181258	Masonic Cancer Center, University of Minnesota	Non-Hodgkin Lymphoma\|Chronic Lymphocytic Leukemia	August 2010	Phase 2
NCT00281983	German CLL Study Group	Chronic Lymphocytic Leukemia	June 2000	Phase 1\|Phase 2
NCT05617625	Baptist Health South Florida	Myelodysplastic Syndromes\|Graft Vs Host Disease\|Graft-versus-host-disease	December 2022	Phase 2
NCT02441803	M.D. Anderson Cancer Center	Leukemia	September 14, 2015	Phase 2
NCT02447055	Washington University School of Medicine	Multiple Myeloma\|Myeloma-Multiple	December 2015	Early Phase 1
NCT01795976	Fiona Thistlethwaite\|The Christie NHS Foundation Trust\|Erasmus Medical Center\|Ospedale San Raffaele\|University College London Hospitals\|Karolinska University Hospital\|The Netherlands Cancer Institute	Oesophageal Cancer	October 2014	Phase 2
NCT04230265	AvenCell Europe GmbH\|PHARMALOG Institut für klinische Forschung GmbH	Acute Myeloid Leukemia (AML)	January 28, 2020	Phase 1
NCT00574496	Memorial Sloan Kettering Cancer Center\|National Cancer Institute (NCI)	Lymphoma	November 13, 2007	Phase 2
NCT00455312	Masonic Cancer Center, University of Minnesota	Dyskeratosis Congenita\|Aplastic Anemia	August 2007	Phase 2\|Phase 3
NCT05605899	Kite, A Gilead Company\|Gilead Sciences	High-risk Large B-cell Lymphoma (LBCL)	November 2022	Phase 3
NCT01824693	Children´s Oncology Group\|National Cancer Institute (NCI)	Juvenile Myelomonocytic Leukemia	June 24, 2013	Phase 2
NCT03821610	University of Birmingham	Acute Lymphoblastic Leukemia	November 22, 2018	Phase 2
NCT04037566	Xijing Hospital\|Xi´An Yufan Biotechnology Co.,Ltd	Leukemia Lymphocytic Acute (ALL) in Relapse\|Leukemia Lymphocytic Acute (All) Refractory\|Lymphoma, B-Cell\|CD19 Positive	August 2019	Phase 1
NCT01212887	Cancer Research UK	Breast Cancer\|Colorectal Cancer\|Gastric Cancer\|Lung Cancer\|Ovarian Cancer\|Pancreatic Cancer\|Unspecified Adult Solid Tumor, Protocol Specific	August 2007	Phase 1
NCT00381004	M.D. Anderson Cancer Center\|Bayer	Chronic Lymphocytic Leukemia	September 2006	Phase 2
NCT04384692	Fred Hutchinson Cancer Center	Primary Myelofibrosis\|Secondary Myelofibrosis	December 18, 2020	Phase 2
NCT02423915	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)\|Cancer Prevention Research Institute of Texas	Leukemia\|Lymphoma	July 30, 2015	Phase 1
NCT04848064	John Reneau\|Ohio State University Comprehensive Cancer Center	Recurrent Adult T-Cell Leukemia+Lymphoma\|Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma\|Refractory Adult T-Cell Leukemia+Lymphoma\|Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma	May 6, 2022	Phase 1
NCT00006379	Case Comprehensive Cancer Center\|National Cancer Institute (NCI)	Chronic Myeloproliferative Disorders\|Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Diseases\|Precancerous+Nonmalignant Condition\|Small Intestine Cancer	June 2000	Phase 2
NCT04892277	Mayo Clinic\|National Cancer Institute (NCI)	Recurrent B-Cell Non-Hodgkin Lymphoma\|Recurrent Chronic Lymphocytic Leukemia\|Recurrent Small Lymphocytic Lymphoma\|Recurrent Transformed Chronic Lymphocytic Leukemia\|Refractory B-Cell Non-Hodgkin Lymphoma\|Refractory Chronic Lymphocytic Leukemia\|Refractory Small Lymphocytic Lymphoma\|Refractory Transformed Chronic Lymphocytic Leukemia	July 14, 2022	Phase 1
NCT00101140	Eastern Cooperative Oncology Group\|National Cancer Institute (NCI)	Adult Acute Erythroid Leukemia\|Adult Acute Monoblastic and Acute Monocytic Leukemia\|Adult Acute Myeloid Leukemia		Phase 2
NCT00959231	Cancer Research UK\|National Cancer Institute (NCI)	Hematopoietic+Lymphoid Cancer	January 2009	Phase 2
NCT03670966	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Acute Lymphoblastic Leukemia in Remission\|Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome\|Acute Myeloid Leukemia in Remission\|Chronic Myelomonocytic Leukemia\|Myelodysplastic Syndrome With Excess Blasts\|Recurrent Acute Lymphoblastic Leukemia\|Recurrent Acute Myeloid Leukemia\|Refractory Acute Lymphoblastic Leukemia\|Refractory Acute Myeloid Leukemia\|Recurrent Mixed Phenotype Acute Leukemia\|Refractory Mixed Phenotype Acute Leukemia\|Hematopoietic and Lymphoid Cell Neoplasm	July 10, 2019	Phase 1\|Phase 2
NCT02414945	University Health Network, Toronto	Pleural Mesothelioma	June 2015	Phase 1\|Phase 2
NCT01814046	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Metastatic Ocular Melanoma\|Metastatic Uveal Melanoma	March 1, 2013	Phase 2
NCT00176878	Masonic Cancer Center, University of Minnesota	Diamond-Blackfan Anemia\|Kostmann´s Neutropenia\|Shwachman-Diamond Syndrome	June 2000	Phase 2\|Phase 3
NCT00048412	Baylor College of Medicine\|The Methodist Hospital Research Institute\|Center for Cell and Gene Therapy, Baylor College of Medicine	Myelodysplastic Disorders\|Leukemia\|Multiple Myeloma\|Plasma Cell Dyscrasia\|Lymphoproliferative Disorders	June 2000	Phase 1\|Phase 2
NCT04088890	Stanford University	B-ALL\|B-cell Non Hodgkin Lymphoma\|DLBCL\|Follicular Lymphoma Grade 3B	September 12, 2019	Phase 1
NCT00086580	Genzyme, a Sanofi Company\|Sanofi	B-Cell Chronic Lymphocytic Leukemia	July 2004	Phase 3
NCT03259516	St. Petersburg State Pavlov Medical University	Myelodysplastic Syndromes	May 25, 2017	Phase 1\|Phase 2
NCT00058825	Baylor College of Medicine\|The Methodist Hospital Research Institute	Hematologic Malignancies	August 2000	Phase 1\|Phase 2
NCT02512497	Ohio State University Comprehensive Cancer Center\|Celgene Corporation	Cutaneous T-cell Lymphoma\|T-Prolymphocytic Leukemia\|T-Large Granulocytic Leukemia\|T-Lymphoblastic Leukemia+Lymphoma\|Peripheral T-Cell Lymphoma	December 8, 2017	Phase 1
NCT00357565	Masonic Cancer Center, University of Minnesota	Leukemia\|Myelodysplastic Syndromes\|Childhood Acute Myeloid Leukemia in Remission\|Recurrent Childhood Acute Myeloid Leukemia\|Secondary Acute Myeloid Leukemia\|Childhood Acute Lymphoblastic Leukemia in Remission\|Previously Treated Myelodysplastic Syndrome\|Secondary Myelodysplastic Syndrome\|Refractory Anemia With Excess Blasts in Transformation\|Refractory Anemia With Excess Blasts\|Refractory Anemia\|De Novo Myelodysplastic Syndrome\|Childhood Myelodysplastic Syndrome	November 2005	Phase 2
NCT00027547	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Leukemia	July 2001	Phase 1\|Phase 2
NCT03110640	First Affiliated Hospital of Wenzhou Medical University\|Hrain Biotechnology Co., Ltd.\|Second Affiliated Hospital of Nanchang University	B-cell Adult Acute Lymphoblastic Leukemia\|B-cell Chronic Lymphocytic Leukemia\|Adult Acute Lymphoblastic Leukemia in Remission\|Hematopoietic+Lymphoid Cancer\|Refractory Chronic Lymphocytic Leukemia	October 1, 2016	Phase 1
NCT02461121	The Affiliated Hospital of the Chinese Academy of Military Medical Sciences	Acute Myeloid Leukemia	May 2004	Phase 3
NCT04099797	Baylor College of Medicine\|Center for Cell and Gene Therapy, Baylor College of Medicine\|Faris Foundation	Diffuse Intrinsic Pontine Glioma\|High Grade Glioma\|Embryonal Tumor\|Ependymal Tumor	February 3, 2020	Phase 1
NCT00004246	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Head and Neck Cancer	June 7, 1995	Phase 1
NCT04083495	UNC Lineberger Comprehensive Cancer Center	Peripheral T Cell Lymphoma	September 17, 2019	Phase 2
NCT00049075	NCIC Clinical Trials Group\|Canadian Cancer Trials Group	Leukemia	August 8, 2002	Phase 2
NCT00612612	National Cancer Institute (NCI)	B-cell Chronic Lymphocytic Leukemia\|Leukemia\|Prolymphocytic Leukemia\|Refractory Chronic Lymphocytic Leukemia\|Stage I Chronic Lymphocytic Leukemia\|Stage II Chronic Lymphocytic Leukemia\|Stage III Chronic Lymphocytic Leukemia\|Stage IV Chronic Lymphocytic Leukemia	January 2008	Phase 1
NCT04007029	Jonsson Comprehensive Cancer Center\|Parker Institute for Cancer Immunotherapy	CD19 Positive\|CD20 Positive\|Recurrent Chronic Lymphocytic Leukemia\|Recurrent Diffuse Large B-Cell Lymphoma\|Recurrent Follicular Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma\|Recurrent Small Lymphocytic Lymphoma\|Refractory Chronic Lymphocytic Leukemia\|Refractory Diffuse Large B-Cell Lymphoma\|Refractory Follicular Lymphoma\|Refractory Mantle Cell Lymphoma\|Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma\|Refractory Small Lymphocytic Lymphoma	October 4, 2019	Phase 1
NCT02781467	Celularity Incorporated	Leukemia, Myeloid, Acute	July 11, 2016	Phase 1
NCT00040846	Fred Hutchinson Cancer Center\|National Heart, Lung, and Blood Institute (NHLBI)\|National Cancer Institute (NCI)	Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities\|Adult Acute Myeloid Leukemia With Del(5q)\|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)\|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)\|Adult Nasal Type Extranodal NK+T-cell Lymphoma\|Anaplastic Large Cell Lymphoma\|Angioimmunoblastic T-cell Lymphoma\|Childhood Burkitt Lymphoma\|Childhood Chronic Myelogenous Leukemia\|Childhood Diffuse Large Cell Lymphoma\|Childhood Immunoblastic Large Cell Lymphoma\|Childhood Nasal Type Extranodal NK+T-cell Lymphoma\|Chronic Phase Chronic Myelogenous Leukemia\|Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma\|Contiguous Stage II Grade 1 Follicular Lymphoma\|Contiguous Stage II Grade 2 Follicular Lymphoma\|Contiguous Stage II Marginal Zone Lymphoma\|Contiguous Stage II Small Lymphocytic Lymphoma\|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue\|Hepatosplenic T-cell Lymphoma\|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable\|Nodal Marginal Zone B-cell Lymphoma\|Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma\|Noncontiguous Stage II Grade 1 Follicular Lymphoma\|Noncontiguous Stage II Grade 2 Follicular Lymphoma\|Noncontiguous Stage II Marginal Zone Lymphoma\|Noncontiguous Stage II Small Lymphocytic Lymphoma\|Peripheral T-cell Lymphoma\|Previously Treated Myelodysplastic Syndromes\|Progressive Hairy Cell Leukemia, Initial Treatment\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Adult Burkitt Lymphoma\|Recurrent Adult Diffuse Large Cell Lymphoma\|Recurrent Adult Diffuse Mixed Cell Lymphoma\|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma\|Recurrent Adult Grade III Lymphomatoid Granulomatosis\|Recurrent Adult Hodgkin Lymphoma\|Recurrent Adult Immunoblastic Large Cell Lymphoma\|Recurrent Adult Lymphoblastic Lymphoma\|Recurrent Adult T-cell Leukemia+Lymphoma\|Recurrent Childhood Acute Lymphoblastic Leukemia\|Recurrent Childhood Acute Myeloid Leukemia\|Recurrent Childhood Anaplastic Large Cell Lymphoma\|Recurrent Childhood Large Cell Lymphoma\|Recurrent Childhood Lymphoblastic Lymphoma\|Recurrent Childhood Small Noncleaved Cell Lymphoma\|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma\|Recurrent Grade 1 Follicular Lymphoma\|Recurrent Grade 2 Follicular Lymphoma\|Recurrent Grade 3 Follicular Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Marginal Zone Lymphoma\|Recurrent Mycosis Fungoides+Sezary Syndrome\|Recurrent Small Lymphocytic Lymphoma\|Recurrent+Refractory Childhood Hodgkin Lymphoma\|Refractory Chronic Lymphocytic Leukemia\|Refractory Hairy Cell Leukemia\|Refractory Multiple Myeloma\|Relapsing Chronic Myelogenous Leukemia\|Splenic Marginal Zone Lymphoma\|Stage I Adult Diffuse Small Cleaved Cell Lymphoma\|Stage I Childhood Anaplastic Large Cell Lymphoma\|Stage I Childhood Large Cell Lymphoma\|Stage I Cutaneous T-cell Non-Hodgkin Lymphoma\|Stage I Grade 1 Follicular Lymphoma\|Stage I Grade 2 Follicular Lymphoma\|Stage I Mantle Cell Lymphoma\|Stage I Marginal Zone Lymphoma\|Stage I Mycosis Fungoides+Sezary Syndrome\|Stage I Small Lymphocytic Lymphoma\|Stage II Childhood Anaplastic Large Cell Lymphoma\|Stage II Childhood Large Cell Lymphoma\|Stage II Cutaneous T-cell Non-Hodgkin Lymphoma\|Stage II Mycosis Fungoides+Sezary Syndrome\|Stage III Adult Diffuse Large Cell Lymphoma\|Stage III Adult Diffuse Small Cleaved Cell Lymphoma\|Stage III Childhood Anaplastic Large Cell Lymphoma\|Stage III Childhood Large Cell Lymphoma\|Stage III Cutaneous T-cell Non-Hodgkin Lymphoma\|Stage III Grade 1 Follicular Lymphoma\|Stage III Grade 2 Follicular Lymphoma\|Stage III Mantle Cell Lymphoma\|Stage III Marginal Zone Lymphoma\|Stage III Mycosis Fungoides+Sezary Syndrome\|Stage III Small Lymphocytic Lymphoma\|Stage IV Adult Diffuse Large Cell Lymphoma\|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma\|Stage IV Childhood Anaplastic Large Cell Lymphoma\|Stage IV Childhood Large Cell Lymphoma\|Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma\|Stage IV Grade 1 Follicular Lymphoma\|Stage IV Grade 2 Follicular Lymphoma\|Stage IV Mantle Cell Lymphoma\|Stage IV Marginal Zone Lymphoma\|Stage IV Mycosis Fungoides+Sezary Syndrome\|Stage IV Small Lymphocytic Lymphoma\|T-cell Large Granular Lymphocyte Leukemia\|Waldenström Macroglobulinemia	November 2001	Phase 2
NCT03121001	University of Illinois at Chicago	Sickle Cell Disease	March 20, 2017	Phase 2
NCT02310997	University College, London\|Cancer Research UK	Leukaemia\|Lymphoma\|Other Haematological Diseases	July 2011	Phase 2
NCT00480987	M.D. Anderson Cancer Center\|Sanofi	Myelodysplastic Syndromes\|Acute Myeloid Leukemia\|Leukemia	July 2007	Phase 1\|Phase 2
NCT00001586	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Chronic Lymphocytic Leukemia	September 1997	Phase 2
NCT03146533	Shenzhen Second People´s Hospital\|The Beijing Pregene Science and Technology Company, Ltd.	B Cell Lymphoma	May 2017	Phase 1\|Phase 2
NCT04425655	University of California, San Diego\|Jazz Pharmaceuticals	Acute Myeloid Leukemia, Adult\|AML\|AML, Adult	August 5, 2020	Phase 2
NCT03600909	Memorial Sloan Kettering Cancer Center\|Pediatric Brain Tumor Consortium	Fanconi Anemia\|Myelodysplastic Syndrome (MDS)\|Acute Myelogenous Leukemia (AML)	May 15, 2018	Phase 2
NCT04673617	Artiva Biotherapeutics, Inc.	Non Hodgkin Lymphoma	March 29, 2021	Phase 1\|Phase 2
NCT04678336	University of Pennsylvania	Acute Myeloid Leukemia, in Relapse\|Acute Myeloid Leukemia, Pediatric\|Acute Myeloid Leukemia, Refractory	February 15, 2021	Phase 1
NCT00290511	M.D. Anderson Cancer Center\|Genentech, Inc.\|Biogen	Lymphoma	June 29, 2004	Phase 2
NCT00230282	Steven E. Coutre\|Bayer\|Stanford University	Leukemia\|B-cell Leukemia\|Chronic Leukemia\|Chronic Lymphocytic Leukemia (CLL)	July 2004	Phase 2
NCT05379647	Zhejiang University\|Hangzhou Qihan Biotech Co.,Ltd.	B-cell Lymphoma\|B-cell Acute Lymphoblastic Leukemia	November 4, 2021	Phase 1
NCT04872595	Memorial Sloan Kettering Cancer Center	Acute Myeloid Leukemia (AML)\|Acute Lymphoid Leukemia (ALL)\|Myelodysplastic Syndromes (MDS)	April 30, 2021	Phase 2
NCT02756572	University of Washington\|National Cancer Institute (NCI)	Blasts 10 Percent or More of Bone Marrow Nucleated Cells\|Chronic Myelomonocytic Leukemia-2\|High Grade Malignant Neoplasm\|Myelodysplastic Syndrome\|Myelodysplastic Syndrome With Excess Blasts-2\|Myeloid Neoplasm\|Previously Treated Myelodysplastic Syndrome\|Recurrent Acute Myeloid Leukemia\|Refractory Acute Myeloid Leukemia	September 22, 2016	Phase 2
NCT00822770	M.D. Anderson Cancer Center\|Genzyme, a Sanofi Company	Stem Cell Transplantation\|Leukemia	January 2009	Phase 1\|Phase 2
NCT00043810	M.D. Anderson Cancer Center	Acute Myelogenous Leukemia\|Myelodysplastic Syndrome	July 2002	Phase 1\|Phase 2
NCT04023071	Fate Therapeutics	Acute Myelogenous Leukemia\|B-cell Lymphoma	October 4, 2019	Phase 1
NCT00005802	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Leukemia	June 1999	Phase 1\|Phase 2
NCT00006252	Cancer and Leukemia Group B\|National Cancer Institute (NCI)\|Alliance for Clinical Trials in Oncology	Leukemia\|Lymphoma	February 2001	Phase 2
NCT00531310	Columbia University	Chronic Myeloid Leukemia	January 2003	Phase 2
NCT00006184	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Multiple Myeloma	February 8, 2001	Phase 2
NCT02029638	National Institute of Allergy and Infectious Diseases (NIAID)\|Immune Tolerance Network (ITN)	Kidney Transplantation	January 7, 2014	Phase 2
NCT03294954	Baylor College of Medicine\|Center for Cell and Gene Therapy, Baylor College of Medicine	Neuroblastoma	January 18, 2018	Phase 1
NCT05183035	LLS PedAL Initiative, LLC\|Princess Maxima Center for Pediatric Oncology (European Sponsor)\|AbbVie\|Roche-Genentech\|EuPAL	Acute Myeloid Leukemia	October 1, 2022	Phase 3
NCT02678143	Washington University School of Medicine	Sickle Cell Disease	April 26, 2016	Phase 1
NCT01883323	University Health Network, Toronto	Metastatic, Stage III or Stage IV, Melanoma	June 2013	Phase 2
NCT02614560	Seagen Inc.	Acute Myeloid Leukemia	November 2015	Phase 1\|Phase 2
NCT05582590	NexImmune Inc.	Oropharyngeal Cancer\|Human Papilloma Virus\|Head and Neck Cancer\|Head and Neck Squamous Cell Carcinoma\|Oropharyngeal Squamous Cell Carcinoma\|Oropharyngeal Cancer, Metastatic\|Head and Neck Cancer Metastatic\|HPV-Related Squamous Cell Carcinoma\|HPV-Related Mucosal Head and Neck Squamous Cell Carcinoma\|Relapsed Oropharyngeal SCC\|Refractory Oropharyngeal Squamous Cell Carcinoma	December 30, 2022	Phase 1
NCT01384513	Sidney Kimmel Cancer Center at Thomas Jefferson University\|Thomas Jefferson University	Adult Acute Lymphoblastic Leukemia in Remission\|Adult Acute Myeloid Leukemia in Remission\|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities\|Adult Acute Myeloid Leukemia With Del(5q)\|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)\|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)\|Adult Nasal Type Extranodal NK+T-cell Lymphoma\|Aplastic Anemia\|Childhood Acute Lymphoblastic Leukemia in Remission\|Childhood Acute Myeloid Leukemia in Remission\|Childhood Myelodysplastic Syndromes\|Chronic Eosinophilic Leukemia\|Chronic Myelomonocytic Leukemia\|Chronic Neutrophilic Leukemia\|Essential Thrombocythemia\|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue\|Juvenile Myelomonocytic Leukemia\|Mastocytosis\|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable\|Nodal Marginal Zone B-cell Lymphoma\|Polycythemia Vera\|Previously Treated Myelodysplastic Syndromes\|Primary Myelofibrosis\|Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma\|Recurrent Adult Grade III Lymphomatoid Granulomatosis\|Recurrent Adult Hodgkin Lymphoma\|Recurrent Childhood Acute Lymphoblastic Leukemia\|Recurrent Childhood Acute Myeloid Leukemia\|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma\|Recurrent Grade 1 Follicular Lymphoma\|Recurrent Grade 2 Follicular Lymphoma\|Recurrent Marginal Zone Lymphoma\|Recurrent Mycosis Fungoides+Sezary Syndrome\|Recurrent Small Lymphocytic Lymphoma\|Recurrent+Refractory Childhood Hodgkin Lymphoma\|Refractory Anemia\|Refractory Anemia With Ringed Sideroblasts\|Refractory Hairy Cell Leukemia\|Refractory Multiple Myeloma\|Secondary Myelodysplastic Syndromes\|Splenic Marginal Zone Lymphoma\|T-cell Large Granular Lymphocyte Leukemia\|Waldenström Macroglobulinemia	August 4, 2011	Phase 2
NCT00790413	Lund University Hospital	Neuroblastoma	August 2005	Early Phase 1
NCT00002833	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Graft Versus Host Disease\|Leukemia\|Myelodysplastic Syndromes	October 1994	Phase 2
NCT02653196	Montefiore Medical Center\|Children´s Hospital Los Angeles\|Nationwide Children´s Hospital	Neuroepithelial Tumor\|Solid Tumor\|Allogeneic Hematopoietic Stem Cell Transplantation	September 2015	Early Phase 1
NCT00243009	OHSU Knight Cancer Institute\|National Cancer Institute (NCI)	Kidney Cancer	June 2005	Phase 2
NCT00004145	University of Chicago\|National Cancer Institute (NCI)	Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes	November 1998	Phase 2
NCT01203722	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins\|National Cancer Institute (NCI)	Hematologic Malignancies	September 2010	Phase 1\|Phase 2
NCT03696784	UNC Lineberger Comprehensive Cancer Center\|Bellicum Pharmaceuticals\|The V Foundation	Lymphoma\|Lymphoma, B-Cell\|Immune System Diseases\|Immunoproliferative Disorders\|Lymphatic Diseases	March 12, 2019	Phase 1
NCT01658319	Case Comprehensive Cancer Center\|National Cancer Institute (NCI)	Adult Nasal Type Extranodal NK+T-cell Lymphoma\|Anaplastic Large Cell Lymphoma\|Angioimmunoblastic T-cell Lymphoma\|Cutaneous B-cell Non-Hodgkin Lymphoma\|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue\|Hepatosplenic T-cell Lymphoma\|Intraocular Lymphoma\|Nodal Marginal Zone B-cell Lymphoma\|Peripheral T-cell Lymphoma\|Recurrent Adult Burkitt Lymphoma\|Recurrent Adult Diffuse Large Cell Lymphoma\|Recurrent Adult Diffuse Mixed Cell Lymphoma\|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma\|Recurrent Adult Grade III Lymphomatoid Granulomatosis\|Recurrent Adult Hodgkin Lymphoma\|Recurrent Adult Immunoblastic Large Cell Lymphoma\|Recurrent Adult Lymphoblastic Lymphoma\|Recurrent Adult T-cell Leukemia+Lymphoma\|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma\|Recurrent Grade 1 Follicular Lymphoma\|Recurrent Grade 2 Follicular Lymphoma\|Recurrent Grade 3 Follicular Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Marginal Zone Lymphoma\|Recurrent Mycosis Fungoides+Sezary Syndrome\|Recurrent Small Lymphocytic Lymphoma\|Refractory Chronic Lymphocytic Leukemia\|Refractory Multiple Myeloma\|Relapsing Chronic Myelogenous Leukemia\|Small Intestine Lymphoma\|Splenic Marginal Zone Lymphoma\|Stage III Chronic Lymphocytic Leukemia\|Testicular Lymphoma\|Waldenström Macroglobulinemia	May 2011	Phase 1
NCT00452374	M.D. Anderson Cancer Center\|Sanofi	Leukemia	November 2004	Phase 1\|Phase 2
NCT02661035	Masonic Cancer Center, University of Minnesota	Acute Myelogenous Leukemia\|Acute Lymphocytic Leukemia\|Chronic Myelogenous Leukemia\|Plasma Cell Leukemia\|Myelodysplastic Syndromes\|Chronic Lymphocytic Leukemia\|Small Lymphocytic Lymphoma\|B-Cell Lymphoma\|Follicular Lymphoma\|Lymphoplasmacytic Lymphoma\|Mantle-Cell Lymphoma\|Prolymphocytic Leukemia\|Lymphoblastic Lymphoma\|Burkitt´s Lymphoma\|Non-Hodgkin´s Lymphoma\|Multiple Myeloma\|Myeloproliferative Syndromes\|Hematological Diseases	March 9, 2017	Phase 2
NCT05168423	University of Pennsylvania\|Tmunity Therapeutics	Glioblastoma	March 19, 2023	Phase 1
NCT05322733	The First Affiliated Hospital with Nanjing Medical University	Chronic Lymphocytic Leukemia+Small Lymphocytic Lymphoma	April 15, 2022	Phase 2
NCT04893915	Washington University School of Medicine\|Wugen, Inc.	Relapsed Acute Myeloid Leukemia\|Refractory Acute Myeloid Leukemia\|Myelodysplastic Syndromes	June 30, 2022	Phase 2
NCT03287674	Inge Marie Svane\|Herlev Hospital	Metastatic Ovarian Cancer	October 9, 2017	Phase 1\|Phase 2
NCT02400281	Arog Pharmaceuticals, Inc.	Acute Myeloid Leukemia	September 2015	Phase 1\|Phase 2
NCT00303836	National Cancer Institute (NCI)	Recurrent Melanoma\|Stage IV Melanoma	November 2005	Phase 2
NCT02070406	Jonsson Comprehensive Cancer Center\|National Cancer Institute (NCI)	Unspecified Adult Solid Tumor, Protocol Specific	July 17, 2014	Phase 1
NCT01247701	Baylor College of Medicine\|Center for Cell and Gene Therapy, Baylor College of Medicine	Myeloid Hematological Malignancies	November 2010	Not Applicable
NCT03318861	Kite, A Gilead Company\|Gilead Sciences	Relapsed+Refractory Multiple Myeloma	October 20, 2017	Phase 1
NCT00577993	M.D. Anderson Cancer Center\|Genentech, Inc.	Lymphoma	March 16, 1998	Phase 3
NCT04674813	Juno Therapeutics, a Subsidiary of Celgene	Multiple Myeloma	February 24, 2021	Phase 1
NCT00040651	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)\|University of Pittsburgh\|Amgen\|Genzyme, a Sanofi Company	Scleroderma\|Systemic Sclerosis	July 2002	Phase 1
NCT00303667	Masonic Cancer Center, University of Minnesota	Acute Myelogenous Leukemia	January 2005	Phase 1\|Phase 2
NCT01850108	Vanderbilt-Ingram Cancer Center	Sickle Cell Disease\|Hemoglobinopathies	May 2013	Not Applicable
NCT00923364	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	MDS\|Immunodeficiency\|GATA2	May 7, 2009	Phase 2
NCT03344705	Beijing Immunochina Medical Science & Technology Co., Ltd.	Hematological Malignancies	August 21, 2017	Phase 1
NCT02861417	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Hematopoietic and Lymphoid Cell Neoplasm\|High Risk Acute Myeloid Leukemia\|High Risk Myelodysplastic Syndrome\|Lymphoproliferative Disorder\|Myelodysplastic Syndrome\|Myelodysplastic+Myeloproliferative Neoplasm\|Recurrent Acute Lymphoblastic Leukemia\|Recurrent Acute Myeloid Leukemia\|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Recurrent High Risk Myelodysplastic Syndrome\|Recurrent Hodgkin Lymphoma\|Recurrent Myelodysplastic Syndrome\|Recurrent Non-Hodgkin Lymphoma\|Recurrent Plasma Cell Myeloma	August 5, 2016	Phase 2
NCT04395222	Weill Medical College of Cornell University	Hematologic Malignancy\|Bone Marrow Transplant	October 7, 2020	Phase 2
NCT00376480	Dana-Farber Cancer Institute\|National Cancer Institute (NCI)\|National Institute of Allergy and Infectious Diseases (NIAID)	Leukemia\|Myelodysplastic Syndromes	June 2005	Phase 1
NCT02431988	University College, London	Diffuse Large B-Cell Lymphoma	June 2016	Phase 1
NCT00075478	Fred Hutchinson Cancer Center\|National Heart, Lung, and Blood Institute (NHLBI)\|National Cancer Institute (NCI)	Acute Lymphoblastic Leukemia in Remission\|Acute Myeloid Leukemia in Remission\|Aggressive Non-Hodgkin Lymphoma\|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Diffuse Large B-Cell Lymphoma\|Hematopoietic and Lymphoid Cell Neoplasm\|Indolent Non-Hodgkin Lymphoma\|Mantle Cell Lymphoma\|Myelodysplastic+Myeloproliferative Neoplasm\|Plasma Cell Myeloma\|Refractory Chronic Lymphocytic Leukemia\|Refractory Hodgkin Lymphoma\|Waldenstrom Macroglobulinemia	October 2003	Phase 3
NCT00807196	Maisonneuve-Rosemont Hospital\|Bayer	Non-Hodgkins Lymphoma	September 2008	Phase 1\|Phase 2
NCT04196491	Celgene	Multiple Myeloma	May 27, 2020	Phase 1
NCT01366612	Hackensack Meridian Health	Myeloid Malignancies\|Acute Myelogenous Leukemia\|Chronic Myelogenous Leukemia\|Myeloproliferative Disorders\|Myelodysplastic Syndrome	June 16, 2010	Phase 3
NCT00006100	Milton S. Hershey Medical Center\|National Cancer Institute (NCI)	Lymphoma	April 2000	Phase 1
NCT05534620	medac GmbH\|Synteract, Inc.	Acute Myeloid Leukaemia (AML)\|Myelodysplastic Syndrome (MDS)\|Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)	October 2022	Phase 1
NCT01423032	WiSP Wissenschaftlicher Service Pharma GmbH\|Klinikum Leverkusen gGmbH\|ribosepharm GmbH\|Mundipharma Research GmbH & Co KG	Chronic Lymphocytic Leukemia	September 2001	Phase 2\|Phase 3
NCT02642965	Children´s Oncology Group\|National Cancer Institute (NCI)	Recurrent Childhood Acute Myeloid Leukemia\|Secondary Acute Myeloid Leukemia\|Therapy-Related Acute Myeloid Leukemia	April 25, 2016	Phase 1\|Phase 2
NCT01105650	Masonic Cancer Center, University of Minnesota	Ovarian Cancer\|Fallopian Tube Cancer\|Primary Peritoneal Cancer\|Breast Cancer	July 2010	Phase 2
NCT04268706	Tessa Therapeutics	Hodgkin Lymphoma, Adult\|Hodgkin Disease Recurrent\|Hodgkin Disease Refractory\|Hodgkin Disease, Pediatric	February 1, 2021	Phase 2
NCT03277729	Fred Hutchinson Cancer Center\|Mustang Bio	Recurrent B-Cell Non-Hodgkin Lymphoma\|Recurrent Chronic Lymphocytic Leukemia\|Recurrent Diffuse Large B-Cell Lymphoma\|Recurrent Follicular Lymphoma\|Recurrent Lymphoplasmacytic Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Marginal Zone Lymphoma\|Refractory B-Cell Non-Hodgkin Lymphoma\|Refractory Diffuse Large B-Cell Lymphoma\|Refractory Follicular Lymphoma\|Refractory Lymphoplasmacytic Lymphoma\|Refractory Mantle Cell Lymphoma\|Refractory Transformed Non-Hodgkin Lymphoma\|Recurrent Transformed B-Cell Non-Hodgkin Lymphoma\|Recurrent Transformed Chronic Lymphocytic Leukemia\|Refractory Marginal Zone Lymphoma\|Refractory Transformed B-Cell Non-Hodgkin Lymphoma\|Refractory Transformed Chronic Lymphocytic Leukemia\|Recurrent Small Lymphocytic Lymphoma\|Refractory Chronic Lymphocytic Leukemia\|Refractory Small Lymphocytic Lymphoma	December 5, 2017	Phase 1\|Phase 2
NCT03622788	M.D. Anderson Cancer Center	Acute Lymphoblastic Leukemia\|Acute Myeloid Leukemia\|Aplastic Anemia\|Bone Marrow Failure\|Chronic Lymphocytic Leukemia\|Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Follicular Lymphoma\|Hodgkin Lymphoma\|Mantle Cell Lymphoma\|Myelodysplastic Syndrome\|Myeloproliferative Neoplasm\|Non-Hodgkin Lymphoma\|Plasma Cell Myeloma	August 8, 2019	Phase 1\|Phase 2
NCT01044745	University of Nebraska\|National Cancer Institute (NCI)	Accelerated Phase Chronic Myelogenous Leukemia\|Adult Acute Lymphoblastic Leukemia in Remission\|Adult Acute Myeloid Leukemia in Remission\|Adult Nasal Type Extranodal NK+T-cell Lymphoma\|Blastic Phase Chronic Myelogenous Leukemia\|Contiguous Stage II Adult Burkitt Lymphoma\|Contiguous Stage II Adult Diffuse Large Cell Lymphoma\|Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma\|Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma\|Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma\|Contiguous Stage II Adult Lymphoblastic Lymphoma\|Contiguous Stage II Grade 1 Follicular Lymphoma\|Contiguous Stage II Grade 2 Follicular Lymphoma\|Contiguous Stage II Grade 3 Follicular Lymphoma\|Contiguous Stage II Mantle Cell Lymphoma\|Contiguous Stage II Marginal Zone Lymphoma\|Contiguous Stage II Small Lymphocytic Lymphoma\|de Novo Myelodysplastic Syndromes\|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue\|Graft Versus Host Disease\|Nodal Marginal Zone B-cell Lymphoma\|Noncontiguous Stage II Adult Burkitt Lymphoma\|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma\|Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma\|Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma\|Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma\|Noncontiguous Stage II Adult Lymphoblastic Lymphoma\|Noncontiguous Stage II Grade 1 Follicular Lymphoma\|Noncontiguous Stage II Grade 2 Follicular Lymphoma\|Noncontiguous Stage II Grade 3 Follicular Lymphoma\|Noncontiguous Stage II Mantle Cell Lymphoma\|Noncontiguous Stage II Marginal Zone Lymphoma\|Noncontiguous Stage II Small Lymphocytic Lymphoma\|Previously Treated Myelodysplastic Syndromes\|Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Adult Burkitt Lymphoma\|Recurrent Adult Diffuse Large Cell Lymphoma\|Recurrent Adult Diffuse Mixed Cell Lymphoma\|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma\|Recurrent Adult Grade III Lymphomatoid Granulomatosis\|Recurrent Adult Immunoblastic Large Cell Lymphoma\|Recurrent Adult Lymphoblastic Lymphoma\|Recurrent Adult T-cell Leukemia+Lymphoma\|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma\|Recurrent Grade 1 Follicular Lymphoma\|Recurrent Grade 2 Follicular Lymphoma\|Recurrent Grade 3 Follicular Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Marginal Zone Lymphoma\|Recurrent Mycosis Fungoides+Sezary Syndrome\|Recurrent Small Lymphocytic Lymphoma\|Refractory Chronic Lymphocytic Leukemia\|Relapsing Chronic Myelogenous Leukemia\|Secondary Myelodysplastic Syndromes\|Splenic Marginal Zone Lymphoma\|Stage I Adult Burkitt Lymphoma\|Stage I Adult Diffuse Large Cell Lymphoma\|Stage I Adult Diffuse Mixed Cell Lymphoma\|Stage I Adult Diffuse Small Cleaved Cell Lymphoma\|Stage I Adult Immunoblastic Large Cell Lymphoma\|Stage I Adult Lymphoblastic Lymphoma\|Stage I Adult T-cell Leukemia+Lymphoma\|Stage I Chronic Lymphocytic Leukemia\|Stage I Cutaneous T-cell Non-Hodgkin Lymphoma\|Stage I Grade 1 Follicular Lymphoma\|Stage I Grade 2 Follicular Lymphoma\|Stage I Grade 3 Follicular Lymphoma\|Stage I Mantle Cell Lymphoma\|Stage I Marginal Zone Lymphoma\|Stage I Mycosis Fungoides+Sezary Syndrome\|Stage I Small Lymphocytic Lymphoma\|Stage II Adult T-cell Leukemia+Lymphoma\|Stage II Chronic Lymphocytic Leukemia\|Stage II Cutaneous T-cell Non-Hodgkin Lymphoma\|Stage II Mycosis Fungoides+Sezary Syndrome\|Stage III Adult Burkitt Lymphoma\|Stage III Adult Diffuse Large Cell Lymphoma\|Stage III Adult Diffuse Mixed Cell Lymphoma\|Stage III Adult Diffuse Small Cleaved Cell Lymphoma\|Stage III Adult Immunoblastic Large Cell Lymphoma\|Stage III Adult Lymphoblastic Lymphoma\|Stage III Adult T-cell Leukemia+Lymphoma\|Stage III Chronic Lymphocytic Leukemia\|Stage III Cutaneous T-cell Non-Hodgkin Lymphoma\|Stage III Grade 1 Follicular Lymphoma\|Stage III Grade 2 Follicular Lymphoma\|Stage III Grade 3 Follicular Lymphoma\|Stage III Mantle Cell Lymphoma\|Stage III Marginal Zone Lymphoma\|Stage III Mycosis Fungoides+Sezary Syndrome\|Stage III Small Lymphocytic Lymphoma\|Stage IV Adult Burkitt Lymphoma\|Stage IV Adult Diffuse Large Cell Lymphoma\|Stage IV Adult Diffuse Mixed Cell Lymphoma\|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma\|Stage IV Adult Immunoblastic Large Cell Lymphoma\|Stage IV Adult Lymphoblastic Lymphoma\|Stage IV Adult T-cell Leukemia+Lymphoma\|Stage IV Chronic Lymphocytic Leukemia\|Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma\|Stage IV Grade 1 Follicular Lymphoma\|Stage IV Grade 2 Follicular Lymphoma\|Stage IV Grade 3 Follicular Lymphoma\|Stage IV Mantle Cell Lymphoma\|Stage IV Marginal Zone Lymphoma\|Stage IV Mycosis Fungoides+Sezary Syndrome\|Stage IV Small Lymphocytic Lymphoma\|Untreated Adult Acute Lymphoblastic Leukemia\|Untreated Adult Acute Myeloid Leukemia\|Waldenström Macroglobulinemia	December 2009	Phase 2
NCT00028730	Memorial Sloan Kettering Cancer Center\|National Cancer Institute (NCI)	Leukemia\|Lymphoma\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Neoplasms	August 2001	Phase 2
NCT01028716	Fred Hutchinson Cancer Center	Acute Biphenotypic Leukemia\|Acute Erythroid Leukemia in Remission\|Acute Leukemia in Remission\|Acute Lymphoblastic Leukemia in Remission\|Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome\|Acute Myeloid Leukemia in Remission\|Acute Myeloid Leukemia With FLT3+ITD Mutation\|Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM\|Acute Myeloid Leukemia With Multilineage Dysplasia\|Acute Myeloid Leukemia With t(6;9) (p23;q34.1); DEK-NUP214\|Acute Undifferentiated Leukemia\|Adult Acute Lymphoblastic Leukemia in Complete Remission\|B Acute Lymphoblastic Leukemia With t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)\|B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1\|Burkitt Lymphoma\|Childhood Acute Lymphoblastic Leukemia in Complete Remission\|DS Stage II Plasma Cell Myeloma\|DS Stage III Plasma Cell Myeloma\|Myelodysplastic Syndrome\|Recurrent Anaplastic Large Cell Lymphoma\|Blasts Under 5 Percent of Bone Marrow Nucleated Cells\|Recurrent Follicular Lymphoma\|Recurrent Hodgkin Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Marginal Zone Lymphoma\|Recurrent Plasma Cell Myeloma\|Refractory Plasma Cell Myeloma\|Secondary Acute Myeloid Leukemia\|T Lymphoblastic Lymphoma\|Hematopoietic Cell Transplant Recipient	February 8, 2010	Phase 2
NCT01349101	Sidney Kimmel Cancer Center at Thomas Jefferson University\|Thomas Jefferson University	Hematological Malignancies	February 10, 2011	Phase 2
NCT02159495	City of Hope Medical Center\|National Cancer Institute (NCI)\|Mustang Bio, Inc.	Adult Acute Myeloid Leukemia in Remission\|Acute Biphenotypic Leukemia\|Early Relapse of Acute Myeloid Leukemia\|Late Relapse of Acute Myeloid Leukemia\|Recurrent Adult Acute Myeloid Leukemia\|Secondary Acute Myeloid Leukemia\|Blastic Plasmacytoid Dendritic Cell Neoplasm\|Acute Myeloid Leukemia\|Adult Acute Lymphoblastic Leukemia\|Interleukin-3 Receptor Subunit Alpha Positive\|Minimal Residual Disease\|Refractory Acute Myeloid Leukemia\|Untreated Adult Acute Myeloid Leukemia	December 15, 2015	Phase 1
NCT00579111	Baylor College of Medicine\|Center for Cell and Gene Therapy, Baylor College of Medicine\|The Methodist Hospital Research Institute	Myelodysplastic and Myeloproliferative Disorders\|Acute Myelogenous Leukemia\|Acute Lymphoblastic Leukemia\|Chronic Myelogenous Leukemia\|Multiple Myeloma\|Plasma Cell Dyscrasia\|Lymphoproliferative Disorders\|Hematologic Diseases	June 2007	Phase 1\|Phase 2
NCT04714372	Masonic Cancer Center, University of Minnesota	Acute Myeloid Leukemia\|Myeloid Leukemia\|Monocytic Leukemia	November 3, 2021	Phase 1
NCT03849651	St. Jude Children´s Research Hospital	Acute Lymphoblastic Leukemia (ALL)\|Acute Myeloid Leukemia (AML)\|Myelodysplastic Syndromes (MDS)\|NK-Cell Leukemia\|Hodgkin Lymphoma\|Non Hodgkin Lymphoma (NHL)\|Juvenile Myelomonocytic Leukemia (JMML)\|Chronic Myeloid Leukemia (CML)	January 31, 2019	Phase 2
NCT00525603	M.D. Anderson Cancer Center\|Bayer	Leukemia\|Chronic Lymphocytic Leukemia	June 2005	Phase 2
NCT03602898	Fred Hutchinson Cancer Center	Acute Lymphoblastic Leukemia in Remission\|Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome\|Chronic Myelomonocytic Leukemia\|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Hematopoietic and Lymphoid System Neoplasm\|Myelodysplastic Syndrome\|Myelofibrosis\|Myeloproliferative Neoplasm\|Recurrent Acute Myeloid Leukemia\|Recurrent Hodgkin Lymphoma\|Recurrent Non-Hodgkin Lymphoma\|Refractory Acute Myeloid Leukemia\|Therapy-Related Acute Myeloid Leukemia	June 1, 2021	Phase 2
NCT01572181	Nantes University Hospital	Hematologic Malignancy	April 2012	Phase 2
NCT04074746	M.D. Anderson Cancer Center	Recurrent Anaplastic Large Cell Lymphoma\|Recurrent B-Cell Non-Hodgkin Lymphoma\|Recurrent Classic Hodgkin Lymphoma\|Recurrent Mycosis Fungoides\|Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified\|Refractory Anaplastic Large Cell Lymphoma\|Refractory B-Cell Non-Hodgkin Lymphoma\|Refractory Classic Hodgkin Lymphoma\|Refractory Mycosis Fungoides\|Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified	July 18, 2020	Phase 1\|Phase 2
NCT00860574	Fred Hutchinson Cancer Center\|National Heart, Lung, and Blood Institute (NHLBI)\|National Cancer Institute (NCI)	Accelerated Phase Chronic Myelogenous Leukemia\|Adult Acute Lymphoblastic Leukemia in Remission\|Adult Acute Myeloid Leukemia in Remission\|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities\|Adult Acute Myeloid Leukemia With Del(5q)\|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)\|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)\|Blastic Phase Chronic Myelogenous Leukemia\|Childhood Acute Lymphoblastic Leukemia in Remission\|Childhood Acute Myeloid Leukemia in Remission\|Childhood Chronic Myelogenous Leukemia\|Childhood Myelodysplastic Syndromes\|Chronic Myelomonocytic Leukemia\|de Novo Myelodysplastic Syndromes\|Previously Treated Myelodysplastic Syndromes\|Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Childhood Acute Lymphoblastic Leukemia\|Recurrent Childhood Acute Myeloid Leukemia\|Secondary Myelodysplastic Syndromes\|Untreated Adult Acute Lymphoblastic Leukemia\|Untreated Childhood Acute Lymphoblastic Leukemia	February 2009	Phase 2
NCT05225363	City of Hope Medical Center\|National Cancer Institute (NCI)	Platinum-Resistant Ovarian Carcinoma	May 5, 2022	Phase 1
NCT02905188	Baylor College of Medicine\|Center for Cell and Gene Therapy, Baylor College of Medicine\|The Methodist Hospital Research Institute\|Cancer Prevention Research Institute of Texas	Hepatocellular Carcinoma	March 28, 2019	Phase 1
NCT00066417	National Heart, Lung, and Blood Institute (NHLBI)\|National Cancer Institute (NCI)	Chronic Myeloproliferative Disorders\|Leukemia\|Myelodysplastic+Myeloproliferative Diseases		Phase 2
NCT02845596	Michael Pulsipher, MD\|Children´s Hospital Los Angeles	Severe Aplastic Anemia	August 2016	Not Applicable
NCT04319757	Acepodia Biotech, Inc.	Locally Advanced Solid Tumor\|Metastatic Cancer\|Solid Tumor\|HER2-positive Gastric Cancer\|HER2-positive Metastatic Breast Cancer	May 19, 2020	Phase 1
NCT05576181	Fundamenta Therapeutics, Ltd.\|The First Affiliated Hospital of Zhengzhou University	Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited	October 15, 2022	Phase 1
NCT05359211	Fred Hutchinson Cancer Center\|Nektar Therapeutics	Recurrent Diffuse Large B-Cell Lymphoma\|Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified\|Recurrent Grade 3b Follicular Lymphoma\|Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma\|Refractory Diffuse Large B-Cell Lymphoma\|Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified\|Refractory Grade 3b Follicular Lymphoma\|Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma\|Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma	November 18, 2022	Phase 1
NCT02844062	Beijing Sanbo Brain Hospital\|Marino Biotechnology Co., Ltd.	Glioblastoma Multiforme	July 2016	Phase 1
NCT05323201	The Affiliated Hospital of Xuzhou Medical University\|Xuzhou Medical University\|IIT MediTech Co. Ltd	Hepatocellular Carcinoma	February 10, 2022	Phase 1\|Phase 2
NCT01490723	M.D. Anderson Cancer Center\|Spectrum Pharmaceuticals, Inc	Leukemia\|Lymphoma	January 2013	Phase 2
NCT01861002	Therapeutic Advances in Childhood Leukemia Consortium\|Gateway for Cancer Research	Lymphoblastic Leukemia, Acute, Childhood\|Myelogenous Leukemia, Acute, Childhood	May 22, 2013	Phase 1
NCT01187017	National Heart, Lung, and Blood Institute (NHLBI)\|National Institutes of Health Clinical Center (CC)	Aplastic Anemia\|Neutropenia\|Pancytopenia\|Severe Aplastic Anemia	August 2010	Phase 1\|Phase 2
NCT05417971	Northside Hospital, Inc.	Hematologic Malignancy	August 29, 2022
NCT00789776	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)\|The Wayne D. Kuni and Joan E. Kuni Foundation	Acute Lymphoblastic Leukemia\|Acute Myeloid Leukemia\|Aggressive Non-Hodgkin Lymphoma\|Diffuse Large B-Cell Lymphoma\|Previously Treated Myelodysplastic Syndrome\|Recurrent Chronic Lymphocytic Leukemia\|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Recurrent Indolent Adult Non-Hodgkin Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Plasma Cell Myeloma\|Recurrent Small Lymphocytic Lymphoma\|Refractory Chronic Lymphocytic Leukemia\|Refractory Hodgkin Lymphoma\|Refractory Plasma Cell Myeloma\|Refractory Small Lymphocytic Lymphoma\|Waldenstrom Macroglobulinemia	October 13, 2008	Phase 1\|Phase 2
NCT01596699	University of California, San Francisco	Myeloid Malignancy\|Bone Marrow Failure Syndrome\|Transfusion-dependent Red Blood Cell (RBC) Defect\|Congenital Immunodeficiency\|Metabolic Disease\|Severe Immune Dysregulation	May 24, 2012	Phase 2
NCT04994808	Fred Hutchinson Cancer Center\|Medexus Pharma, Inc.	Acute Myeloid Leukemia\|Chronic Myelomonocytic Leukemia\|Myelodysplastic Syndrome	November 30, 2022	Phase 2
NCT02718755	M.D. Anderson Cancer Center\|Jazz Pharmaceuticals	Hematologic Malignancy	May 2018	Phase 2
NCT02582775	Masonic Cancer Center, University of Minnesota	Epidermolysis Bullosa	March 2016	Phase 2
NCT01454596	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Malignant Glioma\|Glioblastoma\|Brain Cancer\|Gliosarcoma	May 16, 2012	Phase 1\|Phase 2
NCT00006250	Lymphoma Trials Office\|National Cancer Institute (NCI)	Lymphoma	May 2000	Phase 3
NCT00025519	Fox Chase Cancer Center\|National Cancer Institute (NCI)	Kidney Cancer	June 2001	Phase 2
NCT00338377	M.D. Anderson Cancer Center\|Prometheus Laboratories\|Key Biologics, LLC\|National Cancer Institute (NCI)\|Adelson Medical Research	Melanoma	February 1, 2006	Phase 2
NCT01904136	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome\|Acute Myeloid Leukemia With Gene Mutations\|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|de Novo Myelodysplastic Syndrome\|Myelodysplastic Syndrome\|Recurrent Acute Myeloid Leukemia\|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Therapy-Related Acute Myeloid Leukemia	April 22, 2014	Phase 1\|Phase 2
NCT02328950	Fujian Medical University	Myelodysplastic Syndromes\|Leukemia, Myeloid, Acute\|Precursor Cell Lymphoblastic Leukemia-Lymphoma	December 2014
NCT01369875	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Metastatic Melanoma\|Skin Cancer	June 17, 2011	Phase 2
NCT00040417	Baylor College of Medicine\|The Methodist Hospital Research Institute	Sickle Cell Anemia\|Hemoglobinopathy\|Thalassemia	August 2000	Phase 2
NCT02685670	The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine\|Xinqiao Hospital of Chongqing\|Xuzhou Medical University	Hematopoietic+Lymphoid Cancer\|Adult Acute Lymphoblastic Leukemia in Remission\|B-cell Adult Acute Lymphoblastic Leukemia\|B-cell Chronic Lymphocytic Leukemia\|Recurrent Adult Diffuse Large Cell Lymphoma\|Recurrent Grade 1 Follicular Lymphoma\|Recurrent Grade 2 Follicular Lymphoma\|Recurrent Grade 3 Follicular Lymphoma\|Recurrent Mantle Cell Lymphoma\|Refractory Chronic Lymphocytic Leukemia\|Stage III Adult Diffuse Large Cell Lymphoma\|Stage III Chronic Lymphocytic Leukemia\|Stage III Grade 1 Follicular Lymphoma\|Stage III Grade 2 Follicular Lymphoma\|Stage III Grade 3 Follicular Lymphoma\|Stage III Mantle Cell Lymphoma\|Stage IV Adult Diffuse Large Cell Lymphoma\|Stage IV Chronic Lymphocytic Leukemia\|Stage IV Grade 1 Follicular Lymphoma\|Stage IV Grade 2 Follicular Lymphoma\|Stage IV Grade 3 Follicular Lymphoma\|Stage IV Mantle Cell Lymphoma	February 2016	Phase 1\|Phase 2
NCT00487448	PETHEMA Foundation	Myelodysplastic Syndrome\|Acute Myeloblastic Leukemia	July 1998	Phase 4
NCT03263208	Henan Cancer Hospital\|The Pregene (ShenZhen) Biotechnology Company, Ltd.	B-cell Acute Lymphocytic Leukemia	August 16, 2017	Phase 1\|Phase 2
NCT00488709	PETHEMA Foundation	Acute Myeloid Leukemia	May 2003	Phase 4
NCT02766465	Medical College of Wisconsin\|National Heart, Lung, and Blood Institute (NHLBI)\|Blood and Marrow Transplant Clinical Trials Network\|Dana-Farber Cancer Institute\|National Marrow Donor Program\|Emory University	Sickle Cell Disease	November 2016	Phase 2
NCT01583686	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Cervical Cancer\|Pancreatic Cancer\|Ovarian Cancer\|Mesothelioma\|Lung Cancer	May 4, 2012	Phase 1\|Phase 2
NCT05020444	Marcela V. Maus, M.D.,Ph.D.\|Massachusetts General Hospital	Multiple Myeloma\|Multiple Myeloma in Relapse\|Refractory Multiple Myeloma	October 5, 2021	Phase 1
NCT01144403	Hoffmann-La Roche	Diffuse Large B-Cell Lymphoma	June 2010	Phase 2
NCT01175785	Nohla Therapeutics, Inc.\|National Heart, Lung, and Blood Institute (NHLBI)\|National Cancer Institute (NCI)\|Fred Hutchinson Cancer Center	Accelerated Phase Chronic Myelogenous Leukemia\|Adult Acute Myeloid Leukemia in Remission\|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities\|Adult Acute Myeloid Leukemia With Del(5q)\|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)\|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)\|Childhood Acute Lymphoblastic Leukemia in Remission\|Childhood Acute Myeloid Leukemia in Remission\|Childhood Chronic Myelogenous Leukemia\|Childhood Myelodysplastic Syndromes\|Chronic Phase Chronic Myelogenous Leukemia\|de Novo Myelodysplastic Syndromes\|Previously Treated Myelodysplastic Syndromes\|Refractory Anemia\|Refractory Anemia With Excess Blasts\|Refractory Anemia With Excess Blasts in Transformation\|Relapsing Chronic Myelogenous Leukemia\|Secondary Myelodysplastic Syndromes	August 2010	Phase 2
NCT00199147	Johann Wolfgang Goethe University Hospital	Acute Myeloid Leukemia	January 2000	Phase 4
NCT03502577	Fred Hutchinson Cancer Center\|Juno Therapeutics, Inc.\|The Leukemia and Lymphoma Society	Recurrent Plasma Cell Myeloma\|Refractory Plasma Cell Myeloma	May 23, 2018	Phase 1
NCT01300572	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Chronic Myelomonocytic Leukemia\|Previously Treated Myelodysplastic Syndrome\|Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent Adult Acute Myeloid Leukemia\|Refractory Anemia With Excess Blasts\|Secondary Acute Myeloid Leukemia	January 2012	Phase 1
NCT01659606	Boston Children´s Hospital\|Dana-Farber Cancer Institute\|Children´s Hospital Medical Center, Cincinnati\|Children´s Hospital Los Angeles\|Fred Hutchinson Cancer Research Center+University of Washington Cancer Consortium\|Baylor College of Medicine\|Children´s Hospital of Philadelphia\|University of Wisconsin, Madison\|Karolinska University Hospital\|Hackensack Meridian Health\|Duke University\|Oslo University Hospital\|Children´s Mercy Hospital Kansas City\|Mayo Clinic\|University of Chicago\|Massachusetts General Hospital	Dyskeratosis Congenita\|Hoyeraal Hreidarsson Syndrome\|Revesz Syndrome\|Aplastic Anemia	July 2012	Phase 2
NCT00053196	Alliance for Clinical Trials in Oncology\|National Cancer Institute (NCI)	Leukemia\|Lymphoma\|Multiple Myeloma\|Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Myeloproliferative Neoplasms	December 2002	Phase 2
NCT00924287	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Metastatic Cancer	November 2008	Phase 1\|Phase 2
NCT00301912	University of California, San Francisco\|National Cancer Institute (NCI)	Anemia\|Chronic Myeloproliferative Disorders\|Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Diseases	January 2002	Phase 2
NCT03531736	Memorial Sloan Kettering Cancer Center	Myeloid Diseases	May 9, 2018	Phase 1
NCT00051311	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Hematologic Neoplasms	January 3, 2003	Phase 2
NCT03171831	First Affiliated Hospital of Guangxi Medical University	Thalassemia Major	April 1, 2017	Phase 4
NCT02161783	Masonic Cancer Center, University of Minnesota	Primary Graft Failure\|Secondary Graft Failure	October 2014
NCT00812669	Cancer Trials Ireland	Leukemia	August 2008	Phase 2
NCT04029038	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	CD19 Positive\|CD22 Positive\|Minimal Residual Disease\|Progressive Disease\|Recurrent B Acute Lymphoblastic Leukemia\|Recurrent Chronic Lymphocytic Leukemia\|Recurrent Non-Hodgkin Lymphoma\|Refractory B Acute Lymphoblastic Leukemia\|Refractory Chronic Lymphocytic Leukemia\|Refractory Non-Hodgkin Lymphoma	November 30, 2022	Phase 1\|Phase 2
NCT00850499	Millennium Pharmaceuticals, Inc.\|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Follicular Lymphoma	September 2009	Phase 2
NCT03380039	Xinhua Hospital, Shanghai Jiao Tong University School of Medicine\|CARsgen Therapeutics Co., Ltd.	Refractory or Relapsed Multiple Myeloma	October 13, 2017	Not Applicable
NCT00004194	Jonsson Comprehensive Cancer Center\|National Cancer Institute (NCI)	Graft Versus Host Disease		Phase 1\|Phase 2
NCT02379195	Inge Marie Svane\|Herlev Hospital	Metastatic Melanoma	November 2014	Phase 1\|Phase 2
NCT03743246	Celgene	Precursor Cell Lymphoblastic Leukemia-Lymphoma\|Lymphoma, Non-Hodgkin	October 17, 2018	Phase 1\|Phase 2
NCT02259348	St. Jude Children´s Research Hospital	Acute Lymphoblastic Leukemia (ALL)\|Acute Myeloid Leukemia (AML)\|Myeloid Sarcoma\|Chronic Myelogenous Leukemia (CML)\|Juvenile Myelomonocytic Leukemia (JMML)\|Myelodysplastic Syndrome (MDS)\|Non-Hodgkin Lymphoma (NHL)	October 2014	Phase 2
NCT04250051	Northwestern University\|Agios Pharmaceuticals\|National Cancer Institute (NCI)	Recurrent Acute Myeloid Leukemia\|Recurrent Myelodysplastic Syndrome\|Recurrent Myeloproliferative Neoplasm\|Refractory Acute Myeloid Leukemia\|Refractory Myelodysplastic Syndrome	March 28, 2021	Phase 1
NCT00691015	Barbara Ann Karmanos Cancer Institute\|National Cancer Institute (NCI)	Chronic Myeloproliferative Disorders\|Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Neoplasms	May 2008	Phase 2
NCT05569512	John Horan, MD\|GlycoMimetics Incorporated\|Dana-Farber Cancer Institute	Acute Myeloid Leukemia\|Pediatric Cancer	October 6, 2022	Phase 1\|Phase 2
NCT01283386	Hoffmann-La Roche	Lymphocytic Leukemia, Chronic	April 27, 2011	Phase 4
NCT00027924	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Leukemia\|Myelodysplastic Syndromes	October 2001	Phase 2
NCT03821987	Peking University People´s Hospital	Aplastic Anemia\|Stem Cell Transplant Complications\|Engraft Failure	December 17, 2018	Not Applicable
NCT03642626	Masonic Cancer Center, University of Minnesota	Acute Lymphoblastic Leukemia\|Large B-cell Lymphoma	December 18, 2018
NCT03967223	GlaxoSmithKline	Neoplasms	December 31, 2019	Phase 2
NCT00169208	Lymphoma Study Association	Follicular Lymphoma	April 2001	Phase 2
NCT03384225	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine\|Changhai Hospital\|Xiangya Hospital of Central South University\|Tongji Hospital\|Wuhan Union Hospital, China\|Chengdu PLA General Hospital\|Tang-Du Hospital\|Fujian Medical University Union Hospital	High Risk Acute Myeloid Leukemia\|Allogeneic Hematopoeitic Stem Cell Transplantation	August 1, 2016	Phase 3
NCT05600426	Boston Children´s Hospital\|Center for International Blood and Marrow Transplant Research\|National Institutes of Health (NIH)\|National Heart, Lung, and Blood Institute (NHLBI)\|North American Pediatric Aplastic Anemia Consortium\|Pediatric Transplantation and Cellular Therapy Consortium\|Blood and Marrow Transplant Clinical Trials Network	Severe Aplastic Anemia	December 2022	Phase 3
NCT00536978	M.D. Anderson Cancer Center	Lymphoma\|Leukemia	September 2007	Phase 2
NCT00003729	European Organisation for Research and Treatment of Cancer - EORTC	Leukemia	December 1998	Phase 2
NCT00800150	City of Hope Medical Center\|National Cancer Institute (NCI)	Chronic Myeloproliferative Disorders\|Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Neoplasms	November 2008	Phase 1
NCT00005898	University of Minnesota\|Office of Rare Diseases (ORD)	Fanconi´s Anemia	February 2000	Phase 1\|Phase 2
NCT00506857	M.D. Anderson Cancer Center	Hematologic Malignancies	November 2003	Phase 1\|Phase 2
NCT04052334	H. Lee Moffitt Cancer Center and Research Institute\|Iovance Biotherapeutics, Inc.\|The V Foundation for Cancer Research\|National Cancer Institute (NCI)	Sarcoma	September 27, 2019	Phase 1
NCT01472055	Seoul National University Hospital\|Ministry of Food and Drug Safety, Korea	Acute Leukemia\|Chronic Leukemia\|Severe Aplastic Anemia	October 2011	Phase 2
NCT04614636	Fate Therapeutics	Acute Myeloid Leukemia\|AML, Adult\|Multiple Myeloma\|Myeloma	October 17, 2020	Phase 1
NCT05395052	Fate Therapeutics	Non Small Cell Lung Cancer\|Colorectal Cancer\|Breast Cancer\|Ovarian Cancer\|Pancreatic Cancer\|Head and Neck Cancer\|GastroEsophageal Cancer	May 31, 2022	Phase 1
NCT00827099	Northside Hospital, Inc.	Myeloproliferative Disorders\|Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes	June 2006	Phase 2
NCT04146298	Changhai Hospital	Pancreatic Cancer\|Pancreatic Neoplasms\|Pancreatic Ductal Adenocarcinoma\|Advanced Cancer	October 21, 2021	Phase 1\|Phase 2
NCT00055653	Roswell Park Cancer Institute\|National Heart, Lung, and Blood Institute (NHLBI)	Leukemia\|Lymphoma\|Myelodysplastic Syndromes\|Myelodysplastic-Myeloproliferative Diseases	January 2003	Phase 2
NCT01572662	M.D. Anderson Cancer Center	Leukemia\|Acute Myeloid Leukemia\|Acute Lymphocytic Leukemia\|Chronic Myeloid Leukemia\|Chronic Lymphocytic Leukemia\|Myeloproliferative Diseases\|Non-Hodgkins Lymphoma\|Hodgkins Lymphoma\|Multiple Myeloma\|Myelodysplastic Syndrome	April 11, 2012	Phase 2
NCT00880815	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	CD20 Positive\|Chronic Lymphocytic Leukemia\|Follicular Lymphoma\|Mantle Cell Lymphoma\|Marginal Zone Lymphoma\|Recurrent Diffuse Large B-Cell Lymphoma\|T-Cell Non-Hodgkin Lymphoma	February 17, 2009	Phase 1
NCT02158091	Dana-Farber Cancer Institute\|Secura Bio, Inc.	Chronic Lymphocytic Leukemia	June 27, 2014	Phase 1\|Phase 2
NCT00296023	University of California, San Francisco\|National Cancer Institute (NCI)	Chronic Myeloproliferative Disorders\|Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes	January 1999	Not Applicable
NCT01946373	Karolinska University Hospital	Melanoma	October 2013	Phase 1
NCT02867800	Monica Bhatia\|Columbia University	Sickle Cell Disease\|Graft Versus Host Disease	July 2016	Phase 1
NCT04473911	Zachariah Michael DeFilipp\|Regimmune Corporation\|Massachusetts General Hospital	GVHD\|AML\|ALL\|MDS\|MPN\|CMML\|Hodgkin Lymphoma\|Non Hodgkin Lymphoma\|Blood Stem Cell Transplant Failure\|Graft Vs Host Disease\|Acute Myeloid Leukemia\|Acute Lymphoblastic Leukemia\|Myelodysplastic Syndromes\|Myeloproliferative Disorder\|Chronic Myelomonocytic Leukemia\|Chemosensitive Hodgkin Lymphoma	August 14, 2020	Phase 1
NCT00963872	Masonic Cancer Center, University of Minnesota\|National Heart, Lung, and Blood Institute (NHLBI)	Leukemia\|Lymphoma\|Multiple Myeloma\|Myelodysplastic Syndromes	March 2010	Phase 1\|Phase 2
NCT03610490	M.D. Anderson Cancer Center\|Bristol-Myers Squibb\|Iovance Biotherapeutics\|National Cancer Institute (NCI)	Malignant Solid Neoplasm\|Metastatic Colorectal Adenocarcinoma\|Metastatic Ovarian Carcinoma\|Metastatic Pancreatic Ductal Adenocarcinoma\|Platinum-Resistant Ovarian Carcinoma\|Recurrent High Grade Ovarian Serous Adenocarcinoma\|Recurrent Ovarian Carcinosarcoma\|Refractory Colorectal Carcinoma\|Stage IV Colorectal Cancer AJCC v8\|Stage IVA Colorectal Cancer AJCC v8\|Stage IVB Colorectal Cancer AJCC v8\|Stage IVC Colorectal Cancer AJCC v8	August 17, 2018	Phase 2
NCT00365287	Masonic Cancer Center, University of Minnesota\|National Cancer Institute (NCI)	Breast Cancer\|Kidney Cancer\|Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes	June 2000	Phase 1\|Phase 2
NCT05445011	Wuhan Union Hospital, China\|PersonGen BioTherapeutics (Suzhou) Co., Ltd.	Acute Myeloid Leukemia	June 14, 2022	Phase 1
NCT03676504	University Hospital Heidelberg	Acute Lymphoblastic Leukemia, Adult\|Acute Lymphoblastic Leukemia, Pediatric\|Chronic Lymphocytic Leukemia\|Diffuse Large B Cell Lymphoma\|Follicular Lymphoma\|Mantle Cell Lymphoma	September 7, 2018	Phase 1\|Phase 2
NCT00043979	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Sarcoma	September 19, 2002	Phase 2
NCT02707393	St. Anna Kinderkrebsforschung	Chronic Myeloid Leukemia	April 30, 2009	Phase 2\|Phase 3
NCT03384212	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine\|Changhai Hospital\|Xiangya Hospital of Central South University\|Tongji Hospital\|Wuhan Union Hospital, China\|Chengdu PLA General Hospital\|Tang-Du Hospital\|Fujian Medical University Union Hospital	High Risk Acute Myeloid Leukemia\|Allogeneic Hematopoeitic Stem Cell Transplantation	August 1, 2016	Phase 3
NCT01598025	Memorial Sloan Kettering Cancer Center	Acute Leukemia\|Chronic Leukemia\|Myelodysplastic Syndrome\|Non-Hodgkins Lymphoma	May 2, 2012	Not Applicable
NCT04314843	Kite, A Gilead Company\|Humanigen, Inc.\|Gilead Sciences	Relapsed+Refractory Large B-cell Lymphoma	May 26, 2020	Phase 1
NCT01319565	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Metastatic Melanoma\|Skin Cancer	March 24, 2011	Phase 2
NCT00526292	Memorial Sloan Kettering Cancer Center\|National Cancer Institute (NCI)	Leukemia\|Myelodysplastic Syndromes	August 2007	Phase 2
NCT03302403	Kang YU\|CARsgen Therapeutics Co., Ltd.\|First Affiliated Hospital of Wenzhou Medical University	B Cell Lymphoma\|B Cell Leukemia\|Myeloma\|Hepatocellular Carcinoma\|Pancreatic Carcinoma\|Adenocarcinoma of Esophagogastric Junction	December 29, 2017	Not Applicable
NCT00199056	Johann Wolfgang Goethe University Hospital	Adult Acute Lymphocytic Leukemia	October 1999	Phase 4
NCT00275015	German CLL Study Group	Chronic Lymphocytic Leukemia	January 1998	Phase 2
NCT00623935	University of Michigan Rogel Cancer Center	Acute Myelogenous Leukemia	March 2007	Phase 2
NCT00001677	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)\|National Institutes of Health Clinical Center (CC)	Arthritis, Rheumatoid\|Synovitis	June 1998	Phase 2
NCT00105001	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable\|Previously Treated Myelodysplastic Syndrome\|Refractory Chronic Lymphocytic Leukemia\|Refractory Plasma Cell Myeloma\|Waldenstrom Macroglobulinemia\|Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Adult Acute Lymphoblastic Leukemia in Remission\|Adult Acute Myeloid Leukemia in Remission\|Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL\|Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11\|Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA\|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1\|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative\|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Childhood Acute Lymphoblastic Leukemia in Remission\|Childhood Acute Myeloid Leukemia in Remission\|Childhood Burkitt Lymphoma\|Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Childhood Diffuse Large Cell Lymphoma\|Childhood Immunoblastic Lymphoma\|Childhood Myelodysplastic Syndrome\|Stage II Contiguous Adult Burkitt Lymphoma\|Stage II Contiguous Adult Diffuse Large Cell Lymphoma\|Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma\|Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma\|Stage II Adult Contiguous Immunoblastic Lymphoma\|Stage II Contiguous Adult Lymphoblastic Lymphoma\|Stage II Grade 1 Contiguous Follicular Lymphoma\|Stage II Grade 2 Contiguous Follicular Lymphoma\|Stage II Grade 3 Contiguous Follicular Lymphoma\|Stage II Contiguous Mantle Cell Lymphoma\|Stage II Non-Contiguous Adult Burkitt Lymphoma\|Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma\|Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma\|Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma\|Stage II Adult Non-Contiguous Immunoblastic Lymphoma\|Stage II Non-Contiguous Adult Lymphoblastic Lymphoma\|Stage II Grade 1 Non-Contiguous Follicular Lymphoma\|Stage II Grade 2 Non-Contiguous Follicular Lymphoma\|Stage II Grade 3 Non-Contiguous Follicular Lymphoma\|Stage II Non-Contiguous Mantle Cell Lymphoma\|Stage II Small Lymphocytic Lymphoma\|Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Adult Burkitt Lymphoma\|Recurrent Adult Diffuse Large Cell Lymphoma\|Recurrent Adult Diffuse Mixed Cell Lymphoma\|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma\|Recurrent Adult Hodgkin Lymphoma\|Recurrent Adult Immunoblastic Lymphoma\|Recurrent Adult Lymphoblastic Lymphoma\|Recurrent Childhood Acute Lymphoblastic Leukemia\|Recurrent Childhood Acute Myeloid Leukemia\|Recurrent Childhood Anaplastic Large Cell Lymphoma\|Recurrent Childhood Large Cell Lymphoma\|Recurrent Childhood Lymphoblastic Lymphoma\|Recurrent Childhood Burkitt Lymphoma\|Recurrent Grade 1 Follicular Lymphoma\|Recurrent Grade 2 Follicular Lymphoma\|Recurrent Grade 3 Follicular Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Marginal Zone Lymphoma\|Recurrent Small Lymphocytic Lymphoma\|Recurrent Childhood Hodgkin Lymphoma\|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Secondary Myelodysplastic Syndrome\|Stage I Adult Burkitt Lymphoma\|Stage I Adult Diffuse Large Cell Lymphoma\|Stage I Adult Diffuse Mixed Cell Lymphoma\|Stage I Adult Immunoblastic Lymphoma\|Stage I Adult Lymphoblastic Lymphoma\|Stage I Childhood Anaplastic Large Cell Lymphoma\|Stage I Childhood Large Cell Lymphoma\|Stage I Childhood Lymphoblastic Lymphoma\|Stage I Childhood Burkitt Lymphoma\|Stage I Grade 1 Follicular Lymphoma\|Stage I Grade 2 Follicular Lymphoma\|Stage I Grade 3 Follicular Lymphoma\|Stage I Mantle Cell Lymphoma\|Stage I Marginal Zone Lymphoma\|Stage I Small Lymphocytic Lymphoma\|Stage II Childhood Anaplastic Large Cell Lymphoma\|Stage II Childhood Lymphoblastic Lymphoma\|Stage II Childhood Burkitt Lymphoma\|Stage III Adult Burkitt Lymphoma\|Stage III Adult Diffuse Large Cell Lymphoma\|Stage III Adult Diffuse Mixed Cell Lymphoma\|Stage III Adult Diffuse Small Cleaved Cell Lymphoma\|Stage III Adult Immunoblastic Lymphoma\|Stage III Adult Lymphoblastic Lymphoma\|Stage III Childhood Anaplastic Large Cell Lymphoma\|Stage III Childhood Large Cell Lymphoma\|Stage III Childhood Lymphoblastic Lymphoma\|Stage III Childhood Burkitt Lymphoma\|Stage III Grade 1 Follicular Lymphoma\|Stage III Grade 2 Follicular Lymphoma\|Stage III Grade 3 Follicular Lymphoma\|Stage III Mantle Cell Lymphoma\|Stage III Marginal Zone Lymphoma\|Stage III Small Lymphocytic Lymphoma\|Stage IV Adult Burkitt Lymphoma\|Stage IV Adult Diffuse Large Cell Lymphoma\|Stage IV Adult Diffuse Mixed Cell Lymphoma\|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma\|Stage IV Adult Immunoblastic Lymphoma\|Stage IV Adult Lymphoblastic Lymphoma\|Stage IV Childhood Anaplastic Large Cell Lymphoma\|Stage IV Childhood Large Cell Lymphoma\|Stage IV Childhood Lymphoblastic Lymphoma\|Stage IV Childhood Burkitt Lymphoma\|Stage IV Grade 1 Follicular Lymphoma\|Stage IV Grade 2 Follicular Lymphoma\|Stage IV Grade 3 Follicular Lymphoma\|Stage IV Mantle Cell Lymphoma\|Stage IV Marginal Zone Lymphoma\|Stage IV Small Lymphocytic Lymphoma	November 2004	Phase 2
NCT04796675	Wuhan Union Hospital, China\|Shanghai Simnova Biotechnology Co.,Ltd.	Acute Lymphocytic Leukemia\|Chronic Lymphocytic Leukemia\|Non Hodgkin´s Lymphoma	April 10, 2021	Phase 1
NCT03391466	Kite, A Gilead Company\|Gilead Sciences	Relapsed+Refractory Diffuse Large B-Cell Lymphoma (DLBCL)	January 25, 2018	Phase 3
NCT02065362	Baylor College of Medicine\|National Cancer Institute (NCI)\|Center for Cell and Gene Therapy, Baylor College of Medicine\|The Methodist Hospital Research Institute	EBV-positive Nasopharyngeal Carcinoma	February 2015	Phase 1
NCT00796068	Fred Hutchinson Cancer Center	Acute Biphenotypic Leukemia\|Acute Lymphoblastic Leukemia in Remission\|Acute Myeloid Leukemia in Remission\|Blasts Under 5 Percent of Bone Marrow Nucleated Cells\|Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Myelodysplastic Syndrome	October 29, 2008	Phase 2
NCT00133367	Massachusetts General Hospital\|Dana-Farber Cancer Institute	Multiple Myeloma\|Non-Hodgkin´s Lymphoma\|Hodgkin´s Disease\|Myelogenous Leukemia\|Lymphoblastic Leukemia	August 2005	Phase 2
NCT04626752	Hebei Senlang Biotechnology Inc., Ltd.	Relapsed or Refractory Multiple Myeloma	April 1, 2020	Early Phase 1
NCT00119366	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities\|Adult Acute Myeloid Leukemia With Del(5q)\|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)\|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)\|Childhood Myelodysplastic Syndromes\|Chronic Myelomonocytic Leukemia\|Previously Treated Myelodysplastic Syndromes\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Childhood Acute Myeloid Leukemia\|Refractory Anemia With Excess Blasts\|Refractory Anemia With Excess Blasts in Transformation\|Refractory Anemia With Ringed Sideroblasts\|Refractory Cytopenia With Multilineage Dysplasia\|Secondary Acute Myeloid Leukemia\|Secondary Myelodysplastic Syndromes	May 2003	Phase 2
NCT03970096	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Acute Biphenotypic Leukemia\|Acute Leukemia of Ambiguous Lineage\|Acute Lymphoblastic Leukemia\|Acute Myeloid Leukemia\|Acute Undifferentiated Leukemia\|Blastic Plasmacytoid Dendritic Cell Neoplasm\|Lymphoblastic Lymphoma\|Mixed Phenotype Acute Leukemia\|Acute Leukemia\|Hematopoietic and Lymphoid Cell Neoplasm	November 19, 2019	Phase 2
NCT01759732	Asan Medical Center	Acquired Aplastic Anemia	September 2012	Phase 2
NCT03412526	Sheba Medical Center	Metastatic Ovarian Cancer	January 21, 2018	Phase 2
NCT00373594	University of Bergen	Cold Agglutinin Disease	June 2005	Phase 2
NCT03524235	Noah Merin\|Miltenyi Biomedicine GmbH\|Teva Branded Pharmaceutical Products R&D, Inc.\|Cedars-Sinai Medical Center	Multiple Myeloma\|CLL\|Chronic Lymphocytic Leukemia\|Lymphoma\|Hodgkin Lymphoma	July 18, 2018	Phase 1
NCT00602693	Masonic Cancer Center, University of Minnesota	Leukemia\|Lymphoma\|Multiple Myeloma\|Plasma Cell Neoplasm\|Myelodysplastic Syndromes	July 23, 2007	Phase 1
NCT02830724	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Pancreatic Cancer\|Renal Cell Cancer\|Breast Cancer\|Melanoma\|Ovarian Cancer	April 6, 2017	Phase 1\|Phase 2
NCT03935893	Udai Kammula\|University of Pittsburgh	Gastric Cancer\|Colorectal Cancer\|Pancreatic Cancer\|Sarcoma\|Mesothelioma\|Neuroendocrine Tumors\|Squamous Cell Cancer\|Merkel Cell Carcinoma\|Mismatch Repair Deficiency\|Microsatellite Instability	December 3, 2019	Phase 2
NCT02763475	Instituto de Investigación Hospital Universitario La Paz\|Hospital Infantil Universitario Niño Jesús, Madrid, Spain\|Fundación Mutua Madrileña	Acute Myeloid Leukemia\|Leukemia\|Myeloid Leukemia	May 2016	Phase 2
NCT05400122	Jennifer Eva Selfridge\|Case Comprehensive Cancer Center	Colorectal Cancer\|Hematologic Malignancy\|Rectum Cancer\|Acute Myeloid Leukemia\|Myelodysplastic Syndromes\|Acute Lymphoblastic Leukemia\|Chronic Myeloid Leukemia\|Chronic Lymphocytic Leukemia\|Hodgkin Lymphoma\|Non Hodgkin Lymphoma\|Myeloproliferative Syndrome\|Plasma Cell Myeloma	September 9, 2022	Phase 1
NCT04154735	Northwestern University	Crohn´s Disease	November 2019	Phase 2
NCT04022239	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Hematopoietic and Lymphoid System Neoplasm	March 13, 2020	Phase 1\|Phase 2
NCT02828592	Northside Hospital, Inc.	Severe Aplastic Anemia	September 9, 2016	Phase 2
NCT04735471	Adicet Bio, Inc	Lymphoma, Follicular\|Lymphoma, Mantle-Cell\|Marginal Zone Lymphoma\|Primary Mediastinal B-cell Lymphoma\|Diffuse Large B Cell Lymphoma\|Lymphoma, Non-Hodgkin	March 4, 2021	Phase 1
NCT01995344	The Christie NHS Foundation Trust\|National Institute for Health Research, United Kingdom	Metastatic Melanoma	October 2013	Phase 2
NCT05453552	Nanfang Hospital of Southern Medical University\|Peking University People´s Hospital\|Institute of Hematology and Blood Diseases Hospital\|Guangzhou First People´s Hospital\|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University\|First People´s Hospital of Chenzhou\|The Seventh Affiliated Hospital of Sun Yat-sen University	Myelodysplastic Syndrome\|Allogeneic Hematopoietic Stem Cell Transplantation\|Conditioning	July 2022	Phase 2\|Phase 3
NCT00193466	SCRI Development Innovations, LLC\|Bayer	Non-Hodgkins Lymphoma	January 2002	Phase 2
NCT05537766	Kite, A Gilead Company\|Gilead Sciences	Relapsed+Refractory Waldenstrom Macroglobulinemia\|Relapsed+Refractory Richter Transformation\|Relapsed+Refractory Burkitt Lymphoma\|Relapsed+Refractory Hairy Cell Leukemia	November 1, 2022	Phase 2
NCT01707004	University of Wisconsin, Madison\|National Cancer Institute (NCI)	Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome\|Adult Acute Myeloid Leukemia in Remission\|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities\|Adult Acute Myeloid Leukemia With Del(5q)\|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)\|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)\|de Novo Myelodysplastic Syndromes\|Previously Treated Myelodysplastic Syndromes\|Recurrent Adult Acute Myeloid Leukemia\|Secondary Acute Myeloid Leukemia	May 16, 2013	Phase 2
NCT00005580	Virginia Commonwealth University\|National Cancer Institute (NCI)	Leukemia\|Lymphoma	September 1998	Phase 1
NCT00280241	University of Pittsburgh\|Genentech, Inc.\|Biogen	Chronic Lymphocytic Leukemia	June 2004	Phase 2
NCT04029688	Hoffmann-La Roche	Acute Myeloid Leukemia (AML)\|Acute Lymphoblastic Leukemia (ALL)\|Neuroblastoma\|Solid Tumors	January 27, 2020	Phase 1\|Phase 2
NCT00003764	Eastern Cooperative Oncology Group\|National Cancer Institute (NCI)\|Cancer and Leukemia Group B\|Southwest Oncology Group	Leukemia	December 1999	Phase 3
NCT00002779	Alliance for Clinical Trials in Oncology\|National Cancer Institute (NCI)	Lymphoma	February 1998	Phase 2
NCT01758328	Memorial Sloan Kettering Cancer Center	Multiple Myeloma	December 2012	Phase 1
NCT00469144	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Myelodysplastic Syndrome\|Leukemia\|Acute Myeloid Leukemia	June 2005	Phase 3
NCT04224558	Cedars-Sinai Medical Center	Crohn Disease	December 15, 2020	Phase 1\|Phase 2
NCT00077558	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins\|National Cancer Institute (NCI)	Leukemia\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Diseases	January 2004	Phase 1
NCT04245722	Fate Therapeutics	Lymphoma, B-Cell\|Chronic Lymphocytic Leukemia	March 19, 2020	Phase 1
NCT00759798	M.D. Anderson Cancer Center	Chronic Lymphocytic Leukemia\|Leukemia	August 13, 2008	Phase 2
NCT03674411	Masonic Cancer Center, University of Minnesota	Acute Myeloid Leukemia\|Acute Lymphocytic Leukemia\|Biphenotypic+Undifferentiated Leukemia\|Chronic Myelogenous Leukemia\|Myelodysplasia\|Relapsed Large Cell Lymphoma\|Mantle Cell Lymphoma\|Hodgkin Lymphoma\|Burkitt Lymphoma\|Relapsed T-Cell Lymphoma\|Lymphoplasmacytic Lymphoma	January 2, 2019	Phase 2
NCT03448978	Cartesian Therapeutics	Multiple Myeloma	February 26, 2018	Phase 1\|Phase 2
NCT01010217	M.D. Anderson Cancer Center	Blood Stem Cell Transplant Failure\|Leukemia\|Hematologic Malignancies	November 5, 2009	Phase 2
NCT04643574	Centre Hospitalier Universitaire Vaudois	Solid Tumor, Adult	March 9, 2021	Phase 1
NCT01056614	Fred Hutchinson Cancer Center\|National Heart, Lung, and Blood Institute (NHLBI)\|National Cancer Institute (NCI)	Accelerated Phase Chronic Myelogenous Leukemia\|Adult Acute Myeloid Leukemia in Remission\|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities\|Adult Acute Myeloid Leukemia With Del(5q)\|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)\|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)\|Blastic Phase Chronic Myelogenous Leukemia\|Childhood Acute Myeloid Leukemia in Remission\|Childhood Chronic Myelogenous Leukemia\|Childhood Myelodysplastic Syndromes\|Chronic Phase Chronic Myelogenous Leukemia\|de Novo Myelodysplastic Syndromes\|Hematopoietic+Lymphoid Cancer\|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable\|Previously Treated Myelodysplastic Syndromes\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Childhood Acute Myeloid Leukemia\|Relapsing Chronic Myelogenous Leukemia	September 2004	Phase 2
NCT01359254	University of Chicago	Hematological Disease	April 2010	Phase 2
NCT00818961	Northside Hospital, Inc.\|Blood and Marrow Transplant Group of Georgia	Leukemia\|Lymphoma\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Diseases	May 2005	Phase 2
NCT01955460	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Metastatic Melanoma\|Stage III Cutaneous Melanoma AJCC v7\|Stage IIIA Cutaneous Melanoma AJCC v7\|Stage IIIB Cutaneous Melanoma AJCC v7\|Stage IIIC Cutaneous Melanoma AJCC v7\|Stage IV Cutaneous Melanoma AJCC v6 and v7	October 15, 2014	Phase 1
NCT05003895	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Hepatocellular Carcinoma\|Hepatocellular Cancer\|Metastatic Hepatocellular Carcinoma	December 8, 2021	Phase 1
NCT00322101	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)\|National Heart, Lung, and Blood Institute (NHLBI)	Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome\|Acute Myeloid Leukemia+Transient Myeloproliferative Disorder\|Adult Acute Myeloid Leukemia in Remission\|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities\|Adult Acute Myeloid Leukemia With Del(5q)\|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)\|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)\|Childhood Acute Myeloid Leukemia in Remission\|Childhood Myelodysplastic Syndromes\|de Novo Myelodysplastic Syndromes\|Myelodysplastic Syndrome With Isolated Del(5q)\|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable\|Previously Treated Myelodysplastic Syndromes\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Childhood Acute Myeloid Leukemia\|Secondary Acute Myeloid Leukemia\|Secondary Myelodysplastic Syndromes	January 2006	Phase 3
NCT01445821	Northwestern University	Scleroderma, Systemic	September 15, 2011	Phase 3
NCT03912831	Kite, A Gilead Company\|Gilead Sciences	Human Papillomavirus (HPV) 16&addition; Relapsed+Refractory Cancer	April 30, 2019	Phase 1
NCT02435901	Northwell Health	Sickle Cell Disease\|Beta Thalassemia-Major	December 2008	Phase 1\|Phase 2
NCT04102436	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Endocrine+Neuroendocrine\|Non-Small Cell Lung Cancer\|Breast Cancer\|Gastrointestinal+Genitourinary Cancers\|Ovarian Cancer	November 28, 2022	Phase 2
NCT00890500	Fate Therapeutics\|Dana-Farber Cancer Institute	Hematologic Malignancies\|Allogeneic Stem Cell Transplantation	January 2011	Phase 1
NCT04880434	Kite, A Gilead Company\|Gilead Sciences	Relapsed+Refractory Mantle Cell Lymphoma	April 27, 2021	Phase 2
NCT01350258	Sidney Kimmel Cancer Center at Thomas Jefferson University\|Thomas Jefferson University	Hematologic Malignancies\|Acute Leukemia\|Myelodysplastic Syndromes (MDS) Other Than RA or RARS Subtypes\|Hodgkin´s Lymphoma\|Non-Hodgkin´s Lymphoma\|Myeloma\|Chronic Myelogenous (or Myeloid) Leukemia (CML) Resistant to STI Therapy	April 2011	Phase 1\|Phase 2
NCT00005851	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Recurrent Renal Cell Cancer\|Stage IV Renal Cell Cancer	February 2000	Phase 1\|Phase 2
NCT04240002	Astellas Pharma Global Development, Inc.\|Astellas Pharma Inc	Acute Myeloid Leukemia (AML)\|Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation + Internal Tandem Duplication (ITD)	February 27, 2020	Phase 1\|Phase 2
NCT01082939	M.D. Anderson Cancer Center\|Bayer	Chronic Lymphocytic Leukemia	December 2002	Phase 2
NCT05565105	Baptist Health South Florida	Leukemia, Myeloid, Acute\|Leukemia, Lymphocytic, Acute	October 2022	Phase 2
NCT03204188	National Heart, Lung, and Blood Institute (NHLBI)\|National Institutes of Health Clinical Center (CC)	Progressive Marrow Failure\|Night Sweats for More Than 1 Month Without Evidence of Infection\|Weight Loss of 10% or More Within the Previous 6 Months\|Fevers Higher Than 100.5 Degress F or 38.0 Degrees C for 2 or More Weeks	September 22, 2017	Phase 2
NCT00304018	University of California, San Francisco\|National Cancer Institute (NCI)	Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes	October 2002	Phase 1
NCT00427557	M.D. Anderson Cancer Center	Multiple Myeloma\|Leukemia\|Lymphoma	October 2006	Phase 2
NCT02500576	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Metastatic Melanoma\|Stage IIIB Cutaneous Melanoma AJCC v7\|Stage IIIC Cutaneous Melanoma AJCC v7\|Stage IV Cutaneous Melanoma AJCC v6 and v7	August 7, 2015	Phase 2
NCT00564512	French Innovative Leukemia Organisation	Leukemia	November 2007	Phase 3
NCT02790515	St. Jude Children´s Research Hospital	Acute Lymphoblastic Leukemia (ALL)\|Acute Myeloid Leukemia (AML)\|Myeloid Sarcoma\|Chronic Myeloid Leukemia (CML)\|Juvenile Myelomonocytic Leukemia (JMML)\|Myelodysplastic Syndrome (MDS)\|Non-Hodgkin Lymphoma (NHL)	July 14, 2016	Phase 2
NCT02129582	Case Comprehensive Cancer Center	Acute Myeloid Leukemia\|Hematologic Malignancies\|Acute Lymphocytic Leukemia\|Non Hodgkin Lymphoma\|Hodgkin Lymphoma\|Multiple Myeloma\|Myelodysplastic Syndrome\|Chronic Lymphocytic Leukemia\|Chronic Myeloid Leukemia\|Myelofibrosis\|Myeloproliferative Syndrome	November 5, 2014	Phase 1
NCT00602459	National Cancer Institute (NCI)\|Eastern Cooperative Oncology Group\|NCIC Clinical Trials Group\|Southwest Oncology Group	Stage I Chronic Lymphocytic Leukemia\|Stage II Chronic Lymphocytic Leukemia\|Stage III Chronic Lymphocytic Leukemia\|Stage IV Chronic Lymphocytic Leukemia	January 15, 2008	Phase 2
NCT00281892	German CLL Study Group	Chronic Lymphocytic Leukemia\|Anemia	September 2004	Phase 3
NCT01047072	Fred Hutchinson Cancer Research Center+University of Washington Cancer Consortium\|National Cancer Institute (NCI)\|Fred Hutchinson Cancer Center	Systemic Scleroderma		Phase 2
NCT02845999	Centre Hospitalier Universitaire de Besancon\|National Cancer Institute, France	Gastrointestinal Metastatic Cancer	November 2009	Phase 1
NCT01247688	Baylor College of Medicine\|Center for Cell and Gene Therapy, Baylor College of Medicine	Lymphoid Hematological Malignancies\|Umbilical Cord Blood Transplant	November 2010	Not Applicable
NCT03139370	Kite, A Gilead Company\|Gilead Sciences	Solid Tumor	December 27, 2017	Phase 1
NCT00603954	University of Liege\|Maastricht University Medical Center\|KU Leuven	Hematological Malignancies	January 2008	Phase 2
NCT00544115	City of Hope Medical Center\|National Cancer Institute (NCI)	Chronic Myeloproliferative Disorders\|Graft Versus Host Disease\|Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Diseases\|Precancerous+Nonmalignant Condition	October 16, 2001	Phase 2
NCT03016377	UNC Lineberger Comprehensive Cancer Center\|Bellicum Pharmaceuticals	Acute Lymphoblastic Leukemia\|Immune System Diseases\|Immunoproliferative Disorders	March 22, 2012	Phase 1\|Phase 2
NCT00121186	Southwest Oncology Group\|National Cancer Institute (NCI)	Lymphoma	July 2005	Phase 2
NCT00006126	Northwestern University\|National Cancer Institute (NCI)	Breast Cancer\|Kidney Cancer\|Lung Cancer\|Melanoma (Skin)\|Testicular Germ Cell Tumor	September 1999	Phase 1
NCT04713956	Nanfang Hospital of Southern Medical University\|Peking University People´s Hospital\|Institute of Hematology and Blood Diseases Hospital\|Guangzhou First People´s Hospital\|Third Affiliated Hospital, Sun Yat-Sen University\|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University\|First People´s Hospital of Chenzhou\|First Affiliated Hospital of Guangxi Medical University	Myelodysplastic Syndrome\|Allogeneic Hematopoietic Stem Cell Transplantation\|Conditioning	January 15, 2021	Phase 2\|Phase 3
NCT00112593	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Accelerated Phase Chronic Myelogenous Leukemia\|Acute Undifferentiated Leukemia\|Adult Acute Lymphoblastic Leukemia in Remission\|Adult Acute Myeloid Leukemia in Remission\|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities\|Adult Acute Myeloid Leukemia With Del(5q)\|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)\|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)\|Adult Grade III Lymphomatoid Granulomatosis\|Adult Nasal Type Extranodal NK+T-cell Lymphoma\|Aggressive NK-cell Leukemia\|AIDS-related Diffuse Large Cell Lymphoma\|AIDS-related Diffuse Mixed Cell Lymphoma\|AIDS-related Diffuse Small Cleaved Cell Lymphoma\|AIDS-related Immunoblastic Large Cell Lymphoma\|AIDS-related Lymphoblastic Lymphoma\|AIDS-related Peripheral+Systemic Lymphoma\|AIDS-related Primary CNS Lymphoma\|AIDS-related Small Noncleaved Cell Lymphoma\|Anaplastic Large Cell Lymphoma\|Angioimmunoblastic T-cell Lymphoma\|Blastic Phase Chronic Myelogenous Leukemia\|Childhood Acute Lymphoblastic Leukemia in Remission\|Childhood Acute Myeloid Leukemia in Remission\|Childhood Burkitt Lymphoma\|Childhood Chronic Myelogenous Leukemia\|Childhood Diffuse Large Cell Lymphoma\|Childhood Grade III Lymphomatoid Granulomatosis\|Childhood Immunoblastic Large Cell Lymphoma\|Childhood Myelodysplastic Syndromes\|Childhood Nasal Type Extranodal NK+T-cell Lymphoma\|Chronic Eosinophilic Leukemia\|Chronic Myelomonocytic Leukemia\|Chronic Neutrophilic Leukemia\|Chronic Phase Chronic Myelogenous Leukemia\|Contiguous Stage II Adult Burkitt Lymphoma\|Contiguous Stage II Adult Diffuse Large Cell Lymphoma\|Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma\|Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma\|Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma\|Contiguous Stage II Adult Lymphoblastic Lymphoma\|Contiguous Stage II Grade 1 Follicular Lymphoma\|Contiguous Stage II Grade 2 Follicular Lymphoma\|Contiguous Stage II Grade 3 Follicular Lymphoma\|Contiguous Stage II Mantle Cell Lymphoma\|Contiguous Stage II Marginal Zone Lymphoma\|Contiguous Stage II Small Lymphocytic Lymphoma\|Cutaneous B-cell Non-Hodgkin Lymphoma\|Essential Thrombocythemia\|Extramedullary Plasmacytoma\|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue\|Hepatosplenic T-cell Lymphoma\|HIV Infection\|HIV-associated Hodgkin Lymphoma\|Intraocular Lymphoma\|Isolated Plasmacytoma of Bone\|Juvenile Myelomonocytic Leukemia\|Mast Cell Leukemia\|Meningeal Chronic Myelogenous Leukemia\|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable\|Myeloid+NK-cell Acute Leukemia\|Nodal Marginal Zone B-cell Lymphoma\|Noncontiguous Stage II Adult Burkitt Lymphoma\|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma\|Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma\|Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma\|Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma\|Noncontiguous Stage II Adult Lymphoblastic Lymphoma\|Noncontiguous Stage II Grade 1 Follicular Lymphoma\|Noncontiguous Stage II Grade 2 Follicular Lymphoma\|Noncontiguous Stage II Grade 3 Follicular Lymphoma\|Noncontiguous Stage II Mantle Cell Lymphoma\|Noncontiguous Stage II Marginal Zone Lymphoma\|Noncontiguous Stage II Small Lymphocytic Lymphoma\|Noncutaneous Extranodal Lymphoma\|Peripheral T-cell Lymphoma\|Polycythemia Vera\|Post-transplant Lymphoproliferative Disorder\|Previously Treated Myelodysplastic Syndromes\|Primary Central Nervous System Lymphoma\|Primary Myelofibrosis\|Primary Systemic Amyloidosis\|Progressive Hairy Cell Leukemia, Initial Treatment\|Prolymphocytic Leukemia\|Secondary Acute Myeloid Leukemia\|Secondary Myelodysplastic Syndromes\|Small Intestine Lymphoma\|Splenic Marginal Zone Lymphoma\|Stage 0 Chronic Lymphocytic Leukemia\|Stage I Adult Burkitt Lymphoma\|Stage I Adult Diffuse Large Cell Lymphoma\|Stage I Adult Diffuse Mixed Cell Lymphoma\|Stage I Adult Diffuse Small Cleaved Cell Lymphoma\|Stage I Adult Hodgkin Lymphoma\|Stage I Adult Immunoblastic Large Cell Lymphoma\|Stage I Adult Lymphoblastic Lymphoma\|Stage I Adult T-cell Leukemia+Lymphoma\|Stage I Childhood Anaplastic Large Cell Lymphoma\|Stage I Childhood Hodgkin Lymphoma\|Stage I Childhood Large Cell Lymphoma\|Stage I Childhood Lymphoblastic Lymphoma\|Stage I Childhood Small Noncleaved Cell Lymphoma\|Stage I Chronic Lymphocytic Leukemia\|Stage I Cutaneous T-cell Non-Hodgkin Lymphoma\|Stage I Grade 1 Follicular Lymphoma\|Stage I Grade 2 Follicular Lymphoma\|Stage I Grade 3 Follicular Lymphoma\|Stage I Mantle Cell Lymphoma\|Stage I Marginal Zone Lymphoma\|Stage I Multiple Myeloma\|Stage I Small Lymphocytic Lymphoma\|Stage IA Mycosis Fungoides+Sezary Syndrome\|Stage IB Mycosis Fungoides+Sezary Syndrome\|Stage II Adult Hodgkin Lymphoma\|Stage II Adult T-cell Leukemia+Lymphoma\|Stage II Childhood Anaplastic Large Cell Lymphoma\|Stage II Childhood Hodgkin Lymphoma\|Stage II Childhood Large Cell Lymphoma\|Stage II Childhood Lymphoblastic Lymphoma\|Stage II Childhood Small Noncleaved Cell Lymphoma\|Stage II Chronic Lymphocytic Leukemia\|Stage II Cutaneous T-cell Non-Hodgkin Lymphoma\|Stage II Multiple Myeloma\|Stage IIA Mycosis Fungoides+Sezary Syndrome\|Stage IIB Mycosis Fungoides+Sezary Syndrome\|Stage III Adult Burkitt Lymphoma\|Stage III Adult Diffuse Large Cell Lymphoma\|Stage III Adult Diffuse Mixed Cell Lymphoma\|Stage III Adult Diffuse Small Cleaved Cell Lymphoma\|Stage III Adult Hodgkin Lymphoma\|Stage III Adult Immunoblastic Large Cell Lymphoma\|Stage III Adult Lymphoblastic Lymphoma\|Stage III Adult T-cell Leukemia+Lymphoma\|Stage III Childhood Anaplastic Large Cell Lymphoma\|Stage III Childhood Hodgkin Lymphoma\|Stage III Childhood Large Cell Lymphoma\|Stage III Childhood Lymphoblastic Lymphoma\|Stage III Childhood Small Noncleaved Cell Lymphoma\|Stage III Chronic Lymphocytic Leukemia\|Stage III Cutaneous T-cell Non-Hodgkin Lymphoma\|Stage III Grade 1 Follicular Lymphoma\|Stage III Grade 2 Follicular Lymphoma\|Stage III Grade 3 Follicular Lymphoma\|Stage III Mantle Cell Lymphoma\|Stage III Marginal Zone Lymphoma\|Stage III Multiple Myeloma\|Stage III Small Lymphocytic Lymphoma\|Stage IIIA Mycosis Fungoides+Sezary Syndrome\|Stage IIIB Mycosis Fungoides+Sezary Syndrome\|Stage IV Adult Burkitt Lymphoma\|Stage IV Adult Diffuse Large Cell Lymphoma\|Stage IV Adult Diffuse Mixed Cell Lymphoma\|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma\|Stage IV Adult Hodgkin Lymphoma\|Stage IV Adult Immunoblastic Large Cell Lymphoma\|Stage IV Adult Lymphoblastic Lymphoma\|Stage IV Adult T-cell Leukemia+Lymphoma\|Stage IV Childhood Anaplastic Large Cell Lymphoma\|Stage IV Childhood Hodgkin Lymphoma\|Stage IV Childhood Large Cell Lymphoma\|Stage IV Childhood Lymphoblastic Lymphoma\|Stage IV Childhood Small Noncleaved Cell Lymphoma\|Stage IV Chronic Lymphocytic Leukemia\|Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma\|Stage IV Grade 1 Follicular Lymphoma\|Stage IV Grade 2 Follicular Lymphoma\|Stage IV Grade 3 Follicular Lymphoma\|Stage IV Mantle Cell Lymphoma\|Stage IV Marginal Zone Lymphoma\|Stage IV Small Lymphocytic Lymphoma\|Stage IVA Mycosis Fungoides+Sezary Syndrome\|Stage IVB Mycosis Fungoides+Sezary Syndrome\|T-cell Large Granular Lymphocyte Leukemia\|Testicular Lymphoma\|Unspecified Adult Solid Tumor, Protocol Specific\|Unspecified Childhood Solid Tumor, Protocol Specific\|Waldenström Macroglobulinemia	November 1999	Not Applicable
NCT02294552	Ivan S Moiseev\|St. Petersburg State Pavlov Medical University	Acute Myeloid Leukemia\|Acute Lymphoid Leukemia\|Lymphoma\|Myelodysplastic Syndromes\|Chronic Lymphocytic Leukemia\|Immune System Diseases	October 2014	Phase 2
NCT04088864	Stanford University	B Cell Lymphoma\|Acute Lymphoblastic Leukemia, Pediatric\|Lymphoma	January 10, 2020	Phase 1
NCT01231412	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Acute Lymphoblastic Leukemia\|Acute Myeloid Leukemia\|Aggressive Non-Hodgkin Lymphoma\|Chronic Lymphocytic Leukemia\|Diffuse Large B-Cell Lymphoma\|Hematopoietic and Lymphoid Cell Neoplasm\|Indolent Non-Hodgkin Lymphoma\|Mantle Cell Lymphoma\|Myelodysplastic Syndrome\|Myeloproliferative Neoplasm\|Prolymphocytic Leukemia\|Recurrent Chronic Lymphocytic Leukemia\|Recurrent Plasma Cell Myeloma\|Refractory Chronic Lymphocytic Leukemia\|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Refractory Hodgkin Lymphoma\|Small Lymphocytic Lymphoma\|T-Cell Chronic Lymphocytic Leukemia\|Waldenstrom Macroglobulinemia	November 2010	Phase 3
NCT00104975	Yale University\|National Cancer Institute (NCI)	Chronic Myeloproliferative Disorders\|Leukemia\|Lymphoma\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Neoplasms	February 2005	Phase 1
NCT00683046	University of Chicago	Acute Myelogenous Leukemia\|Lymphoid Leukemia\|Chronic Myelogenous Leukemia\|Malignant Lymphoma\|Hodgkin´s Disease\|Chronic Lymphocytic Leukemia\|Myeloproliferative Disorder\|Anemia, Aplastic\|Myelodysplastic Syndromes	November 2001	Phase 2
NCT00253513	OHSU Knight Cancer Institute\|medac GmbH\|National Cancer Institute (NCI)	Leukemia\|Myelodysplastic Syndromes	June 2005	Phase 1\|Phase 2
NCT03745326	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Gastrointestinal Cancer\|Pancreatic Cancer\|Gastric Cancer\|Colon Cancer\|Rectal Cancer	May 16, 2019	Phase 1\|Phase 2
NCT00925873	French Innovative Leukemia Organisation\|Schering SA\|Novartis	Acute Myeloid Leukemia	June 1996	Phase 3
NCT03018223	H. Lee Moffitt Cancer Center and Research Institute	Non-Hodgkin´s Lymphoma\|Acute Leukemia in Remission\|Chronic Myeloid Leukemia\|Primary Myelofibrosis\|Chronic Myelomonocytic Leukemia\|Myelodysplastic Syndromes\|Hodgkin Lymphoma\|Multiple Myeloma	January 31, 2017	Phase 1
NCT03710421	City of Hope Medical Center\|National Cancer Institute (NCI)	Recurrent Plasma Cell Myeloma\|Refractory Plasma Cell Myeloma	February 13, 2019	Phase 1
NCT00053092	Institute of Cancer Research, United Kingdom\|Australasian Leukaemia and Lymphoma Group\|National Cancer Institute (NCI)	Lymphoma	October 2002	Phase 2
NCT00053014	Southwest Oncology Group\|National Cancer Institute (NCI)	Leukemia	April 2003	Phase 2
NCT01810926	Franco Locatelli\|University of Milano Bicocca\|medac GmbH\|Fresenius AG\|Bambino Gesù Hospital and Research Institute	Graft Versus Host Disease	September 2011	Phase 2
NCT02924753	Henan Cancer Hospital\|The Beijing Pregene Science and Technology Company, Ltd.	B-cell Acute Lymphoblastic Leukemia	July 18, 2016	Phase 1
NCT00004114	Jonsson Comprehensive Cancer Center	Leukemia\|Lymphoma\|Myelodysplastic Syndromes		Phase 1
NCT03192397	Roswell Park Cancer Institute	Acute Myeloid Leukemia in Remission\|Adult Acute Lymphoblastic Leukemia in Complete Remission\|Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission\|Chronic Myelomonocytic Leukemia in Remission\|Graft Versus Host Disease\|Hodgkin Lymphoma\|Minimal Residual Disease\|Myelodysplastic Syndrome\|Myeloproliferative Neoplasm\|Non-Hodgkin Lymphoma\|Plasma Cell Myeloma\|Severe Aplastic Anemia\|Waldenstrom Macroglobulinemia	August 9, 2017	Phase 1\|Phase 2
NCT00652899	Masonic Cancer Center, University of Minnesota	Fallopian Tube Cancer\|Ovarian Cancer\|Peritoneal Cavity Cancer	March 2008	Phase 2
NCT02876510	Immatics US, Inc.\|M.D. Anderson Cancer Center	Cancer\|Solid Tumor	June 30, 2017	Phase 1
NCT00078858	Fred Hutchinson Cancer Center\|National Heart, Lung, and Blood Institute (NHLBI)\|National Cancer Institute (NCI)	Accelerated Phase Chronic Myelogenous Leukemia\|Adult Acute Lymphoblastic Leukemia in Remission\|Adult Acute Myeloid Leukemia in Remission\|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities\|Adult Acute Myeloid Leukemia With Del(5q)\|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)\|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)\|Adult Grade III Lymphomatoid Granulomatosis\|Adult Nasal Type Extranodal NK+T-cell Lymphoma\|Anaplastic Large Cell Lymphoma\|Angioimmunoblastic T-cell Lymphoma\|Childhood Acute Lymphoblastic Leukemia in Remission\|Childhood Acute Myeloid Leukemia in Remission\|Childhood Burkitt Lymphoma\|Childhood Chronic Myelogenous Leukemia\|Childhood Diffuse Large Cell Lymphoma\|Childhood Grade III Lymphomatoid Granulomatosis\|Childhood Immunoblastic Large Cell Lymphoma\|Childhood Myelodysplastic Syndromes\|Childhood Nasal Type Extranodal NK+T-cell Lymphoma\|Childhood Renal Cell Carcinoma\|Chronic Myelomonocytic Leukemia\|Chronic Phase Chronic Myelogenous Leukemia\|Clear Cell Renal Cell Carcinoma\|Contiguous Stage II Adult Burkitt Lymphoma\|Contiguous Stage II Adult Diffuse Large Cell Lymphoma\|Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma\|Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma\|Contiguous Stage II Adult Lymphoblastic Lymphoma\|Contiguous Stage II Grade 3 Follicular Lymphoma\|Contiguous Stage II Mantle Cell Lymphoma\|de Novo Myelodysplastic Syndromes\|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue\|Hepatosplenic T-cell Lymphoma\|Juvenile Myelomonocytic Leukemia\|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable\|Nodal Marginal Zone B-cell Lymphoma\|Noncontiguous Stage II Adult Burkitt Lymphoma\|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma\|Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma\|Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma\|Noncontiguous Stage II Adult Lymphoblastic Lymphoma\|Noncontiguous Stage II Grade 3 Follicular Lymphoma\|Noncontiguous Stage II Mantle Cell Lymphoma\|Noncutaneous Extranodal Lymphoma\|Peripheral T-cell Lymphoma\|Post-transplant Lymphoproliferative Disorder\|Previously Treated Myelodysplastic Syndromes\|Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Adult Burkitt Lymphoma\|Recurrent Adult Diffuse Large Cell Lymphoma\|Recurrent Adult Diffuse Mixed Cell Lymphoma\|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma\|Recurrent Adult Grade III Lymphomatoid Granulomatosis\|Recurrent Adult Hodgkin Lymphoma\|Recurrent Adult Immunoblastic Large Cell Lymphoma\|Recurrent Adult Lymphoblastic Lymphoma\|Recurrent Adult T-cell Leukemia+Lymphoma\|Recurrent Childhood Acute Lymphoblastic Leukemia\|Recurrent Childhood Acute Myeloid Leukemia\|Recurrent Childhood Anaplastic Large Cell Lymphoma\|Recurrent Childhood Grade III Lymphomatoid Granulomatosis\|Recurrent Childhood Large Cell Lymphoma\|Recurrent Childhood Lymphoblastic Lymphoma\|Recurrent Childhood Small Noncleaved Cell Lymphoma\|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma\|Recurrent Grade 1 Follicular Lymphoma\|Recurrent Grade 2 Follicular Lymphoma\|Recurrent Grade 3 Follicular Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Marginal Zone Lymphoma\|Recurrent Mycosis Fungoides+Sezary Syndrome\|Recurrent Renal Cell Cancer\|Recurrent Small Lymphocytic Lymphoma\|Recurrent+Refractory Childhood Hodgkin Lymphoma\|Refractory Anemia\|Refractory Anemia With Ringed Sideroblasts\|Refractory Chronic Lymphocytic Leukemia\|Refractory Hairy Cell Leukemia\|Refractory Multiple Myeloma\|Relapsing Chronic Myelogenous Leukemia\|Splenic Marginal Zone Lymphoma\|Stage I Adult Burkitt Lymphoma\|Stage I Adult Diffuse Large Cell Lymphoma\|Stage I Adult Diffuse Mixed Cell Lymphoma\|Stage I Adult Immunoblastic Large Cell Lymphoma\|Stage I Adult Lymphoblastic Lymphoma\|Stage I Adult T-cell Leukemia+Lymphoma\|Stage I Childhood Anaplastic Large Cell Lymphoma\|Stage I Childhood Large Cell Lymphoma\|Stage I Childhood Lymphoblastic Lymphoma\|Stage I Childhood Small Noncleaved Cell Lymphoma\|Stage I Grade 3 Follicular Lymphoma\|Stage I Mantle Cell Lymphoma\|Stage II Adult T-cell Leukemia+Lymphoma\|Stage II Childhood Anaplastic Large Cell Lymphoma\|Stage II Childhood Large Cell Lymphoma\|Stage II Childhood Lymphoblastic Lymphoma\|Stage II Childhood Small Noncleaved Cell Lymphoma\|Stage III Adult Burkitt Lymphoma\|Stage III Adult Diffuse Large Cell Lymphoma\|Stage III Adult Diffuse Mixed Cell Lymphoma\|Stage III Adult Immunoblastic Large Cell Lymphoma\|Stage III Adult Lymphoblastic Lymphoma\|Stage III Adult T-cell Leukemia+Lymphoma\|Stage III Childhood Anaplastic Large Cell Lymphoma\|Stage III Childhood Large Cell Lymphoma\|Stage III Childhood Lymphoblastic Lymphoma\|Stage III Childhood Small Noncleaved Cell Lymphoma\|Stage III Grade 3 Follicular Lymphoma\|Stage III Mantle Cell Lymphoma\|Stage IV Adult Burkitt Lymphoma\|Stage IV Adult Diffuse Large Cell Lymphoma\|Stage IV Adult Diffuse Mixed Cell Lymphoma\|Stage IV Adult Immunoblastic Large Cell Lymphoma\|Stage IV Adult Lymphoblastic Lymphoma\|Stage IV Adult T-cell Leukemia+Lymphoma\|Stage IV Childhood Anaplastic Large Cell Lymphoma\|Stage IV Childhood Large Cell Lymphoma\|Stage IV Childhood Lymphoblastic Lymphoma\|Stage IV Childhood Small Noncleaved Cell Lymphoma\|Stage IV Grade 3 Follicular Lymphoma\|Stage IV Mantle Cell Lymphoma\|Stage IV Renal Cell Cancer\|T-cell Large Granular Lymphocyte Leukemia\|Type 1 Papillary Renal Cell Carcinoma\|Type 2 Papillary Renal Cell Carcinoma\|Untreated Adult Acute Lymphoblastic Leukemia\|Untreated Adult Acute Myeloid Leukemia\|Untreated Childhood Acute Lymphoblastic Leukemia\|Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies\|Waldenström Macroglobulinemia	September 2003	Phase 1\|Phase 2
NCT04611126	Inge Marie Svane\|Herlev Hospital	Metastatic Ovarian Cancer\|Metastatic Fallopian Tube Cancer\|Peritoneal Cancer	April 22, 2021	Phase 1\|Phase 2
NCT00254163	US Oncology Research\|Astex Pharmaceuticals, Inc.	B-Cell Chronic Lymphocytic Leukemia	December 2003	Phase 3
NCT02105116	Rutgers, The State University of New Jersey\|National Cancer Institute (NCI)\|Rutgers Cancer Institute of New Jersey	Adult Acute Megakaryoblastic Leukemia (M7)\|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)\|Adult Acute Monoblastic Leukemia (M5a)\|Adult Acute Monocytic Leukemia (M5b)\|Adult Acute Myeloblastic Leukemia With Maturation (M2)\|Adult Acute Myeloblastic Leukemia Without Maturation (M1)\|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities\|Adult Acute Myeloid Leukemia With Del(5q)\|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)\|Adult Acute Myelomonocytic Leukemia (M4)\|Adult Erythroleukemia (M6a)\|Adult Pure Erythroid Leukemia (M6b)\|Recurrent Adult Acute Myeloid Leukemia\|Untreated Adult Acute Myeloid Leukemia	February 2014	Not Applicable
NCT05176470	Richard Wu\|Iovance Biotherapeutics, Inc.\|Ohio State University Comprehensive Cancer Center	Locally Advanced Melanoma\|Pathologic Stage IIIB Cutaneous Melanoma AJCC v8\|Pathologic Stage IIIC Cutaneous Melanoma AJCC v8\|Pathologic Stage IIID Cutaneous Melanoma AJCC v8\|Stage IV Melanoma	July 1, 2022	Phase 1
NCT01954784	Case Comprehensive Cancer Center\|National Cancer Institute (NCI)	Refractory Multiple Myeloma\|Stage I Multiple Myeloma\|Stage II Multiple Myeloma\|Stage III Multiple Myeloma	October 7, 2013	Phase 1
NCT00698009	M.D. Anderson Cancer Center	Neuroblastoma	June 2008	Phase 2
NCT01807611	St. Jude Children´s Research Hospital\|Assisi Foundation	Leukemia\|Lymphoma	May 16, 2013	Phase 2
NCT00502905	M.D. Anderson Cancer Center	Leukemia	October 2003	Phase 2
NCT05418088	Sumithira Vasu\|Ohio State University Comprehensive Cancer Center	Recurrent Acute Lymphoblastic Leukemia\|Recurrent B Acute Lymphoblastic Leukemia\|Recurrent B-Cell Prolymphocytic Leukemia\|Recurrent Chronic Lymphocytic Leukemia\|Recurrent High Grade B-Cell Lymphoma\|Recurrent Indolent Non-Hodgkin Lymphoma\|Recurrent Non-Hodgkin Lymphoma\|Recurrent Transformed Chronic Lymphocytic Leukemia\|Refractory Acute Lymphoblastic Leukemia\|Refractory B Acute Lymphoblastic Leukemia\|Refractory B-Cell Prolymphocytic Leukemia\|Refractory Chronic Lymphocytic Leukemia\|Refractory High Grade B-Cell Lymphoma\|Refractory Indolent Non-Hodgkin Lymphoma\|Refractory Non-Hodgkin Lymphoma\|Refractory Transformed Chronic Lymphocytic Leukemia	June 30, 2022	Phase 1
NCT01468818	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Metastatic Melanoma\|Skin Cancer	September 2011	Phase 2
NCT00453388	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)\|National Heart, Lung, and Blood Institute (NHLBI)	Acute Myeloid Leukemia in Remission\|de Novo Myelodysplastic Syndrome\|Fanconi Anemia\|Previously Treated Myelodysplastic Syndrome	February 2007	Phase 2
NCT05303727	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Neuroblastoma	August 2022	Phase 2
NCT00004857	Alliance for Clinical Trials in Oncology\|National Cancer Institute (NCI)	Leukemia	January 2000	Phase 2
NCT02014506	Asan Medical Center	Haploidentical Hematopoietic Stem Cell Transplantation\|Malignant Disease\|Non-malignant Disease	January 2017	Phase 1\|Phase 2
NCT03994705	Cartesian Therapeutics	Multiple Myeloma	August 6, 2019	Phase 1\|Phase 2
NCT00498316	M.D. Anderson Cancer Center\|ViaCell\|National Institutes of Health (NIH)\|National Cancer Institute (NCI)	Myelodysplastic Syndrome\|Leukemia	July 3, 2007	Phase 1
NCT02366546	Mie University\|Takara Bio Inc.\|Shionogi\|Fiverings Co., Ltd.\|Statcom Co. Ltd.	Solid Tumors	March 2015	Phase 1
NCT00005803	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Prolymphocytic Leukemia\|Recurrent Adult Hodgkin Lymphoma\|Recurrent Childhood Hodgkin Lymphoma\|Recurrent Childhood Non-Hodgkin Lymphoma\|Recurrent Chronic Lymphocytic Leukemia\|Recurrent Non-Hodgkin Lymphoma\|Recurrent Small Lymphocytic Lymphoma\|Refractory Childhood Hodgkin Lymphoma\|Refractory Chronic Lymphocytic Leukemia\|Refractory Hodgkin Lymphoma\|Refractory Non-Hodgkin Lymphoma\|Refractory Small Lymphocytic Lymphoma\|T-Cell Chronic Lymphocytic Leukemia\|T-Cell Prolymphocytic Leukemia	September 1999	Phase 1\|Phase 2
NCT00881556	Columbia University	Epidermolysis Bullosa	August 20, 2009	Early Phase 1
NCT00090051	Hoffmann-La Roche\|Biogen\|Genentech, Inc.	Chronic Lymphocytic Leukemia	July 31, 2003	Phase 3
NCT02806375	St. Petersburg State Pavlov Medical University	Primary Myelofibrosis\|Myeloproliferative Disorders	January 2016	Phase 1\|Phase 2
NCT05528887	The Affiliated People´s Hospital of Ningbo University\|UTC Therapeutics Inc.	Relapsed+Refractory Hematological Malignancies\|Lymphoma\|Myeloma\|Leukemia	September 16, 2021	Phase 1
NCT02638428	Samsung Medical Center\|Ministry of Health, Republic of Korea	Relapsed Pediatric Solid Tumor\|Refractory Pediatric Solid Tumor\|Relapsed Pediatric AML\|Refractory Pediatric AML	December 2015	Phase 2
NCT00741455	Dartmouth-Hitchcock Medical Center	Hematologic Malignancies	June 2004	Not Applicable
NCT01033552	Masonic Cancer Center, University of Minnesota	Epidermolysis Bullosa	January 2010	Phase 1\|Phase 2
NCT03939026	Allogene Therapeutics	Relapsed+Refractory Large B Cell Lymphoma\|Relapsed+Refractory Follicular Lymphoma	May 1, 2019	Phase 1
NCT00295997	University of California, San Francisco\|National Cancer Institute (NCI)	Chronic Myeloproliferative Disorders\|Kidney Cancer\|Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Neoplasms	May 2005	Not Applicable
NCT01503242	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Plasma Cell Myeloma\|Refractory Plasma Cell Myeloma	January 9, 2012	Phase 1
NCT00202917	University Hospital Tuebingen	Hematologic Malignancies	February 2004	Phase 1\|Phase 2
NCT02727803	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Acute Biphenotypic Leukemia\|Acute Lymphoblastic Leukemia\|Acute Lymphoblastic Leukemia in Remission\|Acute Myeloid Leukemia With Myelodysplasia-Related Changes\|Acute Myeloid Leukemia With Variant MLL Translocations\|B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1\|Chemotherapy-Related Leukemia\|Chronic Myelomonocytic Leukemia\|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements\|ISS Stage II Plasma Cell Myeloma\|ISS Stage III Plasma Cell Myeloma\|Myelodysplastic Syndrome\|Myelodysplastic Syndrome With Excess Blasts\|Myelodysplastic Syndrome With Gene Mutation\|Myelodysplastic+Myeloproliferative Neoplasm\|Previously Treated Myelodysplastic Syndrome\|Recurrent Acute Myeloid Leukemia\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Hodgkin Lymphoma\|Recurrent Non-Hodgkin Lymphoma\|Refractory Acute Lymphoblastic Leukemia\|Refractory Adult Acute Lymphoblastic Leukemia\|Secondary Acute Myeloid Leukemia\|Therapy-Related Myelodysplastic Syndrome	May 19, 2016	Phase 2
NCT02275663	King Fahad Medical City	Acute Myeloid Leukemia	December 2014	Phase 2
NCT03171220	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	Advanced Malignant Solid Tumor	June 1, 2017	Phase 1\|Phase 2
NCT01300247	Genentech, Inc.	Lymphocytic Leukemia, Chronic	May 2011	Phase 1
NCT00028600	Alliance for Clinical Trials in Oncology\|National Cancer Institute (NCI)	Multiple Myeloma\|Plasma Cell Neoplasm	November 2001	Phase 2
NCT00948922	H. Lee Moffitt Cancer Center and Research Institute\|Millennium Pharmaceuticals, Inc.	Multiple Myeloma	June 18, 2009	Phase 2
NCT00254410	M.D. Anderson Cancer Center\|OSI Pharmaceuticals\|Genentech, Inc.	Chronic Lymphocytic Leukemia	March 14, 2005	Phase 2
NCT03118492	City of Hope Medical Center\|National Cancer Institute (NCI)	Secondary Myelofibrosis	May 24, 2017	Phase 1
NCT05008575	Xinqiao Hospital of Chongqing\|Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.	Leukemia, Myeloid, Acute	December 23, 2021	Phase 1
NCT00941928	M.D. Anderson Cancer Center	Leukemia\|Pediatric Cancer	July 2009	Phase 2
NCT04127721	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Allogeneic Stem Cell Transplant Recipient\|Hematologic and Lymphocytic Disorder\|Hematopoietic and Lymphoid Cell Neoplasm	September 22, 2020	Phase 2
NCT00085423	Dartmouth-Hitchcock Medical Center\|National Cancer Institute (NCI)	Melanoma (Skin)	February 2004	Phase 2
NCT02048813	National Cancer Institute (NCI)	Anemia\|Chronic Lymphocytic Leukemia\|Small Lymphocytic Lymphoma	February 20, 2014	Phase 3
NCT00005593	Case Comprehensive Cancer Center\|National Cancer Institute (NCI)	Leukemia\|Myelodysplastic Syndromes	September 1998	Phase 1
NCT03101709	Henan Cancer Hospital\|The Beijing Pregene Science and Technology Company, Ltd.	B Cell Lymphoma	August 2016	Phase 1
NCT00943293	University of Chicago	Preleukemia\|Myeloproliferative Disorders\|Lymphoma\|Myeloma\|Graft Versus Host Disease	May 2003	Phase 1
NCT05457556	Children´s Oncology Group	Acute Lymphoblastic Leukemia\|Acute Myeloid Leukemia\|Myelodysplastic Syndrome	November 23, 2022	Phase 3
NCT01350232	Sidney Kimmel Cancer Center at Thomas Jefferson University\|National Heart, Lung, and Blood Institute (NHLBI)\|Thomas Jefferson University	Sickle Cell Anemia\|Sickle Cell-hemoglobin C Disease\|Sickle Cell-β0-thalassemia	September 2009	Not Applicable
NCT00704938	National Institutes of Health Clinical Center (CC)\|National Cancer Institute (NCI)	Kidney Cancer\|Melanoma (Skin)\|Unspecified Adult Solid Tumor, Protocol Specific	June 2008	Phase 2
NCT00909948	Massachusetts General Hospital	Non Hodgkin´s Lymphoma\|Hodgkin Disease\|Multiple Myeloma	November 2008	Phase 1
NCT02621021	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Melanoma	December 4, 2015	Phase 2
NCT05115630	M.D. Anderson Cancer Center	Myeloid Malignancies\|Acute Myeloid Leukemia\|Myelodysplastic Syndrome\|Chronic Myeloid Leukemia	April 8, 2022	Phase 1\|Phase 2
NCT00117156	Dana-Farber Cancer Institute\|Beth Israel Deaconess Medical Center\|Massachusetts General Hospital\|University of Rochester\|Genentech, Inc.\|Biogen	Lymphoma, Non-Hodgkin\|MALT Lymphoma	December 2003	Phase 2
NCT03690011	Baylor College of Medicine\|The Methodist Hospital Research Institute\|Center for Cell and Gene Therapy, Baylor College of Medicine	T-cell Acute Lymphoblastic Leukemia\|T-cell Acute Lymphoblastic Lymphoma\|T-non-Hodgkin Lymphoma	August 2, 2021	Phase 1
NCT01640301	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Recurrent Adult Acute Myeloid Leukemia\|Recurrent Childhood Acute Myeloid Leukemia\|Secondary Acute Myeloid Leukemia\|Therapy-Related Acute Myeloid Leukemia\|Donor\|Hematopoietic Cell Transplant Recipient\|HLA-A*0201 Positive Cells Present\|Recurrent Acute Myeloid Leukemia	December 6, 2012	Phase 1\|Phase 2
NCT01410344	Medical College of Wisconsin\|National Heart, Lung, and Blood Institute (NHLBI)\|National Cancer Institute (NCI)\|Blood and Marrow Transplant Clinical Trials Network\|National Marrow Donor Program	Leukemia\|Lymphoma\|HIV	September 2011	Phase 2
NCT00005799	Fred Hutchinson Cancer Center\|National Heart, Lung, and Blood Institute (NHLBI)\|National Cancer Institute (NCI)	Accelerated Phase Chronic Myelogenous Leukemia\|Adult Acute Lymphoblastic Leukemia in Remission\|Adult Acute Myeloid Leukemia in Remission\|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities\|Adult Acute Myeloid Leukemia With Del(5q)\|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)\|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)\|B-cell Chronic Lymphocytic Leukemia\|Childhood Acute Lymphoblastic Leukemia in Remission\|Childhood Acute Myeloid Leukemia in Remission\|Childhood Chronic Myelogenous Leukemia\|Childhood Myelodysplastic Syndromes\|Childhood Renal Cell Carcinoma\|Chronic Phase Chronic Myelogenous Leukemia\|Clear Cell Renal Cell Carcinoma\|de Novo Myelodysplastic Syndromes\|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue\|Nodal Marginal Zone B-cell Lymphoma\|Previously Treated Myelodysplastic Syndromes\|Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma\|Recurrent Adult Hodgkin Lymphoma\|Recurrent Childhood Acute Lymphoblastic Leukemia\|Recurrent Childhood Acute Myeloid Leukemia\|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma\|Recurrent Grade 1 Follicular Lymphoma\|Recurrent Grade 2 Follicular Lymphoma\|Recurrent Marginal Zone Lymphoma\|Recurrent Mycosis Fungoides+Sezary Syndrome\|Recurrent Small Lymphocytic Lymphoma\|Recurrent+Refractory Childhood Hodgkin Lymphoma\|Refractory Chronic Lymphocytic Leukemia\|Refractory Hairy Cell Leukemia\|Refractory Multiple Myeloma\|Relapsing Chronic Myelogenous Leukemia\|Splenic Marginal Zone Lymphoma\|Stage III Renal Cell Cancer\|Stage IV Renal Cell Cancer\|T-cell Large Granular Lymphocyte Leukemia\|Type 1 Papillary Renal Cell Carcinoma\|Type 2 Papillary Renal Cell Carcinoma\|Waldenström Macroglobulinemia	November 1999	Not Applicable
NCT02153905	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Breast Cancer\|Cervical Cancer\|Renal Cancer\|Melanoma\|Bladder Cancer	July 3, 2014	Phase 1\|Phase 2
NCT02128945	University Hospital, Caen\|CNRS, UMR ISTCT 6301, LDM-TEP Groupe, GIP Cyceron, Caen, France	Untreated B-Chronic Lymphocytic Leukemia or Diffuse Large B Cells Lymphoma Patients	April 2014	Phase 1
NCT00924326	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Primary Mediastinal B-cell Lymphoma\|Diffuse, Large B-cell Lymphoma\|Diffuse Large B-Cell Lymphoma Transformed From Follicular Lymphoma\|Mantle Cell	February 17, 2009	Phase 1\|Phase 2
NCT04923893	Janssen Research & Development, LLC	Multiple Myeloma	August 19, 2021	Phase 3
NCT03190941	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Pancreatic Cancer\|Gastric Cancer\|Gastrointestinal Cancer\|Colon Cancer\|Rectal Cancer	September 21, 2017	Phase 1\|Phase 2
NCT05601466	Institute of Hematology & Blood Diseases Hospital\|Hangzhou Qihan Biotech Co.,Ltd.	AML, Adult	October 28, 2022	Phase 1
NCT01117441	University Hospital Schleswig-Holstein\|Deutsche Krebshilfe e.V., Bonn (Germany)	Leukemia	June 2010	Phase 3
NCT04018937	Emory University	Sickle Cell Disease	March 22, 2019	Phase 2
NCT01653717	M.D. Anderson Cancer Center	Advanced Cancers\|Leukemia	June 11, 2013	Phase 1
NCT03579875	Masonic Cancer Center, University of Minnesota	Fanconi Anemia\|Severe Aplastic Anemia\|Myelodysplastic Syndromes	November 13, 2018	Phase 2
NCT03879382	Hrain Biotechnology Co., Ltd.\|Shanghai Changzheng Hospital	POMES Syndrome\|Relapsed and Refractory POMES Syndrome	February 27, 2019	Phase 1
NCT03597594	St. Jude Children´s Research Hospital	Severe Combined Immunodeficiency	September 8, 2021	Phase 1\|Phase 2
NCT01434472	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Post-Transplant Lymphoproliferative Disorder\|Recurrent Adult Diffuse Large Cell Lymphoma\|Recurrent B-Cell Non-Hodgkin Lymphoma\|Recurrent Burkitt Lymphoma\|Refractory B-Cell Non-Hodgkin Lymphoma\|Refractory Burkitt Lymphoma\|Refractory Diffuse Large B-Cell Lymphoma	November 16, 2011	Phase 2
NCT05035407	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Kita-kyushu Lung Cancer Antigen 1, Human	March 8, 2022	Phase 1
NCT00618540	Masonic Cancer Center, University of Minnesota	Histiocytosis, Langerhans-cell	January 2007	Phase 2
NCT01500161	Texas Oncology Cancer Center	Acute Myelogenous Leukemia\|Acute Lymphocytic Leukemia\|Chronic Lymphocytic Leukemia\|Chronic Myelogenous Leukemia\|Hodgkins Disease\|Non-Hodgkins Lymphoma\|Aplastic Anemia\|Multiple Myeloma\|Myelodysplastic Syndrome	November 2011	Phase 2
NCT01762202	Gruppo Italiano Malattie EMatologiche dell´Adulto	B-cell Lymphoid Leukemia\|Young Patients	November 5, 2013	Phase 2
NCT00301951	University of California, San Francisco\|National Cancer Institute (NCI)	Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes	September 2004	Phase 1
NCT00301834	University of California, San Francisco\|National Cancer Institute (NCI)	Congenital Amegakaryocytic Thrombocytopenia\|Diamond-blackfan Anemia\|Leukemia\|Myelodysplastic Syndromes\|Severe Congenital Neutropenia	January 2005	Phase 2
NCT04008888	Institute of Hematology & Blood Diseases Hospital	Multiple Myeloma\|Plasma Cell Leukemia\|Extramedullary Plasmacytoma\|Loss of Chromosome 17p\|t(14;16)\|t(4;14)\|T(14;20)\|1Q21 Amplification\|Complex Karyotype	January 5, 2018	Not Applicable
NCT02489266	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Metastatic Melanoma	June 24, 2015	Phase 1
NCT00045513	University Health Network, Toronto\|National Cancer Institute (NCI)	Leukemia\|Lymphoma	June 2002	Phase 1\|Phase 2
NCT00067002	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)\|Cellgenix	Leukemia, Lymphocytic, Acute\|Leukemia, Myelocytic, Acute\|Leukemia, Myeloid, Chronic\|Lymphoma, Non-Hodgkin	April 2003	Phase 2
NCT01310179	PNP Therapeutics, Inc.	Head and Neck Cancer	February 2011	Phase 1
NCT00590460	Baylor College of Medicine\|The Methodist Hospital Research Institute\|Center for Cell and Gene Therapy, Baylor College of Medicine	Fanconi Anemia\|Severe Aplastic Anemia	July 2001	Phase 1\|Phase 2
NCT00004485	Fred Hutchinson Cancer Center\|Office of Rare Diseases (ORD)	Sickle Cell Anemia	December 1999	Phase 1\|Phase 2
NCT00593554	Sherif S. Farag\|Indiana University	Acute Myeloid Leukemia\|Acute Lymphoblastic Leukemia\|Myelodysplasia\|Chronic Myeloid Leukemia	August 7, 2007	Phase 2
NCT03263767	Nantes University Hospital	Graft Versus Host Disease	January 15, 2018	Phase 2
NCT00553098	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)\|National Heart, Lung, and Blood Institute (NHLBI)	Immunodeficiency Syndrome\|Non-Cancer Diagnosis	June 2006	Phase 2
NCT00275054	German CLL Study Group	Chronic Lymphocytic Leukemia	October 2005	Phase 3
NCT00723099	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Acute Lymphoblastic Leukemia\|Acute Myeloid Leukemia\|Aggressive Non-Hodgkin Lymphoma\|Chronic Myelogenous Leukemia\|Chronic Phase Chronic Myelogenous Leukemia\|Indolent Non-Hodgkin Lymphoma\|Lymphoma\|Mixed Phenotype Acute Leukemia\|Myelodysplastic Syndrome\|Myeloproliferative Neoplasm\|Recurrent Chronic Lymphocytic Leukemia\|Recurrent Follicular Lymphoma\|Recurrent Lymphoplasmacytic Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Marginal Zone Lymphoma\|Recurrent Plasma Cell Myeloma\|Recurrent Small Lymphocytic Lymphoma\|Recurrent T-Cell Non-Hodgkin Lymphoma\|Refractory Chronic Lymphocytic Leukemia\|Refractory Chronic Myelogenous Leukemia\|Refractory Follicular Lymphoma\|Refractory Hodgkin Lymphoma\|Refractory Lymphoplasmacytic Lymphoma\|Refractory Mantle Cell Lymphoma\|Refractory Small Lymphocytic Lymphoma\|T-Cell Non-Hodgkin Lymphoma	June 25, 2008	Phase 2
NCT00245037	OHSU Knight Cancer Institute\|National Cancer Institute (NCI)	Chronic Myeloproliferative Disorders\|Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Neoplasms\|Precancerous Condition	June 2005	Phase 1\|Phase 2
NCT02057770	Washington University School of Medicine	Leukemia, Myeloid, Acute	February 28, 2014	Phase 1
NCT01279616	Nationwide Children´s Hospital	Sickle Cell Disease	September 2010	Phase 2
NCT03467256	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	B-cell Acute Lymphoblastic Leukemia\|Acute Lymphocytic Leukemia, Pediatric	May 14, 2018	Phase 1\|Phase 2
NCT05577000	Thomas Martin, MD\|Actavis Inc.\|University of California, Davis\|Eugia Pharma Specialities Limited\|University of California, San Francisco	Refractory Multiple Myeloma\|Relapsed Multiple Myeloma	March 1, 2023	Phase 1
NCT00188136	University Hospital Carl Gustav Carus	Acute Myeloid Leukemia	August 2002	Phase 2
NCT01105273	Asan Medical Center	Aplastic Anemia	July 2009	Phase 1\|Phase 2
NCT00499889	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Leukemia	February 2003	Phase 2
NCT04024761	Dana-Farber Cancer Institute\|The Leukemia and Lymphoma Society	Acute Myeloid Leukemia\|Myelodysplastic Syndromes\|Myeloproliferative Neoplasm\|Juvenile Myelomonocytic Leukemia	August 31, 2019	Phase 1
NCT02601313	Kite, A Gilead Company\|Gilead Sciences	Relapsed+Refractory Mantle Cell Lymphoma	November 9, 2015	Phase 2
NCT01894477	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)\|National Heart, Lung, and Blood Institute (NHLBI)	Acute Myeloid Leukemia in Remission\|Chronic Myelomonocytic Leukemia\|Minimal Residual Disease\|Myelodysplastic Syndrome\|Myelodysplastic+Myeloproliferative Neoplasm\|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable	November 2013	Phase 2
NCT01008462	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	B-Cell Prolymphocytic Leukemia\|Hypodiploidy\|Loss of Chromosome 17p\|Plasma Cell Leukemia\|Progression of Multiple Myeloma or Plasma Cell Leukemia\|Recurrent Adult Hodgkin Lymphoma\|Recurrent Adult Non-Hodgkin Lymphoma\|Recurrent Childhood Hodgkin Lymphoma\|Recurrent Childhood Non-Hodgkin Lymphoma\|Recurrent Chronic Lymphocytic Leukemia\|Recurrent Plasma Cell Myeloma\|Recurrent Small Lymphocytic Lymphoma\|Refractory Childhood Hodgkin Lymphoma\|Refractory Chronic Lymphocytic Leukemia\|Refractory Non-Hodgkin Lymphoma\|Refractory Plasma Cell Myeloma\|Refractory Small Lymphocytic Lymphoma\|t(14;16)\|t(4;14)\|T-Cell Prolymphocytic Leukemia\|Waldenstrom Macroglobulinemia	March 18, 2010	Phase 2
NCT05370547	Chinese PLA General Hospital	Non Hodgkin´s Lymphoma	May 25, 2022	Phase 1\|Phase 2
NCT03602612	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Myeloma-Multiple\|Myeloma, Plasma-Cell	September 14, 2018	Phase 1
NCT05317403	Medical College of Wisconsin	Acute Myeloid Leukemia, in Relapse\|Acute Myeloid Leukemia Refractory	July 2022	Phase 1
NCT00208923	Emory University	Hematologic Malignancies	July 1998	Phase 2
NCT05139004	City of Hope Medical Center\|National Cancer Institute (NCI)	Acute Lymphoblastic Leukemia\|Acute Myeloid Leukemia\|Myelodysplastic Syndrome\|Secondary Acute Myeloid Leukemia	July 15, 2024	Phase 1
NCT00119340	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Leukemia	April 2005	Phase 1\|Phase 2
NCT03049449	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Lymphoma, Large-Cell, Anaplastic\|Enteropathy-Associated T-Cell Lymphoma\|Lymphoma, Large B-Cell, Diffuse\|Lymphoma, Extranodal NK-T-Cell\|Lymphoma, T-Cell, Peripheral	March 17, 2017	Phase 1
NCT03128359	City of Hope Medical Center\|National Cancer Institute (NCI)	Acute Leukemia\|Chronic Lymphocytic Leukemia+Small Lymphocytic Lymphoma\|Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Diffuse Large B-Cell Lymphoma\|Follicular Lymphoma\|Graft Versus Host Disease\|Hodgkin Lymphoma\|Mantle Cell Lymphoma\|Marginal Zone Lymphoma\|Myelodysplastic Syndrome\|Myeloproliferative Neoplasm\|Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes\|Recurrent Plasma Cell Myeloma\|Refractory Plasma Cell Myeloma\|Secondary Myelodysplastic Syndrome	May 30, 2017	Phase 2
NCT02013817	Hoffmann-La Roche	Lymphocytic Leukemia, Chronic	October 11, 2005	Phase 2
NCT03873805	City of Hope Medical Center\|National Cancer Institute (NCI)	Castration-Resistant Prostate Carcinoma\|Metastatic Prostate Carcinoma\|Stage IV Prostate Cancer AJCC v8\|Stage IVA Prostate Cancer AJCC v8\|Stage IVB Prostate Cancer AJCC v8	August 20, 2019	Phase 1
NCT00565981	Arbeitsgemeinschaft medikamentoese Tumortherapie\|Schering-Plough	B-cell Chronic Lymphocytic Leukemia	March 2004	Phase 2
NCT04002401	Kite, A Gilead Company\|Gilead Sciences	Refractory Large B-cell Lymphoma	November 5, 2019	Phase 2
NCT05027945	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Immunodeficiency\|Hematopoietic Stem Cell Transplantation	November 28, 2022	Phase 2
NCT00719888	Fred Hutchinson Cancer Center	Acute Biphenotypic Leukemia\|Acute Lymphoblastic Leukemia\|Acute Myeloid Leukemia\|Burkitt Lymphoma\|Chronic Lymphocytic Leukemia\|Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Follicular Lymphoma\|Lymphoblastic Lymphoma\|Lymphoplasmacytic Lymphoma\|Mantle Cell Lymphoma\|Marginal Zone Lymphoma\|Myelodysplastic Syndrome\|Myelofibrosis\|Non-Hodgkin Lymphoma\|Plasma Cell Myeloma\|Prolymphocytic Leukemia\|Refractory Anemia\|Small Lymphocytic Lymphoma	November 18, 2005	Phase 2
NCT00521430	Asan Medical Center\|National Cancer Institute (NCI)	Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Nonmalignant Neoplasm\|Unspecified Adult Solid Tumor, Protocol Specific	April 2004	Not Applicable
NCT00110058	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Leukemia	February 2005	Phase 2
NCT01163201	Masonic Cancer Center, University of Minnesota	Hematologic Malignancy\|Acute Myeloid Leukemia\|Acute Lymphocytic Leukemia\|Chronic Myelogenous Leukemia in Blast Crisis\|Anemia, Refractory, With Excess of Blasts\|Chronic Myeloproliferative Disease\|Chronic Lymphocytic Leukemia\|Small Lymphocytic Lymphoma\|Marginal Zone B-cell Lymphoma\|Follicular Lymphoma\|Lymphoplasmacytic Lymphoma\|Mantle-Cell Lymphoma\|Prolymphocytic Lymphoma\|Large Cell Non-Hodgkin´s Lymphoma\|Lymphoblastic Lymphoma\|Burkitt´s Lymphoma\|High Grade Non-Hodgkin´s Lymphoma	January 2014	Phase 1\|Phase 2
NCT01271907	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Metastatic Cutaneous Melanoma	April 15, 2011	Phase 2
NCT00004135	University of Chicago\|National Cancer Institute (NCI)	Kidney Cancer\|Melanoma (Skin)	February 1999	Phase 2
NCT00489281	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins\|National Cancer Institute (NCI)	Sickle Cell Disease	June 23, 2008	Phase 2
NCT03044743	Yang Yang\|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	Stage IV Gastric Carcinoma\|Stage IV Nasopharyngeal Carcinoma\|T-Cell Lymphoma Stage IV\|Stage IV Adult Hodgkin Lymphoma\|Stage IV Diffuse Large B-Cell Lymphoma	April 7, 2017	Phase 1\|Phase 2
NCT00003248	Alliance for Clinical Trials in Oncology\|National Cancer Institute (NCI)	Leukemia	March 1998	Phase 2
NCT01131169	Memorial Sloan Kettering Cancer Center\|Otsuka America Pharmaceutical\|Ludwig Institute for Cancer Research	Multiple Myeloma	May 2010	Phase 2
NCT01810588	Weill Medical College of Cornell University	Hematologic Malignancies	October 16, 2012	Phase 2
NCT00918723	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Chronic Lymphocytic Leukemia\|Stage I Chronic Lymphocytic Leukemia\|Stage I Small Lymphocytic Lymphoma\|Stage II Chronic Lymphocytic Leukemia\|Stage II Small Lymphocytic Lymphoma\|Stage III Chronic Lymphocytic Leukemia\|Stage III Small Lymphocytic Lymphoma\|Stage IV Chronic Lymphocytic Leukemia\|Stage IV Small Lymphocytic Lymphoma	June 2009	Phase 1\|Phase 2
NCT05598593	First Affiliated Hospital of Zhejiang University	Cytarabine&addition;Thiotepa &addition; Fludarabine &addition; Busulfan\|T Cell Acute Lymphoblastic Leukemia+Lymphoblastic Lymphoma	October 23, 2022	Phase 2
NCT04536922	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Metastatic HPV-16 Positive Squamous Cell Anal Cancer	January 27, 2021	Phase 2
NCT05442580	University of Pennsylvania	Acute Myeloid Leukemia (AML)\|Multiple Myeloma (MM)	May 2023	Phase 1
NCT02917096	City of Hope Medical Center\|National Cancer Institute (NCI)	Primary Myelofibrosis\|Secondary Myelofibrosis	November 13, 2016	Phase 1
NCT04191187	H. Lee Moffitt Cancer Center and Research Institute	Acute Myeloid Leukemia\|Acute Lymphoblastic Leukemia\|Biphenotypic Acute Leukemia\|Undifferentiated Leukemia\|Prolymphocytic Leukemia\|Myelodysplastic Syndromes\|Chronic Myelogenous Leukemia\|Myeloproliferative Neoplasm\|Relapsed Large Cell Lymphoma\|Mantle Cell Lymphoma\|Hodgkin Lymphoma\|Burkitt Lymphoma\|Relapsed T-Cell Lymphoma\|Relapsed Chronic Lymphocytic Leukemia\|Relapsed Small Lymphocytic Lymphoma\|Relapsed Marginal B-cell Lymphoma\|Relapsed Follicular Lymphoma\|Lymphoplasmacytic Lymphoma	December 6, 2019	Phase 2
NCT00378534	National Heart, Lung, and Blood Institute (NHLBI)\|National Institutes of Health Clinical Center (CC)	Chronic Myelogenous Leukemia\|Acute Myelogenous Leukemia\|Chronic Lymphocytic Leukemia\|Acute Lymphoblastic Leukemia\|Myelodysplastic Syndrome	September 2006	Phase 2
NCT04002115	Milton S. Hershey Medical Center	Acute Myeloid Leukemia	June 3, 2020	Phase 2
NCT04877613	University of Pennsylvania	Metastatic Medullary Thyroid Cancer	August 19, 2021	Phase 1
NCT01773395	Dana-Farber Cancer Institute\|Massachusetts General Hospital\|Beth Israel Deaconess Medical Center	Myelodysplastic Syndrome\|Acute Myeloid Leukemia\|Chronic Myelomonocytic Leukemia	January 8, 2013	Phase 2
NCT02199041	St. Jude Children´s Research Hospital	Hematological Malignancies	July 11, 2014	Phase 2
NCT03326921	Fred Hutchinson Cancer Center\|HighPass Bio, Inc.	Juvenile Myelomonocytic Leukemia\|Recurrent Acute Biphenotypic Leukemia\|Recurrent Acute Undifferentiated Leukemia\|Recurrent Childhood Acute Lymphoblastic Leukemia\|Recurrent Childhood Acute Myeloid Leukemia\|Refractory Acute Lymphoblastic Leukemia\|Refractory Adult Acute Lymphoblastic Leukemia\|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm\|Recurrent Myelodysplastic Syndrome\|Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm\|Refractory Myelodysplastic Syndrome\|Acute Undifferentiated Leukemia\|Mixed Phenotype Acute Leukemia\|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Recurrent Acute Lymphoblastic Leukemia\|Recurrent Acute Myeloid Leukemia\|Myelodysplastic Syndrome\|Acute Myeloid Leukemia\|Acute Lymphoblastic Leukemia\|Acute Biphenotypic Leukemia\|Chronic Myeloid Leukemia\|Chronic Myelomonocytic Leukemia\|Minimal Residual Disease\|Recurrent Chronic Myelomonocytic Leukemia\|Recurrent Mixed Phenotype Acute Leukemia\|Leukemia	February 23, 2018	Phase 1
NCT02926833	Kite, A Gilead Company\|Genentech, Inc.\|Gilead Sciences	Refractory Diffuse Large B Cell Lymphoma	September 29, 2016	Phase 1\|Phase 2
NCT01071239	Medical College of Wisconsin\|Memorial Sloan Kettering Cancer Center	Fanconi Anemia	April 2009	Phase 2
NCT05400109	James Michael Martin\|Case Comprehensive Cancer Center	Non Hodgkin Lymphoma	October 2023	Phase 1
NCT00305708	University of California, San Francisco\|National Cancer Institute (NCI)	Congenital Amegakaryocytic Thrombocytopenia\|Diamond-blackfan Anemia\|Fanconi Anemia\|Leukemia\|Severe Congenital Neutropenia\|Thrombocytopenia	August 2000	Phase 1\|Phase 2
NCT04530487	M.D. Anderson Cancer Center	Desmoplastic Small Round Cell Tumor\|Ewing Sarcoma+Peripheral Primitive Neuroectodermal Tumor\|Recurrent Desmoplastic Small Round Cell Tumor\|Recurrent Malignant Peripheral Nerve Sheath Tumor\|Recurrent Malignant Solid Neoplasm\|Recurrent Neuroblastoma\|Recurrent Rhabdomyosarcoma\|Refractory Desmoplastic Small Round Cell Tumor\|Refractory Malignant Peripheral Nerve Sheath Tumor\|Refractory Malignant Solid Neoplasm\|Refractory Neuroblastoma\|Refractory Rhabdomyosarcoma	August 19, 2020	Phase 2
NCT03158935	University Health Network, Toronto\|Merck Sharp & Dohme LLC	Advanced Ovarian Cancer\|Malignant Melanoma	July 7, 2017	Phase 1
NCT00091104	National Institutes of Health Clinical Center (CC)\|National Cancer Institute (NCI)	Melanoma (Skin)	July 2004	Phase 1
NCT00412360	Medical College of Wisconsin\|National Heart, Lung, and Blood Institute (NHLBI)\|Blood and Marrow Transplant Clinical Trials Network\|National Cancer Institute (NCI)\|National Marrow Donor Program	Acute Myelogenous Leukemia\|Acute Lymphocytic Leukemia\|Chronic Myelogenous Leukemia\|Myelodysplastic Syndrome\|Natural Killer Cell Lymphoblastic Leukemia+Lymphoma	December 2006	Phase 3
NCT00001832	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Melanoma\|Neoplasm Metastasis	August 1999	Phase 2
NCT00393029	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Anti-p53 TCR-Gene	October 2006	Phase 2
NCT01823198	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Acute Erythroid Leukemia\|Acute Megakaryoblastic Leukemia\|Acute Myeloid Leukemia\|Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome\|Acute Myeloid Leukemia in Remission\|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Blasts Under 20 Percent of Bone Marrow Nucleated Cells\|Blasts Under 20 Percent of Peripheral Blood White Cells\|Chronic Myelomonocytic Leukemia\|High Risk Myelodysplastic Syndrome\|Myelodysplastic Syndrome\|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Therapy-Related Acute Myeloid Leukemia\|Therapy-Related Myelodysplastic Syndrome	June 11, 2013	Phase 1\|Phase 2
NCT00513604	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Melanoma\|Malignant Melanoma\|Melanoma, Experimental\|Experimental Melanomas	June 2007	Phase 2
NCT00008307	Herbert Irving Comprehensive Cancer Center\|National Cancer Institute (NCI)	Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes	April 1998	Phase 2
NCT02482090	Inge Marie Svane\|Herlev Hospital	Metastatic Ovarian Cancer	July 2015	Phase 1
NCT02062359	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Metastatic Cancer\|Metastatic Melanoma	February 2014	Phase 2
NCT00056979	Baylor College of Medicine\|The Methodist Hospital Research Institute	Inherited Metabolic Storage Diseases	June 2002	Phase 1\|Phase 2
NCT00472329	Colorado Blood Cancer Institute	Graft Failure	March 2007	Phase 2
NCT03856216	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Acute Lymphoblastic Leukemia\|B Acute Lymphoblastic Leukemia\|Lymphocytic Neoplasm\|Lymphoma	October 28, 2019	Phase 2
NCT00048399	Baylor College of Medicine\|The Methodist Hospital Research Institute	Graft Failure	December 2000	Phase 1\|Phase 2
NCT03754933	GeoVax, Inc.\|Stanford University\|Emory University\|Thomas Jefferson University	Recurrent Head and Neck Cancer	February 11, 2019	Phase 1\|Phase 2
NCT02775292	Jonsson Comprehensive Cancer Center\|Stand Up To Cancer\|Bristol-Myers Squibb\|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)\|National Cancer Institute (NCI)	Adult Solid Neoplasm\|Childhood Solid Neoplasm\|Metastatic Neoplasm	January 3, 2017	Phase 1
NCT01622556	University of Virginia	Hematologic Malignancies	January 2012	Phase 2
NCT02065596	Case Comprehensive Cancer Center	Sickle Cell Disease\|Sickle Cell Anemia\|SCD	October 19, 2015	Phase 1\|Phase 2
NCT01760655	Sidney Kimmel Cancer Center at Thomas Jefferson University\|Thomas Jefferson University	Accelerated Phase Chronic Myelogenous Leukemia\|Adult Acute Lymphoblastic Leukemia in Remission\|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities\|Adult Acute Myeloid Leukemia With Del(5q)\|Adult Nasal Type Extranodal NK+T-cell Lymphoma\|Anaplastic Large Cell Lymphoma\|Angioimmunoblastic T-cell Lymphoma\|Blastic Phase Chronic Myelogenous Leukemia\|Childhood Acute Lymphoblastic Leukemia in Remission\|Childhood Burkitt Lymphoma\|Childhood Chronic Myelogenous Leukemia\|Childhood Diffuse Large Cell Lymphoma\|Childhood Immunoblastic Large Cell Lymphoma\|Childhood Myelodysplastic Syndromes\|Childhood Nasal Type Extranodal NK+T-cell Lymphoma\|Chronic Myelomonocytic Leukemia\|Chronic Phase Chronic Myelogenous Leukemia\|Cutaneous B-cell Non-Hodgkin Lymphoma\|de Novo Myelodysplastic Syndromes\|Essential Thrombocythemia\|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue\|Hepatosplenic T-cell Lymphoma\|Intraocular Lymphoma\|Juvenile Myelomonocytic Leukemia\|Nodal Marginal Zone B-cell Lymphoma\|Noncutaneous Extranodal Lymphoma\|Peripheral T-cell Lymphoma\|Polycythemia Vera\|Post-transplant Lymphoproliferative Disorder\|Previously Treated Myelodysplastic Syndromes\|Primary Myelofibrosis\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Adult Burkitt Lymphoma\|Recurrent Adult Diffuse Large Cell Lymphoma\|Recurrent Adult Diffuse Mixed Cell Lymphoma\|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma\|Recurrent Adult Grade III Lymphomatoid Granulomatosis\|Recurrent Adult Hodgkin Lymphoma\|Recurrent Adult Immunoblastic Large Cell Lymphoma\|Recurrent Adult Lymphoblastic Lymphoma\|Recurrent Adult T-cell Leukemia+Lymphoma\|Recurrent Childhood Acute Myeloid Leukemia\|Recurrent Childhood Anaplastic Large Cell Lymphoma\|Recurrent Childhood Grade III Lymphomatoid Granulomatosis\|Recurrent Childhood Large Cell Lymphoma\|Recurrent Childhood Lymphoblastic Lymphoma\|Recurrent Childhood Small Noncleaved Cell Lymphoma\|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma\|Recurrent Grade 1 Follicular Lymphoma\|Recurrent Grade 2 Follicular Lymphoma\|Recurrent Grade 3 Follicular Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Marginal Zone Lymphoma\|Recurrent Mycosis Fungoides+Sezary Syndrome\|Recurrent Small Lymphocytic Lymphoma\|Recurrent+Refractory Childhood Hodgkin Lymphoma\|Refractory Anemia With Excess Blasts\|Refractory Anemia With Excess Blasts in Transformation\|Refractory Cytopenia With Multilineage Dysplasia\|Refractory Hairy Cell Leukemia\|Refractory Multiple Myeloma\|Relapsing Chronic Myelogenous Leukemia\|Secondary Acute Myeloid Leukemia\|Small Intestine Lymphoma\|Splenic Marginal Zone Lymphoma\|T-cell Large Granular Lymphocyte Leukemia\|Testicular Lymphoma\|Waldenström Macroglobulinemia	December 24, 2012	Phase 2
NCT00794820	M.D. Anderson Cancer Center\|Genentech, Inc.	Chronic Lymphocytic Leukemia	December 2003	Phase 2
NCT04596033	Genocea Biosciences, Inc.	Melanoma\|Non-small Cell Lung Cancer\|Squamous Cell Carcinoma of Head and Neck\|Urothelial Carcinoma\|Renal Cell Carcinoma\|Small-cell Lung Cancer\|Cutaneous Squamous Cell Carcinoma\|Anal Squamous Cell Carcinoma\|Merkel Cell Carcinoma	November 11, 2020	Phase 1
NCT05566223	Intima Bioscience, Inc.	Carcinoma, Non-Small-Cell Lung\|Metastatic Non Small Cell Lung Cancer\|Stage IV Non-small Cell Lung Cancer\|Squamous Cell Lung Cancer\|Adenocarcinoma of Lung\|Large Cell Lung Cancer	November 2022	Phase 1\|Phase 2
NCT00688883	Genzyme, a Sanofi Company\|Sanofi	Lymphoma	February 2003	Phase 2
NCT02793544	Center for International Blood and Marrow Transplant Research\|National Marrow Donor Program	Myelodysplastic Syndrome (MDS)\|Chronic Lymphocytic Leukemia (CLL)\|Chemotherapy-sensitive Lymphoma\|Acute Lymphoblastic Leukemia (ALL)+T Lymphoblastic Lymphoma\|Acute Myelogenous Leukemia (AML)\|Acute Biphenotypic Leukemia (ABL)\|Acute Undifferentiated Leukemia (AUL)	December 2016	Phase 2
NCT05031897	Thomas Jefferson University	Acute Lymphoblastic Leukemia\|Acute Myeloid Leukemia\|Aplastic Anemia\|Chronic Lymphocytic Leukemia\|Chronic Myelomonocytic Leukemia\|Essential Thrombocythemia\|Hematopoietic and Lymphoid Cell Neoplasm\|Hodgkin Lymphoma\|Myelodysplastic Syndromes\|Myelofibrosis\|Myeloid Leukemia\|Myeloid Neoplasm\|Non-Hodgkin Lymphoma\|Plasma Cell Myeloma\|Polycythemia Vera\|Small Lymphocytic Lymphoma	October 25, 2021	Phase 2
NCT05088356	Stanford University\|Orca Biosystems, Inc.	Allogeneic Hematopoietic Cell Transplantation (HCT)\|Advanced Hematologic Malignancies\|Acute Leukemia\|Chronic Myelogenous Leukemia\|Myelodysplastic Syndromes\|Myeloproliferative Disorders	September 7, 2021	Phase 1
NCT01027000	Alliance for Clinical Trials in Oncology\|National Cancer Institute (NCI)\|Genentech, Inc.\|Biologics, Inc.	Leukemia\|Lymphoma	February 2010	Phase 2
NCT04942730	St. Petersburg State Pavlov Medical University	Leukemia, Acute Lymphoblastic\|Myeloid Leukemia, Acute\|Biphenotypic Acute Leukemia\|Lymphoblastic Lymphoma\|Myelodysplastic Syndromes\|Myeloproliferative Neoplasm	January 21, 2021	Phase 2
NCT00282412	Northwestern University	Rheumatoid Arthritis	September 2002	Phase 1
NCT01745913	Weill Medical College of Cornell University	Acute Myelogenous Leukemia\|Myelodysplastic Syndrome\|Acute Lymphocytic Leukemia\|Hodgkin´s Lymphoma\|Non-Hodgkin´s Lymphoma	October 26, 2012	Phase 2
NCT03615105	Memorial Sloan Kettering Cancer Center	Acute Lymphoid Leukemia (ALL)\|Acute Myeloid Leukemia (AML)\|Chronic Myeloid Leukemia (CML)\|Hodgkin Lymphoma\|Non-Hodgkin Lymphoma\|Chronic Lymphocytic Leukemia	July 25, 2018	Phase 2
NCT00003145	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Accelerated Phase of Disease\|Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Chronic Phase of Disease\|Recurrent Disease	August 1997	Phase 2
NCT00523809	M.D. Anderson Cancer Center	Breast Cancer\|Ovarian Cancer	August 2007	Phase 2
NCT05357027	TCRCure Biopharma Ltd.\|Fudan University	Cervical Carcinoma	August 10, 2022	Phase 1\|Phase 2
NCT00255684	University of Rochester	Chronic Myeloproliferative Disorders\|Graft Versus Host Disease\|Leukemia\|Lymphoma\|Multiple Myeloma\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Neoplasms	December 2003	Not Applicable
NCT00544466	City of Hope Medical Center\|National Cancer Institute (NCI)	Leukemia\|Myelodysplastic Syndromes	July 31, 2006	Phase 1\|Phase 2
NCT02319135	PETHEMA Foundation\|Dynamic Solutions	Acute Myeloid Leukemia	October 2014	Phase 3
NCT00793572	Fred Hutchinson Cancer Center\|Millennium Pharmaceuticals, Inc.\|National Cancer Institute (NCI)	Refractory Plasma Cell Myeloma	October 2008	Phase 2
NCT00006042	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins\|National Cancer Institute (NCI)	Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Diseases	December 1999	Phase 1
NCT00782379	Northside Hospital, Inc.	Leukemia\|Lymphoma\|Myelodysplastic Syndromes	October 2008	Phase 2
NCT01096992	M.D. Anderson Cancer Center	Leukemia	April 19, 2010	Phase 1\|Phase 2
NCT04282174	Baptist Health South Florida	Hematologic Diseases\|Hematologic Malignancy\|Acute Lymphoblastic Leukemia\|Acute Myeloid Leukemia\|Chronic Myelogenous Leukemia\|Chronic Lymphocytic Leukemia	September 2022	Phase 2
NCT01435343	PETHEMA Foundation	Acute Myeloblastic Leukemia	July 2012	Phase 1\|Phase 2
NCT05327023	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Hematologic Neoplasms	May 23, 2022	Phase 1\|Phase 2
NCT00060684	CTI BioPharma	Lymphoma, Low-Grade\|Lymphoma, Small Lymphocytic\|Lymphoma, Mixed-Cell, Follicular\|Lymphoma, Small Cleaved-Cell, Follicular	December 2001	Phase 1
NCT01456351	University of Giessen	Non-Hodgkin´s Lymphoma\|Mantle Cell Lymphoma	September 2003	Phase 3
NCT00209833	Hannover Medical School\|University of Ulm\|Johann Wolfgang Goethe University Hospital\|University Hospital Freiburg\|University Hospital Augsburg\|Humboldt-Universität zu Berlin\|Universitätsklinikum Hamburg-Eppendorf\|University Hospital, Ghent\|Medizinische Universitätsklinik Tübingen\|Klinikum Hanover-Siloah Hospital\|Ev. Krankenhaus Essen-Werden\|Klinikum Wuppertal GmbH	De Novo Akute Myeloid Leukemia (AML)\|Secondary Acute Myeloid Leukemia (AML)\|Refractory Anemia With Excess of Blasts in Transformation	January 1999	Phase 2\|Phase 3
NCT00525876	M.D. Anderson Cancer Center	Lymphoma	January 2005	Not Applicable
NCT01119066	Memorial Sloan Kettering Cancer Center	Acute Lymphoblastic Leukemia\|Acute Myelogenous Leukemia\|Myelodysplastic Syndrome\|Multiple Myeloma	May 3, 2010	Phase 2
NCT00389506	National Institutes of Health Clinical Center (CC)\|National Cancer Institute (NCI)	Lymphoma	September 2006	Not Applicable
NCT00972101	M.D. Anderson Cancer Center	Stem Cell Transplantation\|Leukemia\|Lymphoma\|Pediatric Disorders	September 2009	Phase 1
NCT05442515	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Acute Lymphoid Leukemia\|B-Cell Leukemia\|Leukemia, Lymphocytic, B Cell\|B-Cell Lymphoma\|Lymphoma, Non-Hodgkin	November 28, 2022	Phase 1\|Phase 2
NCT04389229	Immetacyte Ltd	Ovarian Cancer Metastatic	July 1, 2020	Phase 1\|Phase 2
NCT04245839	Celgene	Lymphoma, Non-Hodgkin	July 14, 2020	Phase 2
NCT00625729	Masonic Cancer Center, University of Minnesota\|National Cancer Institute (NCI)	Leukemia\|Lymphoma	January 2008	Phase 1\|Phase 2
NCT04510051	City of Hope Medical Center\|National Cancer Institute (NCI)	Malignant Brain Neoplasm\|Recurrent Malignant Brain Neoplasm\|Refractory Malignant Brain Neoplasm	December 4, 2020	Phase 1
NCT03399448	University of Pennsylvania\|Parker Institute for Cancer Immunotherapy\|Tmunity Therapeutics	Multiple Myeloma\|Melanoma\|Synovial Sarcoma\|Myxoid+Round Cell Liposarcoma	September 5, 2018	Phase 1
NCT00038857	M.D. Anderson Cancer Center	Leukemia\|Lymphoma	September 2001	Phase 2
NCT00915811	King´s College Hospital NHS Trust	Myelodysplastic Syndromes\|Leukemia, Myeloid, Acute	June 2007	Phase 2
NCT00376519	Masonic Cancer Center, University of Minnesota	Graft Versus Host Disease\|Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Secondary Myelofibrosis	May 2007	Phase 1
NCT04135092	National Institutes of Health Clinical Center (CC)
NCT02333162	University of Chicago\|National Cancer Institute (NCI)	Previously Treated Myelodysplastic Syndrome\|Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Hematologic Malignancy	December 5, 2014	Phase 1
NCT03500731	Paul Szabolcs\|University of Pittsburgh	Idiopathic Pulmonary Fibrosis\|Emphysema or COPD	April 19, 2018	Phase 1\|Phase 2
NCT01087398	Tehran University of Medical Sciences	Osteopetrosis	September 2009	Phase 2\|Phase 3
NCT00085462	National Institutes of Health Clinical Center (CC)\|National Cancer Institute (NCI)	Melanoma (Skin)	May 2004	Phase 1
NCT00025038	National Cancer Institute (NCI)	Juvenile Myelomonocytic Leukemia	June 2001	Phase 2
NCT01991457	University of Alabama at Birmingham	Adult Lymphoblastic Lymphoma	August 27, 2013	Phase 2
NCT00053989	Roswell Park Cancer Institute	Chronic Myeloproliferative Disorders\|Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Diseases\|Fanconi Anemia\|Aplastic Anemia	January 29, 2002	Phase 2
NCT00328861	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Metastatic Melanoma\|Metastatic Kidney Cancer	May 2006	Phase 2
NCT02412475	Michael Burke\|Children´s Hospitals and Clinics of Minnesota\|Medical College of Wisconsin	Leukemia, Acute Myeloid	February 21, 2015	Phase 1
NCT00001422	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)\|National Institutes of Health Clinical Center (CC)	Arthritis, Psoriatic\|Psoriasis	June 1995	Phase 2
NCT00608517	Vanderbilt-Ingram Cancer Center\|National Cancer Institute (NCI)	Graft Versus Host Disease\|Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes	September 2005	Not Applicable
NCT02181478	Case Comprehensive Cancer Center\|National Cancer Institute (NCI)	Acute Lymphoblastic Leukemia\|Acute Myelogenous Leukemia\|Myelodysplastic Syndromes\|Myelofibrosis\|Relapsed Non-Hodgkin Lymphoma\|Refractory Non-Hodgkin Lymphoma\|Hodgkin Lymphoma\|Refractory Hodgkin Lymphoma\|Relapsed Chronic Lymphocytic Leukemia\|Refractory Chronic Lymphocytic Leukemia\|Lymphoid Malignancies\|Chronic Myelogenous Leukemia	July 22, 2015	Early Phase 1
NCT01203020	West Virginia University	Hodgkin´s Lymphoma\|Non-Hodgkin´s Lymphoma	October 12, 2010	Phase 2
NCT05513612	Shanghai Pudong Hospital\|UTC Therapeutics Inc.	Acute Myeloid Leukemia (AML)\|B-cell Non-Hodgkin´s Lymphoma (B-NHL)\|Multiple Myeloma (MM)\|T-Cell Leukemia+Lymphoma, Adult\|B-cell Acute Lymphoblastic Leukemia (B-ALL)	August 1, 2020	Phase 1
NCT03103971	Fred Hutchinson Cancer Center\|Juno Therapeutics, Inc.	Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent B-Cell Non-Hodgkin Lymphoma\|Recurrent Diffuse Large B-Cell Lymphoma\|Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma\|Refractory Adult Acute Lymphoblastic Leukemia\|Refractory B-Cell Non-Hodgkin Lymphoma\|Refractory Diffuse Large B-Cell Lymphoma\|Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma\|Recurrent Transformed Non-Hodgkin Lymphoma\|Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements\|Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements\|Recurrent B Acute Lymphoblastic Leukemia\|Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified\|Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements\|Refractory B Acute Lymphoblastic Leukemia\|Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified\|Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements	November 3, 2017	Phase 1
NCT01639456	Masonic Cancer Center, University of Minnesota\|Miltenyi Biomedicine GmbH	Acute Myelogenous Leukemia	October 2013	Phase 2
NCT01168219	National Cancer Institute (NCI)	Acute Myeloid Leukemia\|Adult Acute Megakaryoblastic Leukemia\|Adult Acute Monoblastic Leukemia\|Adult Acute Monocytic Leukemia\|Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11\|Adult Acute Myeloid Leukemia With Maturation\|Adult Acute Myeloid Leukemia With Minimal Differentiation\|Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11\|Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1\|Adult Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLL\|Adult Acute Myeloid Leukemia Without Maturation\|Adult Acute Myelomonocytic Leukemia\|Adult Erythroleukemia\|Adult Pure Erythroid Leukemia\|Alkylating Agent-Related Acute Myeloid Leukemia\|de Novo Myelodysplastic Syndrome\|Myelodysplastic Syndrome\|Myelodysplastic Syndrome With Excess Blasts\|Recurrent Adult Acute Myeloid Leukemia\|Secondary Myelodysplastic Syndrome	July 15, 2010	Phase 2
NCT02248597	Wake Forest University Health Sciences\|National Cancer Institute (NCI)	Graft Versus Host Disease\|Hematopoietic+Lymphoid Cancer	February 25, 2015	Phase 2
NCT01509300	Asan Medical Center	Acute Leukemia\|Myelodysplastic Syndrome\|Solid Tumors	January 2012	Phase 1\|Phase 2
NCT02514083	National Heart, Lung, and Blood Institute (NHLBI)\|National Institutes of Health Clinical Center (CC)	Chronic Lymphocytic Leukemia\|Small Lymphocytic Lymphoma	December 9, 2015	Phase 2
NCT04109482	Mustang Bio	Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)	February 17, 2020	Phase 1\|Phase 2
NCT00475020	M.D. Anderson Cancer Center	Myelofibrosis	January 4, 2006	Phase 2
NCT04214886	Loyola University\|Leukemia Research Foundation	B-Cell Acute Lymphoblastic Leukemia, Adult\|B-cell Lymphoma Refractory\|B-cell Lymphoma Recurrent	December 31, 2019	Phase 1
NCT02916979	Dartmouth-Hitchcock Medical Center	Leukemia, Lymphoid\|Leukemia, Myeloid\|Myelodysplastic Syndromes\|Myelofibrosis\|Lymphoma, Malignant\|Multiple Myeloma\|Waldenstrom Macroglobulinemia	September 6, 2016	Phase 1
NCT02167958	Rafic Farah, MD\|University of Pittsburgh	Leukemia\|MDS\|Myelofibrosis\|Lymphoma	February 11, 2015	Phase 1
NCT02212561	St. Jude Children´s Research Hospital\|Karyopharm Therapeutics Inc	Acute Myeloid Leukemia (AML)\|Acute Lymphoblastic Leukemia (ALL)\|Myelodysplastic Syndrome (MDS)\|Mixed Phenotype Acute Leukemia (MPAL)	August 2014	Phase 1
NCT02406092	Hoffmann-La Roche	Non-Hodgkin Lymphoma	October 13, 2015	Phase 3
NCT03799913	Zhejiang University\|Second Affiliated Hospital, School of Medicine, Zhejiang University\|Hrain Biotechnology Co., Ltd.	Ovarian Cancer	April 10, 2019	Early Phase 1
NCT00589316	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome\|Adult Acute Lymphoblastic Leukemia in Remission\|Adult Acute Myeloid Leukemia in Remission\|CD45-Positive Neoplastic Cells Present\|Chronic Myelomonocytic Leukemia\|Previously Treated Myelodysplastic Syndrome\|Refractory Anemia With Excess Blasts\|Refractory Anemia With Ring Sideroblasts\|Refractory Cytopenia With Multilineage Dysplasia\|Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts	October 5, 2007	Phase 1
NCT03393611	Weill Medical College of Cornell University\|Jazz Pharmaceuticals	Myelodysplastic Syndromes\|Leukemia, Myeloid, Acute\|Leukemia, Relapsed Adult Acute Myeloid\|Myelodysplastic Syndromes, Previously Treated	November 30, 2012	Phase 1
NCT05459571	Kite, A Gilead Company\|Gilead Sciences	Relapsed or Refractory Large B-cell Lymphoma	August 10, 2022	Phase 2
NCT00002798	National Cancer Institute (NCI)	Childhood Acute Erythroleukemia (M6)\|Childhood Acute Megakaryocytic Leukemia (M7)\|Childhood Acute Monoblastic Leukemia (M5a)\|Childhood Acute Monocytic Leukemia (M5b)\|Childhood Acute Myeloblastic Leukemia With Maturation (M2)\|Childhood Acute Myeloblastic Leukemia Without Maturation (M1)\|Childhood Acute Myelomonocytic Leukemia (M4)\|Childhood Myelodysplastic Syndromes\|Chronic Myelomonocytic Leukemia\|de Novo Myelodysplastic Syndromes\|Refractory Anemia\|Refractory Anemia With Excess Blasts\|Refractory Anemia With Excess Blasts in Transformation\|Refractory Anemia With Ringed Sideroblasts\|Secondary Myelodysplastic Syndromes\|Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies	August 1996	Phase 3
NCT00397800	Technical University of Munich	Lymphoma	June 2005	Phase 1\|Phase 2
NCT00802568	Institut Paoli-Calmettes\|National Cancer Institute (NCI)	Multiple Myeloma and Plasma Cell Neoplasm	April 2007	Phase 2
NCT03029273	Guangzhou Institute of Respiratory Disease\|Xiangxue Life Science Research Center\|Guangdong Xiangxue Precision Medical Technology Co., Ltd.\|Xiangxue Pharmaceutical	Lung Cancer, Nonsmall Cell, Recurrent	March 21, 2017	Phase 1
NCT00048737	M.D. Anderson Cancer Center\|Biogen	Lymphoma\|Leukemia	October 2002	Phase 1\|Phase 2
NCT01853631	Baylor College of Medicine\|Center for Cell and Gene Therapy, Baylor College of Medicine\|The Methodist Hospital Research Institute	Non-Hodgkin Lymphoma\|Chronic Lymphocytic Leukemia\|Acute Lymphocytic Leukemia	February 2014	Phase 1
NCT04965597	Fred Hutchinson Cancer Center\|Blood and Marrow Transplant Clinical Trials Network\|National Cancer Institute (NCI)\|National Marrow Donor Program\|National Heart, Lung, and Blood Institute (NHLBI)	Bone Marrow Failure Syndrome\|Congenital Amegakaryocytic Thrombocytopenia\|Congenital Pure Red Cell Aplasia\|Hereditary Sideroblastic Anemia\|Myeloid Neoplasms With Germline GATA2 Mutation\|Paroxysmal Nocturnal Hemoglobinuria\|Shwachman-Diamond Syndrome	April 19, 2022	Phase 2
NCT00636909	Beth Israel Deaconess Medical Center\|Amgen	AML\|ALL\|CML Chronic Phase, Accelerated Phase, or Blast Crisis\|CLL\|MDS\|RELAPSED NON-HODGKIN´S OR HODGKIN´S LYMPHOMA\|APLASTIC ANEMIA\|MULTIPLE MYELOMA\|MYELOPROLIFERATIVE DISORDER (P Vera, CMML, ET)	July 1999	Phase 2
NCT02659943	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Lymphoma, B-Cell\|Lymphoma, Non-hodgkins	January 21, 2016	Phase 1
NCT00521859	M.D. Anderson Cancer Center\|Vion Pharmaceuticals	Hematologic Malignancies	August 2007	Phase 1
NCT02457650	Shenzhen Second People´s Hospital\|Shenzhen Institute for Innovation and Translational Medicine	Bladder Carcinoma\|Breast Cancer\|Esophagus Carcinoma\|Lung Cancer\|Melanoma\|Multiple Myeloma\|Neuroblastoma\|Ovarian Cancer\|Synovial Sarcoma\|Other Metastatic Solid Cancers	April 2015	Phase 1
NCT02950051	German CLL Study Group\|Janssen-Cilag Ltd.\|Hoffmann-La Roche\|AbbVie\|Stichting Hemato-Oncologie voor Volwassenen Nederland\|Nordic CLL Study Group (NCLLSG)\|Swiss Group for Clinical Cancer Research\|Cancer Trials Ireland\|Israeli CLL Study Group	Chronic Lymphocytic Leukemia	December 13, 2016	Phase 3
NCT04629729	Fate Therapeutics	Lymphoma, B-Cell\|Chronic Lymphocytic Leukemia\|Precursor B-Cell Acute Lymphoblastic Leukemia	July 26, 2021	Phase 1
NCT03208556	Peking University\|Marino Biotechnology Co., Ltd.	Relapsed or Refractory B-cell Lymphoma	June 21, 2017	Phase 1
NCT00562965	Pfizer\|UCB Pharma	Lymphoma, Follicular	November 2007	Phase 3
NCT00469014	M.D. Anderson Cancer Center\|Genzyme, a Sanofi Company	Acute Myeloid Leukemia\|Myelodysplastic Syndrome\|Chronic Myeloid Leukemia	September 2006	Phase 2
NCT00104858	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Chronic Lymphocytic Leukemia\|Prolymphocytic Leukemia\|Recurrent Small Lymphocytic Lymphoma\|Refractory Chronic Lymphocytic Leukemia\|Stage III Chronic Lymphocytic Leukemia\|Stage III Small Lymphocytic Lymphoma\|Stage IV Chronic Lymphocytic Leukemia\|Stage IV Small Lymphocytic Lymphoma\|T-Cell Large Granular Lymphocyte Leukemia	December 2004	Phase 2
NCT01814475	Gruppo Italiano Trapianto di Midollo Osseo	Myelofibrosis	July 2011	Phase 2
NCT04083183	Fred Hutchinson Cancer Center\|National Heart, Lung, and Blood Institute (NHLBI)	Non-Malignant Neoplasm	June 16, 2020	Phase 1\|Phase 2
NCT04426669	Intima Bioscience, Inc.\|Masonic Cancer Center, University of Minnesota	Gastrointestinal Epithelial Cancer\|Gastrointestinal Neoplasms\|Cancer of Gastrointestinal Tract\|Cancer, Gastrointestinal\|Gastrointestinal Cancer\|Colo-rectal Cancer\|Pancreatic Cancer\|Gall Bladder Cancer\|Colon Cancer\|Esophageal Cancer\|Stomach Cancer	May 15, 2020	Phase 1\|Phase 2
NCT02250937	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Acute Myeloid Leukemia\|Myelodysplastic Syndrome	October 27, 2014	Phase 2
NCT03241940	Crystal Mackall, MD\|Stanford University	B Acute Lymphoblastic Leukemia\|CD19 Positive\|Minimal Residual Disease\|Philadelphia Chromosome Positive\|Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent Childhood Acute Lymphoblastic Leukemia\|Refractory Acute Lymphoblastic Leukemia	October 20, 2017	Phase 1
NCT02194374	M.D. Anderson Cancer Center\|CLL Global Research Foundation Alliance	Leukemia	January 2015	Phase 1
NCT00074490	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Lymphoma\|Leukemia\|Myeloproliferative Disorders\|Multiple Myleoma\|Myelodysplastic Syndrome	January 1, 2004	Phase 2
NCT00740467	Institut Paoli-Calmettes\|National Cancer Institute (NCI)	Graft Versus Host Disease\|Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Precancerous Condition	January 2008	Phase 2
NCT02556931	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins\|National Cancer Institute (NCI)	Myelodysplastic Syndrome\|Chronic Myelomonocytic Leukemia\|Small Lymphocytic Lymphoma\|Chronic Lymphocytic Leukemia\|Prolymphocytic Leukemia\|Chronic Myeloid Leukemia\|Chronic Myeloproliferative Disorders\|Multiple Myeloma\|Plasma Cell Neoplasm\|Plasma Cell Dyscrasia\|Myelofibrosis\|Polycythemia Vera\|Essential Thrombocythemia\|Plasma Cell Leukemia	December 2015	Phase 2
NCT00968162	Emory University	Bone Marrow Transplantation\|Sickle Cell Disease	February 2009	Phase 1
NCT02937844	Beijing Sanbo Brain Hospital\|Marino Biotechnology Co., Ltd.	Glioblastoma Multiforme	July 2016	Phase 1
NCT00416884	OHSU Knight Cancer Institute\|National Cancer Institute (NCI)	Leukemia	May 2003	Phase 2
NCT04732845	Benjamin Tomlinson\|Case Comprehensive Cancer Center	Non Hodgkin Lymphoma\|Acute Lymphoblastic Leukemia\|Chronic Lymphocytic Leukemia	April 26, 2021	Phase 1
NCT00988715	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Chronic Myelomonocytic Leukemia\|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable\|Previously Treated Myelodysplastic Syndrome\|Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent Adult Acute Myeloid Leukemia\|Refractory Anemia With Excess Blasts\|Refractory Cytopenia With Multilineage Dysplasia\|Refractory Cytopenia With Multilineage Dysplasia and Ringed Sideroblasts\|Secondary Acute Myeloid Leukemia	April 21, 2010	Phase 1
NCT03980769	Fred Hutchinson Cancer Center	Non-Neoplastic Hematologic and Lymphocytic Disorder	May 5, 2021	Phase 2
NCT02917083	Baylor College of Medicine\|The Methodist Hospital Research Institute	Hodgkin´s Lymphoma\|Non-Hodgkin Lymphoma	May 8, 2017	Phase 1
NCT00815568	Samsung Medical Center	AML\|MDS\|ALL\|CML\|Lymphoma	August 2008	Phase 2
NCT00326417	Medical College of Wisconsin\|National Heart, Lung, and Blood Institute (NHLBI)\|Blood and Marrow Transplant Clinical Trials Network\|National Cancer Institute (NCI)\|National Marrow Donor Program	Anemia, Aplastic	January 2006	Phase 1\|Phase 2
NCT00053287	Case Comprehensive Cancer Center\|National Cancer Institute (NCI)	Leukemia\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Diseases	September 2002	Phase 2
NCT00010361	Fred Hutchinson Cancer Center\|Office of Rare Diseases (ORD)	Metabolism, Inborn Errors\|Granulomatous Disease, Chronic	November 2000	Not Applicable
NCT00281931	German CLL Study Group	Prolymphocytic Leukemia	September 1999	Phase 2
NCT00176865	Masonic Cancer Center, University of Minnesota	Hemophagocytic Lymphohistiocytosis\|X-Linked Lymphoproliferative Disorders\|Chediak-Higashi Syndrome\|Griscelli Syndrome\|Immunologic Deficiency Syndromes\|Langerhans-Cell Histiocytosis	August 2002	Phase 2
NCT00027820	Fred Hutchinson Cancer Center\|National Heart, Lung, and Blood Institute (NHLBI)\|National Cancer Institute (NCI)	Adult Acute Myeloid Leukemia in Remission\|Childhood Acute Lymphoblastic Leukemia in Remission\|Childhood Acute Myeloid Leukemia in Remission\|Childhood Myelodysplastic Syndrome\|Childhood Renal Cell Carcinoma\|Chronic Myelomonocytic Leukemia\|Clear Cell Renal Cell Carcinoma\|de Novo Myelodysplastic Syndrome\|Metastatic Renal Cell Cancer\|Previously Treated Myelodysplastic Syndrome\|Progression of Multiple Myeloma or Plasma Cell Leukemia\|Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Adult Hodgkin Lymphoma\|Recurrent Adult Lymphoblastic Lymphoma\|Recurrent Adult Non-Hodgkin Lymphoma\|Recurrent Childhood Acute Lymphoblastic Leukemia\|Recurrent Childhood Acute Myeloid Leukemia\|Recurrent Childhood Lymphoblastic Lymphoma\|Recurrent Childhood Non-Hodgkin Lymphoma\|Refractory Anemia\|Refractory Anemia With Ringed Sideroblasts\|Refractory Childhood Hodgkin Lymphoma\|Refractory Chronic Lymphocytic Leukemia\|Renal Medullary Carcinoma\|Type 1 Papillary Renal Cell Carcinoma\|Type 2 Papillary Renal Cell Carcinoma\|Untreated Adult Acute Lymphoblastic Leukemia\|Untreated Adult Acute Myeloid Leukemia\|Untreated Childhood Acute Lymphoblastic Leukemia	August 2001	Phase 1\|Phase 2
NCT04205240	Srinivas Devarakonda\|Ohio State University Comprehensive Cancer Center	Recurrent Plasma Cell Myeloma	May 27, 2020	Phase 2
NCT03573700	St. Jude Children´s Research Hospital	Acute Lymphoblastic Leukemia, in Relapse\|Acute Lymphoblastic Leukemia, Refractory	July 24, 2018	Phase 1\|Phase 2
NCT00524667	CancerCare Manitoba\|The Leukemia and Lymphoma Society	Chronic Lymphocytic Leukemia	January 2008	Phase 2
NCT05352828	Tessa Therapeutics\|Bristol-Myers Squibb	Classical Hodgkin Lymphoma\|Hodgkin Disease Refractory\|Hodgkin Disease Recurrent	July 25, 2022	Phase 1
NCT00096382	National Institutes of Health Clinical Center (CC)\|National Cancer Institute (NCI)	Melanoma (Skin)	September 2004	Phase 2
NCT01181271	Massachusetts General Hospital\|Dana-Farber Cancer Institute	Diffuse, Large B-Cell, Lymphoma\|Lymphoma, Low-Grade\|T-Cell Lymphoma\|Mantle-Cell Lymphoma\|Hodgkin´s Lymphoma\|Chronic Lymphocytic Leukemia\|Lymphoma, Small Lymphocytic	August 2010	Phase 2
NCT00093743	Fred Hutchinson Cancer Center\|National Heart, Lung, and Blood Institute (NHLBI)\|National Cancer Institute (NCI)	Adult Acute Myeloid Leukemia in Remission\|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities\|Adult Acute Myeloid Leukemia With Del(5q)\|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)\|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)\|Childhood Acute Myeloid Leukemia in Remission\|Childhood Myelodysplastic Syndromes\|Fanconi Anemia\|Previously Treated Myelodysplastic Syndromes	January 2000	Phase 1
NCT00806767	Institut Paoli-Calmettes\|National Cancer Institute (NCI)	Chronic Myeloproliferative Disorders\|Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Neoplasms	March 2007	Phase 2
NCT00058227	National Cancer Institute (NCI)	B-cell Chronic Lymphocytic Leukemia\|Contiguous Stage II Grade 1 Follicular Lymphoma\|Contiguous Stage II Grade 2 Follicular Lymphoma\|Contiguous Stage II Mantle Cell Lymphoma\|Contiguous Stage II Marginal Zone Lymphoma\|Contiguous Stage II Small Lymphocytic Lymphoma\|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue\|Nodal Marginal Zone B-cell Lymphoma\|Noncontiguous Stage II Grade 1 Follicular Lymphoma\|Noncontiguous Stage II Grade 2 Follicular Lymphoma\|Noncontiguous Stage II Mantle Cell Lymphoma\|Noncontiguous Stage II Marginal Zone Lymphoma\|Noncontiguous Stage II Small Lymphocytic Lymphoma\|Progressive Hairy Cell Leukemia, Initial Treatment\|Recurrent Grade 1 Follicular Lymphoma\|Recurrent Grade 2 Follicular Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Marginal Zone Lymphoma\|Recurrent Small Lymphocytic Lymphoma\|Refractory Chronic Lymphocytic Leukemia\|Refractory Hairy Cell Leukemia\|Splenic Marginal Zone Lymphoma\|Stage I Chronic Lymphocytic Leukemia\|Stage I Grade 1 Follicular Lymphoma\|Stage I Grade 2 Follicular Lymphoma\|Stage I Mantle Cell Lymphoma\|Stage I Marginal Zone Lymphoma\|Stage I Small Lymphocytic Lymphoma\|Stage II Chronic Lymphocytic Leukemia\|Stage III Chronic Lymphocytic Leukemia\|Stage III Grade 1 Follicular Lymphoma\|Stage III Grade 2 Follicular Lymphoma\|Stage III Mantle Cell Lymphoma\|Stage III Marginal Zone Lymphoma\|Stage III Small Lymphocytic Lymphoma\|Stage IV Chronic Lymphocytic Leukemia\|Stage IV Grade 1 Follicular Lymphoma\|Stage IV Grade 2 Follicular Lymphoma\|Stage IV Mantle Cell Lymphoma\|Stage IV Marginal Zone Lymphoma\|Stage IV Small Lymphocytic Lymphoma\|Untreated Hairy Cell Leukemia\|Waldenström Macroglobulinemia	April 2003	Phase 1
NCT04303520	The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine\|Hrain Biotechnology Co., Ltd.\|First Affiliated Hospital of Wenzhou Medical University\|Second Affiliated Hospital of Nanchang University	CD19-positive ALL	May 3, 2018	Phase 1
NCT03333486	Roswell Park Cancer Institute	Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Acute Leukemia in Remission\|Acute Lymphoblastic Leukemia\|Acute Myeloid Leukemia\|Acute Myeloid Leukemia With FLT3+ITD Mutation\|Acute Myeloid Leukemia With Gene Mutations\|Aplastic Anemia\|B-Cell Non-Hodgkin Lymphoma\|CD40 Ligand Deficiency\|Chronic Granulomatous Disease\|Chronic Leukemia in Remission\|Chronic Lymphocytic Leukemia\|Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Chronic Myelomonocytic Leukemia\|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Congenital Amegakaryocytic Thrombocytopenia\|Congenital Neutropenia\|Congenital Pure Red Cell Aplasia\|Glanzmann Thrombasthenia\|Immunodeficiency Syndrome\|Myelodysplastic Syndrome\|Myelofibrosis\|Myeloproliferative Neoplasm\|Paroxysmal Nocturnal Hemoglobinuria\|Plasma Cell Myeloma\|Polycythemia Vera\|Recurrent Non-Hodgkin Lymphoma\|Refractory Non-Hodgkin Lymphoma\|Secondary Acute Myeloid Leukemia\|Secondary Myelodysplastic Syndrome\|Severe Aplastic Anemia\|Shwachman-Diamond Syndrome\|Sickle Cell Disease\|T-Cell Non-Hodgkin Lymphoma\|Thalassemia\|Waldenstrom Macroglobulinemia\|Wiskott-Aldrich Syndrome	December 7, 2017	Phase 2
NCT00686556	Masonic Cancer Center, University of Minnesota	Acute Lymphoblastic Leukemia\|Myelodysplastic Syndrome\|Multiple Myeloma	August 2012	Phase 1
NCT04526795	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Recurrent Acute Biphenotypic Leukemia\|Recurrent Acute Lymphoblastic Leukemia\|Recurrent Acute Myeloid Leukemia\|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Recurrent T-Cell Prolymphocytic Leukemia\|Refractory Acute Biphenotypic Leukemia\|Refractory Acute Lymphoblastic Leukemia\|Refractory Acute Myeloid Leukemia\|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Refractory T-Cell Prolymphocytic Leukemia	April 9, 2021	Phase 1
NCT04173988	Children´s Hospital of Fudan University	ALL, Childhood B-Cell	January 9, 2020	Early Phase 1
NCT03661515	PETHEMA Foundation	Acute Myeloid Leukemia	July 17, 2018	Phase 1
NCT01697527	Jonsson Comprehensive Cancer Center	Malignant Neoplasm	November 2, 2012	Phase 2
NCT03016988	Tingbo Liu\|Union hospital of Fujian Medical University\|Fujian Medical University	Mantle Cell Lymphoma	January 2017	Phase 2
NCT02959905	BGI, China\|Sun Yat-sen University	Solid Cancer	December 22, 2016	Phase 1
NCT00473551	M.D. Anderson Cancer Center	Leukemia\|Lymphoma\|Myeloma	May 2007	Phase 1
NCT00054353	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Refractory Multiple Myeloma	October 2002	Phase 1\|Phase 2
NCT05077527	AIDS Malignancy Consortium\|National Cancer Institute (NCI)	AIDS-Related Diffuse Large B-cell Lymphoma\|AIDS-Related Non-Hodgkin Lymphoma\|HIV Infection\|Recurrent Diffuse Large B-Cell Lymphoma\|Recurrent Grade 3b Follicular Lymphoma\|Recurrent High Grade B-Cell Lymphoma\|Recurrent Non-Hodgkin Lymphoma\|Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma\|Recurrent Transformed B-Cell Non-Hodgkin Lymphoma\|Refractory Diffuse Large B-Cell Lymphoma\|Refractory Grade 3b Follicular Lymphoma\|Refractory High Grade B-Cell Lymphoma\|Refractory Non-Hodgkin Lymphoma\|Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma\|Refractory Transformed B-Cell Non-Hodgkin Lymphoma	April 1, 2022	Phase 1
NCT03704298	Kite, A Gilead Company\|Pfizer\|Gilead Sciences	Relapsed+Refractory Large B-cell Lymphoma	November 20, 2018	Phase 1
NCT01967823	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Melanoma\|Meningioma\|Breast Cancer\|Non-Small Cell Lung Cancer\|Hepatocellular Cancer	October 24, 2013	Phase 2
NCT05495464	M.D. Anderson Cancer Center\|Kite, A Gilead Company\|Acerta Pharma, LLC	Lymphoma\|Mantle Cell Lymphoma	November 18, 2022	Early Phase 1
NCT05379569	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	Acute B Lymphoblastic Leukemia\|Allogeneic Hematopoietic Stem Cell Transplantation	May 15, 2022	Phase 4
NCT01949129	St. Anna Kinderkrebsforschung\|ALL SCTped Forum\|European Society for Blood and Marrow Transplantation\|ALL-BFM Study Group\|Assistance Publique - Hôpitaux de Paris\|Dutch Childhood Oncology Group\|Swiss Pediatric Oncology Group\|Australian & New Zealand Children´s Haematology+Oncology Group	Acute Lymphoblastic Leukaemia	April 2013	Phase 2\|Phase 3
NCT00402558	M.D. Anderson Cancer Center	Myelodysplastic Syndrome\|Leukemia	May 2006	Phase 1
NCT03324243	Arog Pharmaceuticals, Inc.	Relapsed+Refractory FLT3-mutated AML	January 2018	Phase 2
NCT00513474	Massachusetts General Hospital	Chronic Myeloproliferative Disorders\|Graft Versus Host Disease\|Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Neoplasms	January 2008	Phase 1
NCT00505921	M.D. Anderson Cancer Center\|Bayer	Lymphoma	March 2003	Phase 2
NCT04025216	Tmunity Therapeutics	Non-Small Cell Lung Cancer\|Ovarian Cancer\|Fallopian Tube Cancer\|Triple Negative Breast Cancer\|Multiple Myeloma\|Pancreatic Ductal Adenocarcinoma	October 10, 2019	Phase 1
NCT00206726	Genzyme, a Sanofi Company\|Sanofi	Leukemia, Lymphocytic, Chronic, B-Cell	May 2005	Phase 2
NCT04653493	Sabz Biomedicals\|Gene Therapy Research Center, Shariati Hospital, Tehran University of Medical Sciences, Iran\|Research Institute for Oncology- Hematology and Cell Therapy (RIOHCT), Tehran University of Medical Sciences, Iran	Relapsed B Cell Acute Lymphoblastic Leukemia (ALL)\|Refractory B Cell Acute Lymphoblastic Leukemia (ALL)	August 2021	Phase 1
NCT00062036	National Institutes of Health Clinical Center (CC)\|National Cancer Institute (NCI)	Melanoma (Skin)	June 2003	Phase 1\|Phase 2
NCT00919503	Fred Hutchinson Cancer Center\|medac GmbH\|National Cancer Institute (NCI)\|National Heart, Lung, and Blood Institute (NHLBI)	Non-Neoplastic Hematologic and Lymphocytic Disorder	July 31, 2009	Phase 2
NCT00024440	Genta Incorporated\|National Cancer Institute (NCI)	Leukemia	July 2001	Phase 3
NCT00800839	M.D. Anderson Cancer Center	Hematologic Diseases\|Leukemia\|Lymphoma\|Myeloma	September 2008	Phase 2
NCT00020800	Jonsson Comprehensive Cancer Center\|National Cancer Institute (NCI)	Lymphoma	September 2001	Phase 2
NCT04696731	Allogene Therapeutics	Advanced+Metastatic Clear Cell Renal Cell Carcinoma	February 24, 2021	Phase 1
NCT01529827	Roswell Park Cancer Institute	Accelerated Phase Chronic Myelogenous Leukemia\|Adult Acute Lymphoblastic Leukemia in Remission\|Adult Acute Myeloid Leukemia in Remission\|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities\|Adult Acute Myeloid Leukemia With Del(5q)\|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)\|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)\|Adult Grade III Lymphomatoid Granulomatosis\|Adult Nasal Type Extranodal NK+T-cell Lymphoma\|Anaplastic Large Cell Lymphoma\|Angioimmunoblastic T-cell Lymphoma\|Aplastic Anemia\|Burkitt Lymphoma\|Childhood Acute Lymphoblastic Leukemia in Remission\|Childhood Acute Myeloid Leukemia in Remission\|Childhood Chronic Myelogenous Leukemia\|Childhood Diffuse Large Cell Lymphoma\|Childhood Grade III Lymphomatoid Granulomatosis\|Childhood Immunoblastic Large Cell Lymphoma\|Childhood Myelodysplastic Syndromes\|Childhood Nasal Type Extranodal NK+T-cell Lymphoma\|Chronic Myelomonocytic Leukemia\|Chronic Phase Chronic Myelogenous Leukemia\|Congenital Amegakaryocytic Thrombocytopenia\|Diamond-Blackfan Anemia\|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue\|Hepatosplenic T-cell Lymphoma\|Juvenile Myelomonocytic Leukemia\|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable\|Nodal Marginal Zone B-cell Lymphoma\|Paroxysmal Nocturnal Hemoglobinuria\|Peripheral T-cell Lymphoma\|Polycythemia Vera\|Post-transplant Lymphoproliferative Disorder\|Previously Treated Myelodysplastic Syndromes\|Primary Myelofibrosis\|Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Adult Burkitt Lymphoma\|Recurrent Adult Diffuse Large Cell Lymphoma\|Recurrent Adult Diffuse Mixed Cell Lymphoma\|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma\|Recurrent Adult Grade III Lymphomatoid Granulomatosis\|Recurrent Adult Hodgkin Lymphoma\|Recurrent Adult Immunoblastic Large Cell Lymphoma\|Recurrent Adult Lymphoblastic Lymphoma\|Recurrent Adult T-cell Leukemia+Lymphoma\|Recurrent Childhood Acute Lymphoblastic Leukemia\|Recurrent Childhood Acute Myeloid Leukemia\|Recurrent Childhood Anaplastic Large Cell Lymphoma\|Recurrent Childhood Grade III Lymphomatoid Granulomatosis\|Recurrent Childhood Large Cell Lymphoma\|Recurrent Childhood Lymphoblastic Lymphoma\|Recurrent Childhood Small Noncleaved Cell Lymphoma\|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma\|Recurrent Grade 1 Follicular Lymphoma\|Recurrent Grade 2 Follicular Lymphoma\|Recurrent Grade 3 Follicular Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Marginal Zone Lymphoma\|Recurrent Mycosis Fungoides+Sezary Syndrome\|Recurrent Small Lymphocytic Lymphoma\|Recurrent+Refractory Childhood Hodgkin Lymphoma\|Refractory Chronic Lymphocytic Leukemia\|Refractory Hairy Cell Leukemia\|Refractory Multiple Myeloma\|Secondary Acute Myeloid Leukemia\|Secondary Myelodysplastic Syndromes\|Secondary Myelofibrosis\|Severe Combined Immunodeficiency\|Severe Congenital Neutropenia\|Shwachman-Diamond Syndrome\|Splenic Marginal Zone Lymphoma\|T-cell Large Granular Lymphocyte Leukemia\|Waldenstrom Macroglobulinemia\|Wiskott-Aldrich Syndrome	February 28, 2012	Phase 2
NCT00448201	UNC Lineberger Comprehensive Cancer Center\|National Cancer Institute (NCI)	Chronic Myeloproliferative Disorders\|Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes	January 7, 2011	Phase 2
NCT02876978	CARsgen Therapeutics Co., Ltd.	Lung Squamous Cell Carcinoma	March 2016	Phase 1
NCT04526509	GlaxoSmithKline	Neoplasms	December 21, 2020	Phase 1
NCT01085617	University College, London	Leukemia\|Mucositis\|Oral Complications	December 2010	Phase 3
NCT00627666	Asan Medical Center\|National Cancer Institute (NCI)	Leukemia\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Neoplasms	January 2003	Phase 2
NCT00636155	David Rizzieri\|Eleos, Inc.\|Duke University	Lymphoma, Small Lymphocytic\|Leukemia, Lymphocytic, Chronic	February 2008	Phase 2
NCT04825496	Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd\|The First Affiliated Hospital of Soochow University	Relapsed or Refractory Acute Lymphoblastic Leukemia	April 9, 2021	Phase 1
NCT04796688	Wuhan Union Hospital, China\|Chengdu USino Technology Biology Co., Ltd	Acute Lymphoblastic Leukemia\|Chronic Lymphoblastic Leukemia\|B-cell Lymphoma	March 10, 2021	Phase 1
NCT04049513	Malaghan Institute of Medical Research\|Wellington Zhaotai Therapies Limited (WZTL)	Lymphomas Non-Hodgkin´s B-Cell\|Diffuse Large B-cell Lymphoma (DLBCL)\|Primary Mediastinal B-cell Lymphoma (PMBCL)\|Transformed Follicular Lymphoma (TFL)\|Follicular Lymphoma (FL)\|Mantle Cell Lymphoma (MCL)	October 11, 2019	Phase 1
NCT00262795	German CLL Study Group	Chronic Lymphocytic Leukemia	September 2003	Phase 3
NCT00274846	Masonic Cancer Center, University of Minnesota	Leukemia	March 2005	Phase 2
NCT02706405	Fred Hutchinson Cancer Center\|AstraZeneca\|Juno Therapeutics, Inc.\|MedImmune LLC\|National Cancer Institute (NCI)	Diffuse Large B-Cell Lymphoma, Not Otherwise Specified\|Recurrent Diffuse Large B-Cell Lymphoma\|Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma\|Refractory Diffuse Large B-Cell Lymphoma\|Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements\|Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma	November 15, 2016	Phase 1
NCT02722668	Masonic Cancer Center, University of Minnesota	Acute Leukemia\|Acute Myeloid Leukemia\|Acute Lymphoblastic Leukemia+Lymphoma\|Burkitt´s Lymphoma\|Natural Killer Cell Malignancies\|Chronic Myelogenous Leukemia\|Myelodysplastic Syndrome\|Large-cell Lymphoma\|Hodgkin Lymphoma\|Multiple Myeloma\|Relapsed Chronic Lymphocytic Leukemia\|Relapsed Small Lymphocytic Lymphoma\|Marginal Zone B-cell Lymphoma\|Follicular Lymphoma\|Lymphoplasmacytic Lymphoma\|Mantle-cell Lymphoma\|Prolymphocytic Leukemia\|Bone Marrow Failure Syndromes\|Myeloproliferative Neoplasms+Myelofibrosis\|Biphenotypic+Undifferentiated+Prolymphocytic Leukemias\|MRD Positive Leukemia\|Leukemia or MDS in Aplasia\|Relapsed T-Cell Lymphoma\|Relapsed Multiple Myeloma\|Plasma Cell Leukemia	May 15, 2017	Phase 2
NCT05114837	Masonic Cancer Center, University of Minnesota	Lymphoma Leukemia	November 2022	Phase 1\|Phase 2
NCT00343798	Fred Hutchinson Cancer Center\|National Heart, Lung, and Blood Institute (NHLBI)\|National Cancer Institute (NCI)\|Damon Runyon Cancer Research Foundation	Accelerated Phase Chronic Myelogenous Leukemia\|Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome\|Adult Acute Lymphoblastic Leukemia in Remission\|Adult Acute Myeloid Leukemia in Remission\|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities\|Adult Acute Myeloid Leukemia With Del(5q)\|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)\|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)\|Adult Nasal Type Extranodal NK+T-cell Lymphoma\|Anaplastic Large Cell Lymphoma\|Childhood Acute Lymphoblastic Leukemia in Remission\|Childhood Acute Myeloid Leukemia in Remission\|Childhood Burkitt Lymphoma\|Childhood Chronic Myelogenous Leukemia\|Childhood Diffuse Large Cell Lymphoma\|Childhood Immunoblastic Large Cell Lymphoma\|Childhood Myelodysplastic Syndromes\|Childhood Nasal Type Extranodal NK+T-cell Lymphoma\|Chronic Phase Chronic Myelogenous Leukemia\|Contiguous Stage II Adult Burkitt Lymphoma\|Contiguous Stage II Adult Diffuse Large Cell Lymphoma\|Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma\|Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma\|Contiguous Stage II Adult Lymphoblastic Lymphoma\|Contiguous Stage II Grade 3 Follicular Lymphoma\|Contiguous Stage II Mantle Cell Lymphoma\|de Novo Myelodysplastic Syndromes\|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue\|Nodal Marginal Zone B-cell Lymphoma\|Noncontiguous Stage II Adult Burkitt Lymphoma\|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma\|Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma\|Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma\|Noncontiguous Stage II Adult Lymphoblastic Lymphoma\|Noncontiguous Stage II Grade 3 Follicular Lymphoma\|Noncontiguous Stage II Mantle Cell Lymphoma\|Previously Treated Myelodysplastic Syndromes\|Prolymphocytic Leukemia\|Recurrent Adult Burkitt Lymphoma\|Recurrent Adult Diffuse Large Cell Lymphoma\|Recurrent Adult Diffuse Mixed Cell Lymphoma\|Recurrent Adult Grade III Lymphomatoid Granulomatosis\|Recurrent Adult Immunoblastic Large Cell Lymphoma\|Recurrent Adult Lymphoblastic Lymphoma\|Recurrent Childhood Anaplastic Large Cell Lymphoma\|Recurrent Childhood Grade III Lymphomatoid Granulomatosis\|Recurrent Childhood Large Cell Lymphoma\|Recurrent Childhood Lymphoblastic Lymphoma\|Recurrent Grade 1 Follicular Lymphoma\|Recurrent Grade 2 Follicular Lymphoma\|Recurrent Grade 3 Follicular Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Marginal Zone Lymphoma\|Recurrent Small Lymphocytic Lymphoma\|Refractory Anemia\|Refractory Anemia With Excess Blasts\|Refractory Anemia With Excess Blasts in Transformation\|Refractory Chronic Lymphocytic Leukemia\|Refractory Multiple Myeloma\|Secondary Acute Myeloid Leukemia\|Secondary Myelodysplastic Syndromes\|Splenic Marginal Zone Lymphoma\|Stage I Adult Burkitt Lymphoma\|Stage I Adult Diffuse Large Cell Lymphoma\|Stage I Adult Diffuse Mixed Cell Lymphoma\|Stage I Adult Immunoblastic Large Cell Lymphoma\|Stage I Adult Lymphoblastic Lymphoma\|Stage I Childhood Lymphoblastic Lymphoma\|Stage I Grade 3 Follicular Lymphoma\|Stage I Mantle Cell Lymphoma\|Stage II Childhood Lymphoblastic Lymphoma\|Stage III Adult Burkitt Lymphoma\|Stage III Adult Diffuse Large Cell Lymphoma\|Stage III Adult Diffuse Mixed Cell Lymphoma\|Stage III Adult Immunoblastic Large Cell Lymphoma\|Stage III Adult Lymphoblastic Lymphoma\|Stage III Childhood Lymphoblastic Lymphoma\|Stage III Grade 3 Follicular Lymphoma\|Stage III Mantle Cell Lymphoma\|Stage IV Adult Burkitt Lymphoma\|Stage IV Adult Diffuse Large Cell Lymphoma\|Stage IV Adult Diffuse Mixed Cell Lymphoma\|Stage IV Adult Immunoblastic Large Cell Lymphoma\|Stage IV Adult Lymphoblastic Lymphoma\|Stage IV Childhood Lymphoblastic Lymphoma\|Stage IV Grade 3 Follicular Lymphoma\|Stage IV Mantle Cell Lymphoma	April 2006	Phase 1
NCT02224872	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Severe Aplastic Anemia\|Bone Marrow Failure Syndromes	August 2014	Phase 2
NCT02724163	University of Birmingham\|Assistance Publique - Hôpitaux de Paris\|Cancer Research UK\|National Cancer Institute, France\|Pfizer	Acute Myeloid Leukaemia	April 2016	Phase 3
NCT04098393	Memorial Sloan Kettering Cancer Center	Hematologic Malignancies	September 18, 2019	Phase 1
NCT00003816	Roswell Park Cancer Institute	Chronic Myeloproliferative Disorders\|Leukemia\|Lymphoma\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Diseases\|Nonmalignant Neoplasm\|Unspecified Adult Solid Tumor, Protocol Specific\|Unspecified Childhood Solid Tumor, Protocol Specific	October 19, 1998	Phase 2\|Phase 3
NCT00727415	Gruppo Italiano Malattie EMatologiche dell´Adulto	Chronic Lymphocytic Leukemia	February 2008	Phase 1\|Phase 2
NCT00153985	Dana-Farber Cancer Institute\|Beth Israel Deaconess Medical Center\|Massachusetts General Hospital\|Brigham and Women´s Hospital\|Emory University\|Feist-Weiller Cancer Center at Louisiana State University Health Sciences\|Ohio State University	Hemoglobinopathies\|Sickle Cell Disease\|Thalassemia	March 2004	Phase 2
NCT04678401	Dana-Farber Cancer Institute	Stem Cell Transplant Complications\|Graft Vs Host Disease\|Myeloid Leukemia, Acute\|Myeloid Leukemia in Relapse (Disorder)\|Myelodysplastic Syndromes	January 12, 2021	Phase 1
NCT01303887	University of Liverpool\|Liverpool University Hospitals NHS Foundation Trust\|Cancer Research UK\|Roche Pharma AG	Follicular Lymphoma	October 2009	Phase 3
NCT04670068	UNC Lineberger Comprehensive Cancer Center\|National Institutes of Health (NIH)	Epithelial Ovarian Cancer	January 27, 2021	Phase 1
NCT00579137	Baylor College of Medicine\|Center for Cell and Gene Therapy, Baylor College of Medicine	Severe Combined Immunodeficiency Disease\|Severe Primary Immunodeficiency Disorder\|Undefined T Cell Deficiency Disorder\|Wiskott-Aldrick Syndrome	October 2007	Phase 1\|Phase 2
NCT02118285	Masonic Cancer Center, University of Minnesota\|Incyte Corporation	Ovarian Cancer\|Fallopian Tube Carcinoma\|Primary Peritoneal Carcinoma	July 28, 2014	Phase 1
NCT02049580	Istituto Clinico Humanitas	Lymphoma	July 2013	Phase 2
NCT04545762	C. Babis Andreadis\|University of California, Davis\|University of California, San Francisco	Refractory Non-Hodgkin Lymphoma\|Burkitt Lymphoma\|Mantle Cell Lymphoma\|Follicular Lymphoma\|Lymphoplasmacytic Lymphoma\|Primary Mediastinal Large B Cell Lymphoma\|Diffuse Large B Cell Lymphoma\|Small Lymphocytic Lymphoma\|Transformed Lymphoma	September 11, 2020	Phase 1
NCT04697940	Han weidong\|Chinese PLA General Hospital	Relapsed and Refractory B-cell Non-Hodgkin´s Lymphoma\|Decitabine-primed Tandem CD19+CD20 CAR T Cells	December 15, 2020	Phase 1\|Phase 2
NCT00914940	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Graft Versus Host Disease\|Leukemia\|Myelodysplastic Syndromes	December 17, 2009	Phase 2
NCT01740557	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Metastatic Melanoma\|Stage III Cutaneous Melanoma AJCC v7\|Stage IV Cutaneous Melanoma AJCC v6 and v7	January 28, 2015	Phase 1\|Phase 2
NCT00943319	University of Chicago	Leukemia\|Lymphoma\|Myeloma	March 2012	Phase 1\|Phase 2
NCT02666898	French Innovative Leukemia Organisation\|Roche Pharma AG\|Janssen-Cilag Ltd.	Leukemia, Lymphocytic, Chronic, B-Cell	October 2015	Phase 2
NCT05182073	Fate Therapeutics	Multiple Myeloma\|Myeloma	November 24, 2021	Phase 1
NCT03528421	Beijing Immunochina Medical Science & Technology Co., Ltd.\|Peking University Cancer Hospital & Institute	Non Hodgkin Lymphoma	May 22, 2018	Phase 1
NCT04989803	Kite, A Gilead Company\|Gilead Sciences	Relapsed and+or Refractory B-cell Lymphoma	October 27, 2021	Phase 1
NCT01408563	Massachusetts General Hospital	Non-Hodgkin´s Lymphoma\|Hodgkin´s Lymphoma\|Multiple Myeloma\|Chronic Lymphocytic Leukemia\|Acute Myelogenous Leukemia	December 2011	Phase 2
NCT03766126	University of Pennsylvania	Acute Myeloid Leukemia, in Relapse\|Acute Myeloid Leukemia, Adult\|Acute Myeloid Leukemia, Refractory	December 6, 2018	Phase 1
NCT00070135	Alliance for Clinical Trials in Oncology\|National Cancer Institute (NCI)	Adult Acute Myeloid Leukemia in Remission\|Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome	January 2004	Phase 2
NCT05625594	City of Hope Medical Center\|National Cancer Institute (NCI)	Central Nervous System Lymphoma	December 30, 2022	Phase 1
NCT05005299	Melbourne Health	Leukemia, Myeloid, Acute\|Leukemia, Lymphoblastic, Acute, L1\|Leukemia, Lymphoblastic, Acute, L2\|Myelodysplastic Syndromes\|Non-hodgkin Lymphoma\|Plasma Cell Myeloma	June 8, 2022	Phase 1
NCT01156350	University Hospital, Clermont-Ferrand	Neuroblastoma	September 2011	Phase 2
NCT01518153	M.D. Anderson Cancer Center	Leukemia\|Lymphoma\|Myeloma\|Myeloproliferative Diseases	February 2012	Phase 2
NCT01570348	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)\|National Institutes of Health (NIH)	Crohn Disease	July 17, 2012	Phase 2
NCT00462332	Gruppo Italiano Malattie EMatologiche dell´Adulto	Leukemia	May 2007	Phase 2
NCT02881086	Goethe University	Acute Lymphoblastic Leukemia\|Lymphoblastic Lymphoma	August 2016	Phase 3
NCT04009525	First Affiliated Hospital of Guangxi Medical University\|Peking University People´s Hospital\|Ruijin Hospital\|The 923th Hospital of People´s Liberation Army\|Fourth Affiliated Hospital of Guangxi Medical University\|Liuzhou General Hospital\|Hainan General Hospital\|The Affiliated Hospital Of Guizhou Medical University\|The First People´s Hospital of Yunnan	Thalassemia Major	June 1, 2019	Phase 4
NCT02528877	City of Hope Medical Center\|National Cancer Institute (NCI)	Acute Myeloid Leukemia in Remission\|Primary Myelofibrosis\|Primary Myelofibrosis, Prefibrotic Stage\|Secondary Acute Myeloid Leukemia\|Secondary Myelofibrosis	November 2015	Phase 1
NCT01370772	French Innovative Leukemia Organisation\|Roche Pharma AG	B-cell Chronic Lymphocytic Leukemia CLL	May 2011	Phase 2
NCT00079443	National Cancer Institute (NCI)	Recurrent Grade 1 Follicular Lymphoma\|Recurrent Grade 2 Follicular Lymphoma\|Recurrent Small Lymphocytic Lymphoma	January 2004	Phase 2
NCT00536341	SCRI Development Innovations, LLC\|Celgene Corporation\|Genentech, Inc.	Chronic Lymphocytic Leukemia	January 2008	Phase 1\|Phase 2
NCT01749293	University of Illinois at Chicago	Hematologic Malignancies	August 30, 2012	Phase 2
NCT02280525	M.D. Anderson Cancer Center\|The Leukemia and Lymphoma Society\|Celgene Corporation	Leukemia	March 5, 2015	Phase 1
NCT02529813	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)\|Ziopharm Oncology	Acute Biphenotypic Leukemia\|Acute Lymphoblastic Leukemia\|Blasts 5 Percent or More of Bone Marrow Nucleated Cells\|CD19 Positive\|Minimal Residual Disease\|Non-Hodgkin Lymphoma\|Small Lymphocytic Lymphoma\|Stage III Chronic Lymphocytic Leukemia\|Stage IV Chronic Lymphocytic Leukemia	December 16, 2015	Phase 1
NCT04223765	UNC Lineberger Comprehensive Cancer Center	Mantle Cell Lymphoma\|Follicular Lymphoma\|Splenic Marginal Zone Lymphoma\|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue\|Nodal Marginal Zone Lymphoma\|Indolent Non-hodgkin Lymphoma	November 12, 2020	Phase 1
NCT00392782	Masonic Cancer Center, University of Minnesota\|Center for International Blood and Marrow Transplant Research	Leukemia\|Myelodysplastic Syndromes	July 2005	Phase 2
NCT01679041	Seah Lim M.D.\|Texas Oncology Cancer Center	Multiple Sclerosis	November 2012	Phase 2
NCT02649764	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Chronic Myelomonocytic Leukemia\|Recurrent Acute Myeloid Leukemia\|Recurrent High Risk Myelodysplastic Syndrome\|Refractory Acute Myeloid Leukemia\|Refractory High Risk Myelodysplastic Syndrome	May 4, 2016	Phase 1
NCT01471444	M.D. Anderson Cancer Center\|Sanofi	Disorder Related to Bone Marrow Transplantation\|Leukemia\|Transplantation Infection	November 2, 2011	Phase 3
NCT03105336	Kite, A Gilead Company\|Gilead Sciences	Follicular Lymphoma\|Marginal Zone Lymphoma\|Indolent Non-Hodgkin Lymphoma	June 20, 2017	Phase 2
NCT00044954	University of Texas Southwestern Medical Center	Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Diseases	November 1999	Phase 2
NCT00543114	Dana-Farber Cancer Institute\|Brigham and Women´s Hospital\|Massachusetts General Hospital\|Beth Israel Deaconess Medical Center\|Celgene Corporation	Chronic Lymphocytic Leukemia\|Small Lymphocytic Leukemia	October 2007	Phase 1
NCT00056966	Baylor College of Medicine\|The Methodist Hospital Research Institute\|Center for Cell and Gene Therapy, Baylor College of Medicine	Hematologic Malignancy	November 2002	Phase 1\|Phase 2
NCT01343043	GlaxoSmithKline	Neoplasms	September 27, 2012	Phase 1
NCT00589563	City of Hope Medical Center\|National Cancer Institute (NCI)	Chronic Myeloproliferative Disorders\|Graft Versus Host Disease\|Infection\|Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Neoplasms\|Precancerous Condition\|Secondary Myelofibrosis\|Small Intestine Cancer	May 2007	Phase 2
NCT02439788	Baylor College of Medicine\|Center for Cell and Gene Therapy, Baylor College of Medicine\|Alex´s Lemonade Stand Foundation	Neuroblastoma	August 2017	Phase 1
NCT00134004	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins\|National Cancer Institute (NCI)	Chronic Myeloproliferative Disorders\|Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes	October 2004	Phase 2
NCT05146739	National Cancer Institute (NCI)\|Childrens Oncology Group (COG)\|LLS PedAL LLC	Down Syndrome\|Recurrent Acute Myeloid Leukemia\|Recurrent Mixed Phenotype Acute Leukemia\|Recurrent Myelodysplastic Syndrome\|Refractory Acute Myeloid Leukemia\|Refractory Mixed Phenotype Acute Leukemia\|Refractory Myelodysplastic Syndrome\|Therapy-Related Acute Myeloid Leukemia\|Therapy-Related Myelodysplastic Syndrome	August 19, 2022	Phase 1
NCT04644016	Memorial Sloan Kettering Cancer Center	AML\|ALL\|MDS\|MPD Withou Myelofibrosis\|NHL or HL\|Inherited Metabolic Disorders\|Hemoglobinopathies\|Bone Marrow Failure\|HLH	November 20, 2020	Phase 2
NCT03885947	Alla Keyzner\|Icahn School of Medicine at Mount Sinai	Hematological Malignancy\|Acute Leukemia in Remission\|Acute Lymphoblastic Leukemia in Remission\|Myelodysplastic Syndromes\|Non-Hodgkin Lymphoma\|Hodgkin Lymphoma	February 21, 2019	Phase 1
NCT00376805	Masonic Cancer Center, University of Minnesota	Breast Cancer	April 2006	Phase 2
NCT01312376	Abramson Cancer Center of the University of Pennsylvania	Ovarian Carcinoma\|Fallopian Tube Cancer\|Primary Peritoneal Cancer	March 2011	Phase 1
NCT05016063	Xinqiao Hospital of Chongqing\|Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.	Leukemia, Myeloid, Acute	September 1, 2021	Early Phase 1
NCT00594308	Indiana University	Acute Myelogenous Leukemia\|Acute Lymphocytic Leukemia\|Chronic Myelogenous Leukemia\|Chronic Lymphocytic Leukemia\|Myelodysplasia\|Lymphoma, Non-Hodgkin´s\|Mantle-Cell Lymphoma\|Hodgkin´s Disease\|Multiple Myeloma\|Myelofibrosis	October 2007	Not Applicable
NCT03653338	Paul Szabolcs\|University of Pittsburgh	Sickle Cell Anemia\|Beta-thalassemia Major\|Diamond-blackfan Anemia	August 2, 2018	Phase 1\|Phase 2
NCT04626765	Hebei Senlang Biotechnology Inc., Ltd.\|The Second Hospital of Hebei Medical University	Childhood Acute Lymphoblastic Leukemia	April 1, 2020	Early Phase 1
NCT00038831	M.D. Anderson Cancer Center	Acute Myelogenous Leukemia\|Myelodysplastic Syndrome\|Chronic Lymphocytic Leukemia	May 2001	Phase 1\|Phase 2
NCT04227275	Tmunity Therapeutics	Metastatic Castration-resistant Prostate Cancer	November 22, 2019	Phase 1
NCT03071276	St. Jude Children´s Research Hospital\|Karyopharm Therapeutics Inc	Acute Myeloid Leukemia (AML)	January 14, 2016	Phase 2
NCT04354025	Washington University School of Medicine	Refractory Acute Myeloid Leukemia\|Relapsed Acute Myeloid Leukemia	December 31, 2022	Phase 2
NCT00138229	National Institutes of Health Clinical Center (CC)\|National Cancer Institute (NCI)	Melanoma (Skin)	July 2005	Phase 2
NCT00317759	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Melanoma (Skin)	May 2003	Phase 1
NCT02007863	University of Miami	Leukemia\|Myelodysplasia\|Acute Lymphocytic Leukemia\|Acute Myelogenous Leukemia	August 2008	Not Applicable
NCT00006261	Case Comprehensive Cancer Center\|National Cancer Institute (NCI)	Breast Cancer	May 2000	Phase 2
NCT01236573	National Institutes of Health Clinical Center (CC)\|National Cancer Institute (NCI)	Skin Cancer\|Metastatic Melanoma	October 2010	Phase 1\|Phase 2
NCT00014235	Fred Hutchinson Cancer Center\|National Heart, Lung, and Blood Institute (NHLBI)\|National Cancer Institute (NCI)	Acute Myeloid Leukemia+Transient Myeloproliferative Disorder\|Acute Undifferentiated Leukemia\|Adult Acute Lymphoblastic Leukemia in Remission\|Adult Acute Myeloid Leukemia in Remission\|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities\|Adult Acute Myeloid Leukemia With Del(5q)\|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)\|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)\|Adult Nasal Type Extranodal NK+T-cell Lymphoma\|Anaplastic Large Cell Lymphoma\|Angioimmunoblastic T-cell Lymphoma\|Blastic Plasmacytoid Dendritic Cell Neoplasm\|Childhood Acute Lymphoblastic Leukemia in Remission\|Childhood Acute Myeloid Leukemia in Remission\|Childhood Burkitt Lymphoma\|Childhood Diffuse Large Cell Lymphoma\|Childhood Immunoblastic Large Cell Lymphoma\|Childhood Myelodysplastic Syndromes\|Childhood Nasal Type Extranodal NK+T-cell Lymphoma\|Chronic Myelomonocytic Leukemia\|Cutaneous B-cell Non-Hodgkin Lymphoma\|de Novo Myelodysplastic Syndromes\|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue\|Hepatosplenic T-cell Lymphoma\|Intraocular Lymphoma\|Juvenile Myelomonocytic Leukemia\|Mast Cell Leukemia\|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable\|Nodal Marginal Zone B-cell Lymphoma\|Noncutaneous Extranodal Lymphoma\|Peripheral T-cell Lymphoma\|Post-transplant Lymphoproliferative Disorder\|Previously Treated Myelodysplastic Syndromes\|Primary Systemic Amyloidosis\|Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Adult Burkitt Lymphoma\|Recurrent Adult Diffuse Large Cell Lymphoma\|Recurrent Adult Diffuse Mixed Cell Lymphoma\|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma\|Recurrent Adult Grade III Lymphomatoid Granulomatosis\|Recurrent Adult Hodgkin Lymphoma\|Recurrent Adult Immunoblastic Large Cell Lymphoma\|Recurrent Adult Lymphoblastic Lymphoma\|Recurrent Adult T-cell Leukemia+Lymphoma\|Recurrent Childhood Acute Lymphoblastic Leukemia\|Recurrent Childhood Acute Myeloid Leukemia\|Recurrent Childhood Anaplastic Large Cell Lymphoma\|Recurrent Childhood Grade III Lymphomatoid Granulomatosis\|Recurrent Childhood Large Cell Lymphoma\|Recurrent Childhood Lymphoblastic Lymphoma\|Recurrent Childhood Small Noncleaved Cell Lymphoma\|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma\|Recurrent Grade 1 Follicular Lymphoma\|Recurrent Grade 2 Follicular Lymphoma\|Recurrent Grade 3 Follicular Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Marginal Zone Lymphoma\|Recurrent Mycosis Fungoides+Sezary Syndrome\|Recurrent Small Lymphocytic Lymphoma\|Recurrent+Refractory Childhood Hodgkin Lymphoma\|Refractory Chronic Lymphocytic Leukemia\|Refractory Hairy Cell Leukemia\|Refractory Multiple Myeloma\|Small Intestine Lymphoma\|Splenic Marginal Zone Lymphoma\|Stage II Multiple Myeloma\|Stage III Multiple Myeloma\|T-cell Large Granular Lymphocyte Leukemia\|Testicular Lymphoma\|Untreated Adult Acute Lymphoblastic Leukemia\|Untreated Adult Acute Myeloid Leukemia\|Untreated Childhood Acute Lymphoblastic Leukemia\|Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies\|Waldenström Macroglobulinemia	December 2000	Not Applicable
NCT03263559	Medical College of Wisconsin\|National Heart, Lung, and Blood Institute (NHLBI)\|National Cancer Institute (NCI)\|Blood and Marrow Transplant Clinical Trials Network\|National Marrow Donor Program	Sickle Cell Disease	October 3, 2017	Phase 2
NCT04093648	Baylor College of Medicine\|The Methodist Hospital Research Institute	Hepatocellular Carcinoma\|Hepatoblastoma	January 2020	Phase 1
NCT00513747	Alliance for Clinical Trials in Oncology\|National Cancer Institute (NCI)	Leukemia	January 2008	Phase 3
NCT00586274	Baylor College of Medicine\|University of Texas, Southwestern Medical Center at Dallas\|Center for Cell and Gene Therapy, Baylor College of Medicine	FANCONI ANEMIA	March 2002	Phase 1
NCT05040568	M.D. Anderson Cancer Center	Colon Cancer\|Resected Stage	February 28, 2022	Phase 1
NCT00423709	M.D. Anderson Cancer Center	Hodgkin´s Disease	January 1998	Not Applicable
NCT00990496	Milton S. Hershey Medical Center	Glioblastoma Multiforme	September 2009	Phase 1
NCT00056095	UNICANCER	Kidney Cancer	November 4, 2002	Phase 2
NCT01163357	City of Hope Medical Center\|National Cancer Institute (NCI)	Autologous Hematopoietic Stem Cell Transplant Recipient\|Loss of Chromosome 17p\|Plasma Cell Leukemia\|Recurrent Plasma Cell Myeloma\|Refractory Plasma Cell Myeloma	January 28, 2011	Phase 1
NCT05521087	Janssen Research & Development, LLC	Acute Leukemias\|Acute Myeloid Leukemia\|Acute Lymphoblastic Leukemia\|Acute Leukemia of Ambiguous Lineage	December 22, 2022	Phase 1
NCT01369888	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Metastatic Melanoma\|Skin Cancer	May 2011	Phase 1\|Phase 2
NCT00354172	Masonic Cancer Center, University of Minnesota	Leukemia\|Myelodysplastic Syndromes	February 2006	Phase 2
NCT03426969	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Primary Myelofibrosis\|Secondary Myelofibrosis	January 31, 2018	Early Phase 1
NCT03081910	Baylor College of Medicine\|Center for Cell and Gene Therapy, Baylor College of Medicine\|The Methodist Hospital Research Institute	T-cell Acute Lymphoblastic Lymphoma\|T-non-Hodgkin Lymphoma\|T-cell Acute Lymphoblastic Leukemia	November 1, 2017	Phase 1
NCT00314106	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Metastatic Melanoma	April 2006	Phase 2
NCT00276809	German CLL Study Group	Chronic Lymphocytic Leukemia	June 2001	Phase 2
NCT02096614	Mie University\|Takara Bio Inc.\|Shionogi\|Fiverings Co., Ltd.\|Statcom Co. Ltd.	Solid Tumors	April 2014	Phase 1
NCT00813124	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)\|Celgene Corporation	Stem Cell Transplantation\|Leukemia	December 2008	Phase 2
NCT03214562	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	High Risk Myelodysplastic Syndrome\|Recurrent Acute Myeloid Leukemia\|Refractory Acute Myeloid Leukemia	September 26, 2017	Phase 1\|Phase 2
NCT00505895	M.D. Anderson Cancer Center	Multiple Myeloma	January 2002	Phase 2
NCT03658785	Tongji Hospital	Recurrence Tumor\|Metastatic Cancer\|Solid Tumor	December 10, 2018	Phase 1\|Phase 2
NCT00262886	University of Rochester	Kidney Cancer	August 2001	Phase 2
NCT01316549	University of California, San Francisco\|Thrasher Research Fund	Hematologic Malignancies\|Nonmalignant Diseases\|Immunodeficiencies\|Hemoglobinopathies\|Genetic Inborn Errors of Metabolism\|Fanconi Anemia\|Thalassemia\|Sickle Cell Disease	January 1, 2011
NCT05477589	Vastra Gotaland Region	Acute Myeloid Leukemia (AML) in Remission\|Stem Cell Transplantation	June 7, 2022	Phase 3
NCT01701674	H. Lee Moffitt Cancer Center and Research Institute\|Bristol-Myers Squibb\|Iovance Biotherapeutics, Inc.	Metastatic Melanoma	October 9, 2012	Not Applicable
NCT03173417	Beijing Immunochina Medical Science & Technology Co., Ltd.	Leukemia	May 23, 2017	Phase 1\|Phase 2
NCT03250338	Arog Pharmaceuticals, Inc.	Relapsed+Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations	June 5, 2018	Phase 3
NCT03937544	National University of Malaysia\|Gaia Science	Relapsed B Acute Lymphoblastic Leukaemia\|Refractory B Acute Lymphoblastic Leukaemia	March 19, 2019	Phase 2\|Phase 3
NCT01135329	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Lymphoma\|Leukemia\|Myelodysplastic Syndrome	August 2010	Phase 2
NCT01701323	Nohla Therapeutics, Inc.\|National Cancer Institute (NCI)\|Fred Hutchinson Cancer Center	Acute Leukemia of Ambiguous Lineage\|Acute Myeloid Leukemia	December 10, 2012	Phase 1
NCT02143830	Children´s Hospital Medical Center, Cincinnati\|Memorial Sloan Kettering Cancer Center\|Fred Hutchinson Cancer Center	Fanconi Anemia\|Severe Marrow Failure\|Myelodysplastic Syndrome (MDS)\|Acute Myelogenous Leukemia (AML)	April 2014	Phase 2
NCT00069992	Baylor College of Medicine\|The Methodist Hospital Research Institute\|Center for Cell and Gene Therapy, Baylor College of Medicine	Chronic Myeloproliferative Disorders\|Leukemia\|Myelodysplastic Syndromes	December 2001	Phase 2
NCT03943472	Hrain Biotechnology Co., Ltd.\|Shanghai Changzheng Hospital	Multiple Myeloma	July 8, 2019	Early Phase 1
NCT00093522	St. Luke´s Medical Center\|National Cancer Institute (NCI)	Kidney Cancer	August 2004	Phase 2
NCT01875237	M.D. Anderson Cancer Center\|Bellicum Pharmaceuticals	Leukemia\|Myeloma\|Myeloproliferative Diseases	December 27, 2013	Phase 1\|Phase 2
NCT01690520	Nohla Therapeutics, Inc.\|National Cancer Institute (NCI)\|National Heart, Lung, and Blood Institute (NHLBI)	Acute Biphenotypic Leukemia\|Acute Lymphoblastic Leukemia in Remission\|Acute Myeloid Leukemia in Remission\|Chronic Myelogenous Leukemia\|Myelodysplastic Syndrome	December 11, 2012	Phase 2
NCT02080195	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins\|Maryland Stem Cell Research Fund	Lupus Erythematosus\|Graft-versus-host Disease	September 13, 2016	Phase 1\|Phase 2
NCT00856388	Roswell Park Cancer Institute\|National Cancer Institute (NCI)	Accelerated Phase Chronic Myelogenous Leukemia\|Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome\|Adult Acute Lymphoblastic Leukemia in Remission\|Adult Acute Myeloid Leukemia in Remission\|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities\|Adult Acute Myeloid Leukemia With Del(5q)\|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)\|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)\|Adult Nasal Type Extranodal NK+T-cell Lymphoma\|Anaplastic Large Cell Lymphoma\|Angioimmunoblastic T-cell Lymphoma\|Aplastic Anemia\|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative\|Childhood Acute Lymphoblastic Leukemia in Remission\|Childhood Acute Myeloid Leukemia in Remission\|Childhood Chronic Myelogenous Leukemia\|Childhood Diffuse Large Cell Lymphoma\|Childhood Immunoblastic Large Cell Lymphoma\|Childhood Myelodysplastic Syndromes\|Childhood Nasal Type Extranodal NK+T-cell Lymphoma\|Chronic Eosinophilic Leukemia\|Chronic Myelomonocytic Leukemia\|Chronic Neutrophilic Leukemia\|Chronic Phase Chronic Myelogenous Leukemia\|de Novo Myelodysplastic Syndromes\|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue\|Fanconi Anemia\|Juvenile Myelomonocytic Leukemia\|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable\|Nodal Marginal Zone B-cell Lymphoma\|Noncontiguous Stage II Adult Burkitt Lymphoma\|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma\|Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma\|Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma\|Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma\|Noncontiguous Stage II Adult Lymphoblastic Lymphoma\|Noncontiguous Stage II Grade 1 Follicular Lymphoma\|Noncontiguous Stage II Grade 2 Follicular Lymphoma\|Noncontiguous Stage II Grade 3 Follicular Lymphoma\|Noncontiguous Stage II Mantle Cell Lymphoma\|Noncontiguous Stage II Marginal Zone Lymphoma\|Noncontiguous Stage II Small Lymphocytic Lymphoma\|Paroxysmal Nocturnal Hemoglobinuria\|Previously Treated Myelodysplastic Syndromes\|Primary Myelofibrosis\|Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Adult Burkitt Lymphoma\|Recurrent Adult Diffuse Large Cell Lymphoma\|Recurrent Adult Diffuse Mixed Cell Lymphoma\|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma\|Recurrent Adult Grade III Lymphomatoid Granulomatosis\|Recurrent Adult Hodgkin Lymphoma\|Recurrent Adult Immunoblastic Large Cell Lymphoma\|Recurrent Adult Lymphoblastic Lymphoma\|Recurrent Adult T-cell Leukemia+Lymphoma\|Recurrent Childhood Acute Lymphoblastic Leukemia\|Recurrent Childhood Acute Myeloid Leukemia\|Recurrent Childhood Anaplastic Large Cell Lymphoma\|Recurrent Childhood Grade III Lymphomatoid Granulomatosis\|Recurrent Childhood Large Cell Lymphoma\|Recurrent Childhood Lymphoblastic Lymphoma\|Recurrent Childhood Small Noncleaved Cell Lymphoma\|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma\|Recurrent Grade 1 Follicular Lymphoma\|Recurrent Grade 2 Follicular Lymphoma\|Recurrent Grade 3 Follicular Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Marginal Zone Lymphoma\|Recurrent Mycosis Fungoides+Sezary Syndrome\|Recurrent Small Lymphocytic Lymphoma\|Recurrent+Refractory Childhood Hodgkin Lymphoma\|Refractory Chronic Lymphocytic Leukemia\|Refractory Multiple Myeloma\|Relapsing Chronic Myelogenous Leukemia\|Secondary Acute Myeloid Leukemia\|Secondary Myelodysplastic Syndromes\|Splenic Marginal Zone Lymphoma\|Stage III Adult Diffuse Small Cleaved Cell Lymphoma\|Stage III Adult Immunoblastic Large Cell Lymphoma\|Stage III Adult Lymphoblastic Lymphoma\|Stage III Grade 1 Follicular Lymphoma\|Stage III Grade 2 Follicular Lymphoma\|Stage III Grade 3 Follicular Lymphoma\|Stage III Mantle Cell Lymphoma\|Stage III Marginal Zone Lymphoma\|Stage III Small Lymphocytic Lymphoma\|Stage IV Adult Burkitt Lymphoma\|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma\|Stage IV Adult Immunoblastic Large Cell Lymphoma\|Stage IV Adult Lymphoblastic Lymphoma\|Stage IV Grade 1 Follicular Lymphoma\|Stage IV Grade 2 Follicular Lymphoma\|Stage IV Grade 3 Follicular Lymphoma\|Stage IV Mantle Cell Lymphoma\|Stage IV Marginal Zone Lymphoma\|Stage IV Small Lymphocytic Lymphoma\|Waldenström Macroglobulinemia	January 14, 2009	Not Applicable
NCT03692663	Allife Medical Science and Technology Co., Ltd.\|Tianjin People´s Hospital	Metastatic Castration-resistant Prostate Cancer	December 1, 2018	Early Phase 1
NCT02626338	Arog Pharmaceuticals, Inc.	Relapsed+Refractory Acute Myeloid Leukemia (AML)	February 2016	Phase 1\|Phase 2
NCT05110742	M.D. Anderson Cancer Center	Hematological Malignancy	June 30, 2022	Phase 1\|Phase 2
NCT00073879	Baylor College of Medicine	Kidney Cancer	April 2003	Not Applicable
NCT02153580	City of Hope Medical Center\|National Cancer Institute (NCI)	B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma\|B-Cell Prolymphocytic Leukemia\|High Grade B-Cell Lymphoma, Not Otherwise Specified\|Post-Transplant Lymphoproliferative Disorder\|Recurrent Adult Burkitt Lymphoma\|Recurrent Chronic Lymphocytic Leukemia\|Recurrent Diffuse Large B-Cell Lymphoma\|Recurrent Follicular Lymphoma\|Recurrent Hairy Cell Leukemia\|Recurrent Lymphoplasmacytic Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Marginal Zone Lymphoma\|Recurrent Small Lymphocytic Lymphoma	September 24, 2014	Phase 1
NCT00408447	Columbia University	Sickle Cell Disease\|Beta Thalassemia	September 2004	Phase 2
NCT03706547	Peng Liu\|Hrain Biotechnology\|Shanghai East Hospital\|Shanghai Zhongshan Hospital	Multiple Myeloma in Relapse\|Multiple Myeloma Progression	October 30, 2018	Phase 1
NCT01251575	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Adult Acute Lymphoblastic Leukemia\|Adult Acute Myeloid Leukemia\|Adult Diffuse Large B-Cell Lymphoma\|Adult Myelodysplastic Syndrome\|Adult Non-Hodgkin Lymphoma\|Aggressive Non-Hodgkin Lymphoma\|Childhood Acute Lymphoblastic Leukemia\|Childhood Acute Myeloid Leukemia\|Childhood Diffuse Large B-Cell Lymphoma\|Childhood Myelodysplastic Syndrome\|Childhood Non-Hodgkin Lymphoma\|Chronic Lymphocytic Leukemia\|Chronic Lymphocytic Leukemia in Remission\|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Hematopoietic and Lymphoid Cell Neoplasm\|Mantle Cell Lymphoma\|Plasma Cell Myeloma\|Prolymphocytic Leukemia\|Recurrent Chronic Lymphocytic Leukemia\|Refractory Chronic Lymphocytic Leukemia\|T-Cell Prolymphocytic Leukemia\|Waldenstrom Macroglobulinemia\|Recurrent Diffuse Large B-Cell Lymphoma\|Recurrent Hodgkin Lymphoma	December 1, 2010	Phase 2
NCT01106950	Masonic Cancer Center, University of Minnesota	Leukemia, Myelogenous, Acute	July 2010	Phase 2
NCT00509288	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Melanoma\|Skin Cancer	June 2007	Phase 2
NCT04579523	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Plasma Cell Myeloma\|Recurrent Plasma Cell Myeloma\|Refractory Plasma Cell Myeloma	May 1, 2023	Phase 1
NCT05207722	Celularity Incorporated	Metastatic HER2 Positive Gastroesophageal Junction Cancer	April 14, 2022	Phase 1\|Phase 2
NCT03852407	University of Liege\|Belgian Hematological Society	Acute Myeloid Leukemia in Remission\|Myelodysplastic Syndromes\|Chronic Myeloid Leukemia in Remission\|Myeloproliferative Syndrome\|Myeloproliferative Disorder\|Acute Lymphoid Leukemia in Remission\|Multiple Myeloma\|Chronic Lymphoid Leukemia\|Non Hodgkin Lymphoma\|Hodgkin Lymphoma	February 4, 2019	Phase 2
NCT00085449	Alliance for Clinical Trials in Oncology\|National Cancer Institute (NCI)	Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Neoplasms	May 2006	Phase 1\|Phase 2
NCT00606437	Duke University	Lymphoma\|Myeloma\|Leukemia\|Myelodysplasia\|Solid Tumors\|Hodgkin´s Disease\|Myelofibrosis	September 2005	Phase 1
NCT00551239	CTI BioPharma	Leukemia\|Lymphoma	August 2007	Phase 3
NCT05579769	St. Jude Children´s Research Hospital	Hematologic Malignancy\|Myeloid Malignancy	November 4, 2022	Phase 2
NCT00610311	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Metastatic Melanoma\|Skin Cancer	January 2008	Phase 2
NCT01020539	Columbia University	Acute Myelogenous Leukemia\|Myelodysplastic Syndrome\|Juvenile Myelomonocytic Leukemia	September 11, 2002	Phase 1
NCT03475134	Centre Hospitalier Universitaire Vaudois	Metastatic Melanoma	February 21, 2018	Phase 1
NCT04881240	St. Jude Children´s Research Hospital	Acute Lymphoblastic Leukemia, in Relapse\|Acute Lymphoblastic Leukemia, Refractory\|Pediatric ALL	November 2022	Phase 1
NCT05589896	Ossium Health, Inc.\|Center for International Blood and Marrow Transplant Research	Acute Leukemia\|Acute Lymphoblastic Leukemia\|Acute Myeloid Leukemia\|Acute Biphenotypic Leukemia\|Acute Undifferentiated Leukemia	March 2023	Phase 1\|Phase 2
NCT00003619	Drexel University College of Medicine\|National Cancer Institute (NCI)	Chronic Myeloproliferative Disorders\|Leukemia\|Myelodysplastic Syndromes\|Thrombocytopenia	February 1998	Phase 1\|Phase 2
NCT05554939	Chinese PLA General Hospital	Non Hodgkin´s Lymphoma	December 1, 2022	Phase 1\|Phase 2
NCT00045435	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome\|Adult Acute Megakaryoblastic Leukemia (M7)\|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)\|Adult Acute Monoblastic Leukemia (M5a)\|Adult Acute Monocytic Leukemia (M5b)\|Adult Acute Myeloblastic Leukemia With Maturation (M2)\|Adult Acute Myeloblastic Leukemia Without Maturation (M1)\|Adult Acute Myeloid Leukemia in Remission\|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities\|Adult Acute Myeloid Leukemia With Del(5q)\|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)\|Adult Acute Myelomonocytic Leukemia (M4)\|Adult Erythroleukemia (M6a)\|Adult Pure Erythroid Leukemia (M6b)\|Secondary Acute Myeloid Leukemia	April 2002	Phase 2
NCT01273181	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Metastatic Cancer\|Metastatic Renal Cancer\|Metastatic Melanoma	December 2010	Phase 1\|Phase 2
NCT01898793	Washington University School of Medicine\|American Society of Clinical Oncology\|American Society of Hematology\|Gabrielle´s Angel Foundation\|The Leukemia and Lymphoma Society\|National Cancer Institute (NCI)\|ImmunityBio, Inc.	Leukemia, Myeloid, Acute	August 11, 2014	Phase 1\|Phase 2
NCT00612222	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Metastatic Melanoma\|Skin Cancer	January 2008	Phase 2
NCT00352976	Masonic Cancer Center, University of Minnesota	Fanconi Anemia	May 18, 2006	Phase 2\|Phase 3
NCT04339101	City of Hope Medical Center\|National Cancer Institute (NCI)	Acute Leukemia\|Hematologic and Lymphocytic Disorder\|Myelodysplastic Syndrome\|Primary Myelofibrosis\|Secondary Myelofibrosis	November 11, 2020	Phase 2
NCT02472392	University of Louisville	EWINGS SARCOMA	April 2013	Phase 1
NCT03096782	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Acute Biphenotypic Leukemia\|Acute Leukemia\|Acute Lymphoblastic Leukemia\|Acute Lymphoblastic Leukemia in Remission\|Acute Myeloid Leukemia\|Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome\|Chemotherapy-Related Leukemia\|Chronic Lymphocytic Leukemia\|Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Chronic Myelomonocytic Leukemia\|Hodgkin Lymphoma\|Langerhans Cell Histiocytosis\|Minimal Residual Disease\|Myelodysplastic Syndrome\|Myelodysplastic Syndrome With Excess Blasts\|Non-Hodgkin Lymphoma\|Recurrent Hodgkin Lymphoma\|Refractory Acute Lymphoblastic Leukemia\|Refractory Myelodysplastic Syndrome\|Small Lymphocytic Lymphoma\|Therapy-Related Myelodysplastic Syndrome	October 13, 2017	Phase 2
NCT00089011	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Accelerated Phase Chronic Myelogenous Leukemia\|Adult Acute Lymphoblastic Leukemia in Remission\|Adult Acute Myeloid Leukemia in Remission\|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities\|Adult Acute Myeloid Leukemia With Del(5q)\|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)\|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)\|Adult Nasal Type Extranodal NK+T-cell Lymphoma\|Anaplastic Large Cell Lymphoma\|Angioimmunoblastic T-cell Lymphoma\|Blastic Phase Chronic Myelogenous Leukemia\|Childhood Acute Lymphoblastic Leukemia in Remission\|Childhood Acute Myeloid Leukemia in Remission\|Childhood Burkitt Lymphoma\|Childhood Chronic Myelogenous Leukemia\|Childhood Diffuse Large Cell Lymphoma\|Childhood Immunoblastic Large Cell Lymphoma\|Childhood Myelodysplastic Syndromes\|Childhood Nasal Type Extranodal NK+T-cell Lymphoma\|Chronic Phase Chronic Myelogenous Leukemia\|Contiguous Stage II Adult Burkitt Lymphoma\|Contiguous Stage II Adult Diffuse Large Cell Lymphoma\|Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma\|Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma\|Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma\|Contiguous Stage II Adult Lymphoblastic Lymphoma\|Contiguous Stage II Grade 1 Follicular Lymphoma\|Contiguous Stage II Grade 2 Follicular Lymphoma\|Contiguous Stage II Grade 3 Follicular Lymphoma\|Contiguous Stage II Mantle Cell Lymphoma\|Contiguous Stage II Marginal Zone Lymphoma\|Contiguous Stage II Small Lymphocytic Lymphoma\|Cutaneous B-cell Non-Hodgkin Lymphoma\|de Novo Myelodysplastic Syndromes\|Essential Thrombocythemia\|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue\|Hepatosplenic T-cell Lymphoma\|Intraocular Lymphoma\|Nodal Marginal Zone B-cell Lymphoma\|Noncontiguous Stage II Adult Burkitt Lymphoma\|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma\|Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma\|Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma\|Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma\|Noncontiguous Stage II Adult Lymphoblastic Lymphoma\|Noncontiguous Stage II Grade 1 Follicular Lymphoma\|Noncontiguous Stage II Grade 2 Follicular Lymphoma\|Noncontiguous Stage II Grade 3 Follicular Lymphoma\|Noncontiguous Stage II Mantle Cell Lymphoma\|Noncontiguous Stage II Marginal Zone Lymphoma\|Noncontiguous Stage II Small Lymphocytic Lymphoma\|Noncutaneous Extranodal Lymphoma\|Peripheral T-cell Lymphoma\|Polycythemia Vera\|Post-transplant Lymphoproliferative Disorder\|Previously Treated Myelodysplastic Syndromes\|Primary Myelofibrosis\|Prolymphocytic Leukemia\|Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Adult Burkitt Lymphoma\|Recurrent Adult Diffuse Large Cell Lymphoma\|Recurrent Adult Diffuse Mixed Cell Lymphoma\|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma\|Recurrent Adult Grade III Lymphomatoid Granulomatosis\|Recurrent Adult Hodgkin Lymphoma\|Recurrent Adult Immunoblastic Large Cell Lymphoma\|Recurrent Adult Lymphoblastic Lymphoma\|Recurrent Adult T-cell Leukemia+Lymphoma\|Recurrent Childhood Acute Lymphoblastic Leukemia\|Recurrent Childhood Acute Myeloid Leukemia\|Recurrent Childhood Anaplastic Large Cell Lymphoma\|Recurrent Childhood Grade III Lymphomatoid Granulomatosis\|Recurrent Childhood Large Cell Lymphoma\|Recurrent Childhood Lymphoblastic Lymphoma\|Recurrent Childhood Small Noncleaved Cell Lymphoma\|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma\|Recurrent Grade 1 Follicular Lymphoma\|Recurrent Grade 2 Follicular Lymphoma\|Recurrent Grade 3 Follicular Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Marginal Zone Lymphoma\|Recurrent Mycosis Fungoides+Sezary Syndrome\|Recurrent Small Lymphocytic Lymphoma\|Recurrent+Refractory Childhood Hodgkin Lymphoma\|Refractory Chronic Lymphocytic Leukemia\|Refractory Hairy Cell Leukemia\|Refractory Multiple Myeloma\|Relapsing Chronic Myelogenous Leukemia\|Small Intestine Lymphoma\|Splenic Marginal Zone Lymphoma\|Stage I Adult Burkitt Lymphoma\|Stage I Adult Diffuse Large Cell Lymphoma\|Stage I Adult Diffuse Mixed Cell Lymphoma\|Stage I Adult Diffuse Small Cleaved Cell Lymphoma\|Stage I Adult Immunoblastic Large Cell Lymphoma\|Stage I Adult Lymphoblastic Lymphoma\|Stage I Adult T-cell Leukemia+Lymphoma\|Stage I Childhood Anaplastic Large Cell Lymphoma\|Stage I Childhood Large Cell Lymphoma\|Stage I Childhood Lymphoblastic Lymphoma\|Stage I Childhood Small Noncleaved Cell Lymphoma\|Stage I Chronic Lymphocytic Leukemia\|Stage I Cutaneous T-cell Non-Hodgkin Lymphoma\|Stage I Grade 1 Follicular Lymphoma\|Stage I Grade 2 Follicular Lymphoma\|Stage I Grade 3 Follicular Lymphoma\|Stage I Mantle Cell Lymphoma\|Stage I Marginal Zone Lymphoma\|Stage I Multiple Myeloma\|Stage I Small Lymphocytic Lymphoma\|Stage IA Mycosis Fungoides+Sezary Syndrome\|Stage IB Mycosis Fungoides+Sezary Syndrome\|Stage II Adult T-cell Leukemia+Lymphoma\|Stage II Childhood Anaplastic Large Cell Lymphoma\|Stage II Childhood Large Cell Lymphoma\|Stage II Childhood Lymphoblastic Lymphoma\|Stage II Childhood Small Noncleaved Cell Lymphoma\|Stage II Chronic Lymphocytic Leukemia\|Stage II Cutaneous T-cell Non-Hodgkin Lymphoma\|Stage II Multiple Myeloma\|Stage IIA Mycosis Fungoides+Sezary Syndrome\|Stage IIB Mycosis Fungoides+Sezary Syndrome\|Stage III Adult Burkitt Lymphoma\|Stage III Adult Diffuse Large Cell Lymphoma\|Stage III Adult Diffuse Mixed Cell Lymphoma\|Stage III Adult Diffuse Small Cleaved Cell Lymphoma\|Stage III Adult Immunoblastic Large Cell Lymphoma\|Stage III Adult Lymphoblastic Lymphoma\|Stage III Adult T-cell Leukemia+Lymphoma\|Stage III Childhood Anaplastic Large Cell Lymphoma\|Stage III Childhood Large Cell Lymphoma\|Stage III Childhood Lymphoblastic Lymphoma\|Stage III Childhood Small Noncleaved Cell Lymphoma\|Stage III Chronic Lymphocytic Leukemia\|Stage III Cutaneous T-cell Non-Hodgkin Lymphoma\|Stage III Grade 1 Follicular Lymphoma\|Stage III Grade 2 Follicular Lymphoma\|Stage III Grade 3 Follicular Lymphoma\|Stage III Mantle Cell Lymphoma\|Stage III Marginal Zone Lymphoma\|Stage III Multiple Myeloma\|Stage III Small Lymphocytic Lymphoma\|Stage IIIA Mycosis Fungoides+Sezary Syndrome\|Stage IIIB Mycosis Fungoides+Sezary Syndrome\|Stage IV Adult Burkitt Lymphoma\|Stage IV Adult Diffuse Large Cell Lymphoma\|Stage IV Adult Diffuse Mixed Cell Lymphoma\|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma\|Stage IV Adult Immunoblastic Large Cell Lymphoma\|Stage IV Adult Lymphoblastic Lymphoma\|Stage IV Adult T-cell Leukemia+Lymphoma\|Stage IV Childhood Anaplastic Large Cell Lymphoma\|Stage IV Childhood Large Cell Lymphoma\|Stage IV Childhood Lymphoblastic Lymphoma\|Stage IV Childhood Small Noncleaved Cell Lymphoma\|Stage IV Chronic Lymphocytic Leukemia\|Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma\|Stage IV Grade 1 Follicular Lymphoma\|Stage IV Grade 2 Follicular Lymphoma\|Stage IV Grade 3 Follicular Lymphoma\|Stage IV Mantle Cell Lymphoma\|Stage IV Marginal Zone Lymphoma\|Stage IV Small Lymphocytic Lymphoma\|Stage IVA Mycosis Fungoides+Sezary Syndrome\|Stage IVB Mycosis Fungoides+Sezary Syndrome\|Testicular Lymphoma\|Untreated Adult Acute Lymphoblastic Leukemia\|Untreated Adult Acute Myeloid Leukemia\|Untreated Childhood Acute Lymphoblastic Leukemia\|Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies\|Waldenström Macroglobulinemia	April 2004	Phase 2
NCT00311129	Genzyme, a Sanofi Company\|Sanofi	Lymphoma, Low-Grade	December 2005	Phase 2
NCT05201183	Naoyuki G. Saito, M.D., Ph.D.\|Indiana University	Acute Myeloid Leukemia\|Chronic Myeloid Leukemia\|Acute Lymphocytic Leukemia\|Myelodysplastic Syndromes	May 17, 2022	Phase 1\|Phase 2
NCT02761915	Cancer Research UK	Relapsed or Refractory Neuroblastoma	February 29, 2016	Phase 1
NCT00209209	European Mantle Cell Lymphoma Network\|German Low Grade Lymphoma Study Group\|Lymphoma Study Association\|HOVON - Dutch Haemato-Oncology Association\|Nordic Lymphoma Group	Lymphoma, Mantle-Cell	January 14, 2004	Phase 3
NCT02784561	Chinese PLA General Hospital\|309th Hospital of Chinese People´s Liberation Army\|Beijing Naval General Hospital\|Space Center Hospital, Peking University	Leukemia	July 2016	Phase 4
NCT00001676	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)\|National Institutes of Health Clinical Center (CC)	Glomerulonephritis\|Lupus Nephritis\|Systemic Lupus Erythematosus	January 1998	Phase 1
NCT00080925	National Institutes of Health Clinical Center (CC)\|National Cancer Institute (NCI)	Chronic Myeloproliferative Disorders\|Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Neoplasms	February 2004	Phase 1
NCT01173679	Massachusetts General Hospital\|Dana-Farber Cancer Institute\|Beth Israel Deaconess Medical Center\|Bristol-Myers Squibb	Chronic Lymphocytic Leukemia\|Small Lymphocytic Lymphoma	July 2010	Phase 2
NCT00118352	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Acute Undifferentiated Leukemia\|Adult Acute Lymphoblastic Leukemia in Remission\|Adult Acute Myeloid Leukemia in Remission\|Adult Nasal Type Extranodal NK+T-cell Lymphoma\|Anaplastic Large Cell Lymphoma\|Angioimmunoblastic T-cell Lymphoma\|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative\|Childhood Acute Lymphoblastic Leukemia in Remission\|Childhood Acute Myeloid Leukemia in Remission\|Childhood Burkitt Lymphoma\|Childhood Chronic Myelogenous Leukemia\|Childhood Diffuse Large Cell Lymphoma\|Childhood Immunoblastic Large Cell Lymphoma\|Childhood Myelodysplastic Syndromes\|Childhood Nasal Type Extranodal NK+T-cell Lymphoma\|Chronic Myelomonocytic Leukemia\|Chronic Phase Chronic Myelogenous Leukemia\|Cutaneous B-cell Non-Hodgkin Lymphoma\|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue\|Hepatosplenic T-cell Lymphoma\|Intraocular Lymphoma\|Juvenile Myelomonocytic Leukemia\|Mast Cell Leukemia\|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable\|Nodal Marginal Zone B-cell Lymphoma\|Noncutaneous Extranodal Lymphoma\|Peripheral T-cell Lymphoma\|Previously Treated Myelodysplastic Syndromes\|Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Adult Burkitt Lymphoma\|Recurrent Adult Diffuse Large Cell Lymphoma\|Recurrent Adult Diffuse Mixed Cell Lymphoma\|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma\|Recurrent Adult Grade III Lymphomatoid Granulomatosis\|Recurrent Adult Hodgkin Lymphoma\|Recurrent Adult Immunoblastic Large Cell Lymphoma\|Recurrent Adult Lymphoblastic Lymphoma\|Recurrent Adult T-cell Leukemia+Lymphoma\|Recurrent Childhood Acute Lymphoblastic Leukemia\|Recurrent Childhood Acute Myeloid Leukemia\|Recurrent Childhood Anaplastic Large Cell Lymphoma\|Recurrent Childhood Grade III Lymphomatoid Granulomatosis\|Recurrent Childhood Large Cell Lymphoma\|Recurrent Childhood Lymphoblastic Lymphoma\|Recurrent Childhood Small Noncleaved Cell Lymphoma\|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma\|Recurrent Grade 1 Follicular Lymphoma\|Recurrent Grade 2 Follicular Lymphoma\|Recurrent Grade 3 Follicular Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Marginal Zone Lymphoma\|Recurrent Mycosis Fungoides+Sezary Syndrome\|Recurrent Small Lymphocytic Lymphoma\|Recurrent+Refractory Childhood Hodgkin Lymphoma\|Refractory Chronic Lymphocytic Leukemia\|Refractory Hairy Cell Leukemia\|Refractory Multiple Myeloma\|Relapsing Chronic Myelogenous Leukemia\|Secondary Myelodysplastic Syndromes\|Small Intestine Lymphoma\|Splenic Marginal Zone Lymphoma\|Testicular Lymphoma\|Waldenström Macroglobulinemia	March 2005	Phase 2
NCT00003552	National Heart, Lung, and Blood Institute (NHLBI)\|National Cancer Institute (NCI)	Stage IV Melanoma\|Recurrent Melanoma	January 1999	Phase 1\|Phase 2
NCT04836507	Curocell Inc.	Relapsed Large B-cell Lymphoma\|Refractory Large B-cell Lymphoma\|Diffuse Large B-cell Lymphoma (DLBCL)\|Primary Mediastinal Large B-Cell Lymphoma (PMBCL)\|High-grade B-cell Lymphoma\|Transformed Follicular Lymphoma (TFL)	March 2, 2021	Phase 1\|Phase 2
NCT03089203	University of Pennsylvania	Prostate Cancer	March 8, 2017	Phase 1
NCT03935347	Roswell Park Cancer Institute\|Iovance Biotherapeutics, Inc.	Metastatic Bladder Urothelial Carcinoma\|Metastatic Renal Pelvis Urothelial Carcinoma\|Metastatic Ureter Urothelial Carcinoma\|Metastatic Urethral Urothelial Carcinoma\|Unresectable Renal Pelvis Urothelial Carcinoma\|Unresectable Ureter Urothelial Carcinoma	June 20, 2019	Phase 2
NCT00397813	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)\|National Heart, Lung, and Blood Institute (NHLBI)	Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative\|Chronic Myelomonocytic Leukemia\|de Novo Myelodysplastic Syndrome\|Essential Thrombocythemia\|Myeloproliferative Neoplasm\|Paroxysmal Nocturnal Hemoglobinuria\|Polycythemia Vera\|Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase\|Primary Myelofibrosis\|Refractory Anemia\|Refractory Anemia With Excess Blasts\|Refractory Anemia With Ring Sideroblasts\|Refractory Cytopenia With Multilineage Dysplasia\|Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts	January 2006	Phase 2
NCT04776850	M.D. Anderson Cancer Center	Beta Thalassemia Major\|Sickle Beta 0 Thalassemia\|Sickle Beta Plus Thalassemia\|Sickle Beta Thalassemia\|Sickle Cell Disease\|Sickle Cell-SS Disease	December 29, 2020	Early Phase 1
NCT02162420	Masonic Cancer Center, University of Minnesota	Dyskeratosis Congenita\|Aplastic Anemia	January 2015	Not Applicable
NCT01585428	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Cervical Cancer\|Oropharyngeal Cancer\|Vaginal Cancer\|Anal Cancer\|Penile Cancer	April 13, 2012	Phase 2
NCT01427881	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Accelerated Phase Chronic Myelogenous Leukemia\|Adult Acute Lymphoblastic Leukemia in Remission\|Adult Acute Megakaryoblastic Leukemia (M7)\|Adult Acute Myeloid Leukemia in Remission\|Adult Erythroleukemia (M6a)\|Adult Nasal Type Extranodal NK+T-cell Lymphoma\|Adult Pure Erythroid Leukemia (M6b)\|Anaplastic Large Cell Lymphoma\|Angioimmunoblastic T-cell Lymphoma\|Blastic Phase Chronic Myelogenous Leukemia\|Childhood Acute Erythroleukemia (M6)\|Childhood Acute Lymphoblastic Leukemia in Remission\|Childhood Acute Megakaryocytic Leukemia (M7)\|Childhood Acute Myeloid Leukemia in Remission\|Childhood Burkitt Lymphoma\|Childhood Chronic Myelogenous Leukemia\|Childhood Diffuse Large Cell Lymphoma\|Childhood Immunoblastic Large Cell Lymphoma\|Childhood Myelodysplastic Syndromes\|Childhood Nasal Type Extranodal NK+T-cell Lymphoma\|Chronic Myelomonocytic Leukemia\|Chronic Phase Chronic Myelogenous Leukemia\|Cutaneous B-cell Non-Hodgkin Lymphoma\|de Novo Myelodysplastic Syndromes\|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue\|Hepatosplenic T-cell Lymphoma\|Intraocular Lymphoma\|Nodal Marginal Zone B-cell Lymphoma\|Noncutaneous Extranodal Lymphoma\|Peripheral T-cell Lymphoma\|Philadelphia Chromosome Negative Chronic Myelogenous Leukemia\|Post-transplant Lymphoproliferative Disorder\|Previously Treated Myelodysplastic Syndromes\|Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Adult Burkitt Lymphoma\|Recurrent Adult Diffuse Large Cell Lymphoma\|Recurrent Adult Diffuse Mixed Cell Lymphoma\|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma\|Recurrent Adult Grade III Lymphomatoid Granulomatosis\|Recurrent Adult Hodgkin Lymphoma\|Recurrent Adult Immunoblastic Large Cell Lymphoma\|Recurrent Adult Lymphoblastic Lymphoma\|Recurrent Adult T-cell Leukemia+Lymphoma\|Recurrent Childhood Acute Lymphoblastic Leukemia\|Recurrent Childhood Acute Myeloid Leukemia\|Recurrent Childhood Anaplastic Large Cell Lymphoma\|Recurrent Childhood Grade III Lymphomatoid Granulomatosis\|Recurrent Childhood Large Cell Lymphoma\|Recurrent Childhood Lymphoblastic Lymphoma\|Recurrent Childhood Small Noncleaved Cell Lymphoma\|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma\|Recurrent Grade 1 Follicular Lymphoma\|Recurrent Grade 2 Follicular Lymphoma\|Recurrent Grade 3 Follicular Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Marginal Zone Lymphoma\|Recurrent Mycosis Fungoides+Sezary Syndrome\|Recurrent Small Lymphocytic Lymphoma\|Recurrent+Refractory Childhood Hodgkin Lymphoma\|Relapsing Chronic Myelogenous Leukemia\|Secondary Acute Myeloid Leukemia\|Secondary Myelodysplastic Syndromes\|Small Intestine Lymphoma\|Splenic Marginal Zone Lymphoma\|Stage III Multiple Myeloma\|Testicular Lymphoma\|Waldenström Macroglobulinemia	September 2011	Phase 2
NCT00416910	German CLL Study Group	Chronic Lymphocytic Leukemia	July 1999	Phase 3
NCT05170828	Ossium Health, Inc.\|Center for International Blood and Marrow Transplant Research	Acute Leukemia\|Myelodysplastic Syndromes\|T-lymphoblastic Lymphoma\|Acute Lymphocytic Leukemia\|Acute Myeloid Leukemia\|Acute Biphenotypic Leukemia\|Acute Undifferentiated Leukemia	March 2022	Phase 1
NCT00670748	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Metastatic Melanoma\|Metastatic Renal Cell Cancer\|Metastatic Cancer	May 29, 2008	Phase 2
NCT04633148	AvenCell Europe GmbH\|PHARMALOG Institut für klinische Forschung GmbH	Prostate Cancer	November 23, 2020	Phase 1
NCT03056339	M.D. Anderson Cancer Center	B-Lymphoid Malignancies\|Acute Lymphocytic Leukemia\|Chronic Lymphocytic Leukemia\|Non-hodgkin Lymphoma	June 21, 2017	Phase 1\|Phase 2
NCT04639245	Fred Hutchinson Cancer Center\|SignalOne Bio, Inc.	Anatomic Stage IV Breast Cancer AJCC v8\|Metastatic Lung Non-Small Cell Carcinoma\|Metastatic Malignant Solid Neoplasm\|Metastatic Triple-Negative Breast Carcinoma\|Metastatic Urothelial Carcinoma\|Prognostic Stage IV Breast Cancer AJCC v8\|Stage IV Lung Cancer AJCC v8\|Stage IVA Lung Cancer AJCC v8\|Stage IVB Lung Cancer AJCC v8	July 19, 2021	Phase 1\|Phase 2
NCT01174121	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Metastatic Colorectal Cancer\|Metastatic Pancreatic Cancer\|Metastatic Ovarian Cancer\|Metastatic Breast Carcinoma\|Metastatic Endocrine Tumors+ Neuroendocrine Tumors	August 26, 2010	Phase 2
NCT04112589	PETHEMA Foundation\|Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company\|Syntax for Science, S.L	Acute Myeloid Leukemia	December 26, 2019	Phase 1\|Phase 2
NCT00795132	University of Utah	Acute Leukaemia\|Chronic Disease\|Leukemia\|Myelodysplasia\|Lymphoma	April 2004	Phase 2
NCT01787474	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Recurrent Adult Acute Myeloid Leukemia\|Refractory Acute Myeloid Leukemia	May 19, 2014	Phase 1
NCT03396575	University of Florida\|Accelerate Brain Cancer Cure\|Lyla Nsouli Foundation	Diffuse Intrinsic Pontine Glioma (DIPG)\|Brain Stem Glioma	May 17, 2018	Phase 1
NCT01993719	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Metastatic Melanoma	December 12, 2013	Phase 2
NCT04285567	Hoffmann-La Roche	Chronic Lymphocytic Leukemia (CLL)	May 28, 2020	Phase 3
NCT01118013	Alliance for Clinical Trials in Oncology\|National Cancer Institute (NCI)	Leukemia\|Lymphoma\|Lymphoproliferative Disorder\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Neoplasms	December 2010	Phase 2
NCT02278887	The Netherlands Cancer Institute\|Copenhagen University Hospital at Herlev	Metastatic Melanoma	September 23, 2014	Phase 3
NCT00027573	Alliance for Clinical Trials in Oncology\|National Cancer Institute (NCI)	Kidney Cancer	October 2001	Phase 2
NCT05590221	Peking University Cancer Hospital & Institute\|Shanghai Ming Ju Biotechnology Co., Ltd.	B-cell Lymphoma	December 10, 2022	Phase 2
NCT02145039	Masonic Cancer Center, University of Minnesota	Acute Leukemias\|Burkitt´s Lymphoma\|Chronic Myelogenous Leukemia	October 2014	Not Applicable
NCT03084380	Xinqiao Hospital of Chongqing	Hepatocellular Carcinoma	June 1, 2017	Phase 1\|Phase 2
NCT02548468	Sidney Kimmel Cancer Center at Thomas Jefferson University\|Thomas Jefferson University	Cutaneous T-Cell Non-Hodgkin Lymphoma\|Recurrent Mycosis Fungoides and Sezary Syndrome\|Stage IIB Mycosis Fungoides and Sezary Syndrome\|Stage IIIA Mycosis Fungoides and Sezary Syndrome\|Stage IIIB Mycosis Fungoides and Sezary Syndrome\|Stage IVA Mycosis Fungoides and Sezary Syndrome\|Stage IVB Mycosis Fungoides and Sezary Syndrome	November 20, 2015	Phase 1
NCT00679536	Ann & Robert H Lurie Children´s Hospital of Chicago	Leukemia	May 2008	Phase 1\|Phase 2
NCT05616468	The Affiliated Hospital of Xuzhou Medical University\|Guangzhou Bioresette Biomedical Technology Co., Ltd.	Nasopharyngeal Carcinoma	November 30, 2022	Early Phase 1
NCT04904185	Inge Marie Svane\|Technical University of Denmark\|Herlev Hospital	Malignant Melanoma	August 17, 2021	Phase 1
NCT01019317	M.D. Anderson Cancer Center	Leukemia\|AML\|MDS\|CML	November 2009	Phase 2
NCT03240861	Jonsson Comprehensive Cancer Center\|California Institute for Regenerative Medicine (CIRM)	HLA-A*0201 Positive Cells Present\|Locally Advanced Malignant Neoplasm\|NY-ESO-1 Positive\|Unresectable Malignant Neoplasm\|Sarcoma	July 26, 2017	Phase 1
NCT03615144	Memorial Sloan Kettering Cancer Center	Non-Malignant Hematologic Disorders	July 23, 2018	Phase 2
NCT02629809	M.D. Anderson Cancer Center	Chronic Lymphocytic Leukemia\|Small Lymphocytic Lymphoma	March 18, 2016	Phase 2
NCT02625480	Kite, A Gilead Company\|Gilead Sciences	Relapsed+Refractory B-precursor Acute Lymphoblastic Leukemia\|Relapsed+Refractory B-Cell Non-Hodgkin Lymphoma	February 1, 2016	Phase 1\|Phase 2
NCT04626726	Hebei Senlang Biotechnology Inc., Ltd.	Adult B Acute Lymphoblastic Leukemia	April 1, 2020	Early Phase 1
NCT00048893	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Breast Neoplasms\|Metastases, Neoplasm	November 2002	Phase 1\|Phase 2
NCT03774654	Baylor College of Medicine\|Center for Cell and Gene Therapy, Baylor College of Medicine\|The Methodist Hospital Research Institute	Refractory B-Cell Non-Hodgkin Lymphoma\|Refractory B-Cell Small Lymphocytic Lymphoma\|Relapsed Adult ALL\|Relapsed CLL\|Relapsed Non Hodgkin Lymphoma	June 22, 2020	Phase 1
NCT04626739	Hebei Senlang Biotechnology Inc., Ltd.	Refractory Indolent Adult Non-Hodgkin Lymphoma	April 1, 2020	Early Phase 1
NCT00737685	The Korean Society of Pediatric Hematology Oncology	Anemia, Aplastic	January 2006	Phase 2
NCT03958656	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Myeloma-Multiple\|Myeloma, Plasma-Cell	June 13, 2019	Phase 1
NCT05052528	Mehrdad Abedi, MD\|National Cancer Institute (NCI)\|University of California, Davis	Recurrent Diffuse Large B-Cell Lymphoma\|Refractory Diffuse Large B-Cell Lymphoma	September 17, 2021	Phase 1
NCT00004878	Jonsson Comprehensive Cancer Center	Graft Versus Host Disease\|Leukemia		Phase 2
NCT00002838	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Leukemia	December 1995	Phase 1\|Phase 2
NCT01390402	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Leukemia\|Chronic Myelogenous Leukemia	January 2012	Phase 2
NCT00110071	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue\|Nodal Marginal Zone B-cell Lymphoma\|Recurrent Adult Burkitt Lymphoma\|Recurrent Adult Diffuse Large Cell Lymphoma\|Recurrent Adult Diffuse Mixed Cell Lymphoma\|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma\|Recurrent Adult Immunoblastic Large Cell Lymphoma\|Recurrent Adult Lymphoblastic Lymphoma\|Recurrent Grade 1 Follicular Lymphoma\|Recurrent Grade 2 Follicular Lymphoma\|Recurrent Grade 3 Follicular Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Marginal Zone Lymphoma\|Splenic Marginal Zone Lymphoma\|Waldenström Macroglobulinemia	January 2005	Phase 1
NCT00167206	Masonic Cancer Center, University of Minnesota	Fanconi Anemia	March 2004	Phase 1\|Phase 2
NCT03961919	Ciceri Fabio\|IRCCS San Raffaele	Acute Myeloid Leukemia\|Myelodysplastic Syndromes\|Transplant-Related Hematologic Malignancy	February 10, 2009	Phase 2
NCT00068523	Case Comprehensive Cancer Center	Chronic Myeloproliferative Disorders\|Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Diseases	June 2003	Not Applicable
NCT02061800	Diane George\|Columbia University	Chronic Myeloid Leukemia (CML)\|Acute Myelogenous Leukemia (AML)\|Myelodysplastic Syndrome (MDS)\|Juvenile Myelomonocytic Leukemia (JMML)\|Acute Lymphoblastic Leukemia (ALL)\|Lymphoma (Hodgkin´s and Non-Hodgkin´s)	June 3, 2013	Phase 1\|Phase 2
NCT01050764	Everett Meyer\|Doris Duke Charitable Foundation\|Stanford University	Leukemia, Acute\|Chronic Myelogenous Leukemia (CML)\|Myelodysplastic Syndrome (MDS)\|Non-Hodgkin Lymphoma (NHL)\|Chronic Lymphocytic Leukemia (CLL)\|Acute Myelogenous Leukemia (AML)\|Acute Lymphoblastic Leukemia (ALL)	June 2009	Phase 1\|Phase 2
NCT02566304	Sidney Kimmel Cancer Center at Thomas Jefferson University\|Thomas Jefferson University	Acute Myeloid Leukemia\|Acute Myeloid Leukemia in Remission\|Aplastic Anemia\|Chronic Myelomonocytic Leukemia\|Hodgkin Lymphoma\|Indolent Non-Hodgkin Lymphoma\|Malignant Neoplasm\|Myelodysplastic Syndrome\|Myeloproliferative Neoplasm\|Plasma Cell Myeloma\|Refractory Anemia\|Refractory Anemia With Excess Blasts\|Refractory Anemia With Ring Sideroblasts\|Refractory Cytopenia With Multilineage Dysplasia\|Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts	November 13, 2015	Phase 2
NCT05371093	Kite, A Gilead Company\|Gilead Sciences	Relapsed+Refractory Follicular Lymphoma	September 12, 2022	Phase 3
NCT04897321	St. Jude Children´s Research Hospital	Pediatric Solid Tumor\|Osteosarcoma\|Rhabdomyosarcoma\|Neuroblastoma\|Ewing Sarcoma\|Wilms Tumor\|Adrenocortical Cancer\|Desmoplastic Small Round Cell Tumor\|Germ Cell Cancer\|Rhabdoid Tumor\|Clear Cell Sarcoma\|Hepatoblastoma\|Melanoma\|Carcinoma\|Malignant Peripheral Nerve Sheath Tumors\|Soft Tissue Sarcoma	June 29, 2022	Phase 1
NCT03215810	H. Lee Moffitt Cancer Center and Research Institute\|Bristol-Myers Squibb\|Prometheus Inc.\|Stand Up To Cancer\|Iovance Biotherapeutics, Inc.	Non-Small Cell Lung Cancer\|Metastatic Non-small Cell Lung Cancer\|Squamous Cell Carcinoma\|Advanced NSCLC\|Adenosquamous Carcinoma\|Adenocarcinomas	October 11, 2017	Phase 1
NCT00008151	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Leukemia\|Myelodysplastic Syndromes	October 2000	Phase 2
NCT00079144	National Cancer Institute (NCI)	Melanoma (Skin)	January 2004	Phase 2
NCT00182650	City of Hope Medical Center\|National Cancer Institute (NCI)	Lymphoma	June 2004	Phase 1
NCT00684255	New York Medical College	Systemic Lupus Erythematosus\|Systemic Sclerosis	August 2007	Phase 1
NCT03593902	Northwestern University	Systemic Sclerosis\|Scleroderma	May 17, 2018	Phase 2\|Phase 3
NCT02529839	Hadassah Medical Organization	Multiple Sclerosis	October 2015	Not Applicable
NCT03121014	University of Illinois at Chicago	Acute Myeloid Leukemia\|Myelodysplastic Syndromes	April 24, 2017	Phase 2
NCT03579888	M.D. Anderson Cancer Center\|Ziopharm Oncology	B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged\|Recurrent B Acute Lymphoblastic Leukemia\|Recurrent Chronic Lymphocytic Leukemia\|Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified\|Recurrent Mantle Cell Lymphoma\|Recurrent Non-Hodgkin Lymphoma\|Recurrent Ph-Like Acute Lymphoblastic Leukemia\|Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma\|Recurrent Small Lymphocytic Lymphoma\|Refractory B Acute Lymphoblastic Leukemia\|Refractory Chronic Lymphocytic Leukemia\|Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified\|Refractory Mantle Cell Lymphoma\|Refractory Non-Hodgkin Lymphoma\|Refractory Ph-Like Acute Lymphoblastic Leukemia\|Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma\|Refractory Small Lymphocytic Lymphoma	June 26, 2020	Phase 1
NCT03779854	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Acute Biphenotypic Leukemia\|Acute Leukemia\|Acute Leukemia of Ambiguous Lineage\|Acute Lymphoblastic Leukemia\|Acute Undifferentiated Leukemia\|Allogeneic Hematopoietic Stem Cell Transplantation Recipient\|Blastic Plasmacytoid Dendritic Cell Neoplasm\|Blasts Under 25 Percent of Bone Marrow Nucleated Cells\|Blasts Under 5 Percent of Bone Marrow Nucleated Cells\|Mixed Phenotype Acute Leukemia\|Myelodysplastic Syndrome With Excess Blasts-1\|Myelodysplastic Syndrome With Excess Blasts-2	August 29, 2019	Phase 2
NCT05122221	Corregene Biotechnology Co., Ltd	Cervical Cancer\|Anal Cancer\|Head and Neck Cancers	July 17, 2022	Phase 1
NCT00049504	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Accelerated Phase Chronic Myelogenous Leukemia\|Adult Acute Lymphoblastic Leukemia in Remission\|Adult Acute Myeloid Leukemia in Remission\|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities\|Adult Acute Myeloid Leukemia With Del(5q)\|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)\|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)\|Adult Nasal Type Extranodal NK+T-cell Lymphoma\|Anaplastic Large Cell Lymphoma\|Angioimmunoblastic T-cell Lymphoma\|Childhood Acute Lymphoblastic Leukemia in Remission\|Childhood Acute Myeloid Leukemia in Remission\|Childhood Burkitt Lymphoma\|Childhood Chronic Myelogenous Leukemia\|Childhood Myelodysplastic Syndromes\|Childhood Nasal Type Extranodal NK+T-cell Lymphoma\|Cutaneous B-cell Non-Hodgkin Lymphoma\|de Novo Myelodysplastic Syndromes\|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue\|Hematopoietic+Lymphoid Cancer\|Hepatosplenic T-cell Lymphoma\|Intraocular Lymphoma\|Nodal Marginal Zone B-cell Lymphoma\|Peripheral T-cell Lymphoma\|Post-transplant Lymphoproliferative Disorder\|Previously Treated Myelodysplastic Syndromes\|Recurrent Adult Burkitt Lymphoma\|Recurrent Adult Diffuse Large Cell Lymphoma\|Recurrent Adult Diffuse Mixed Cell Lymphoma\|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma\|Recurrent Adult Grade III Lymphomatoid Granulomatosis\|Recurrent Adult Hodgkin Lymphoma\|Recurrent Adult Immunoblastic Large Cell Lymphoma\|Recurrent Adult Lymphoblastic Lymphoma\|Recurrent Adult T-cell Leukemia+Lymphoma\|Recurrent Childhood Anaplastic Large Cell Lymphoma\|Recurrent Childhood Grade III Lymphomatoid Granulomatosis\|Recurrent Childhood Large Cell Lymphoma\|Recurrent Childhood Lymphoblastic Lymphoma\|Recurrent Childhood Small Noncleaved Cell Lymphoma\|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma\|Recurrent Grade 1 Follicular Lymphoma\|Recurrent Grade 2 Follicular Lymphoma\|Recurrent Grade 3 Follicular Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Marginal Zone Lymphoma\|Recurrent Mycosis Fungoides+Sezary Syndrome\|Recurrent Small Lymphocytic Lymphoma\|Recurrent+Refractory Childhood Hodgkin Lymphoma\|Refractory Chronic Lymphocytic Leukemia\|Refractory Multiple Myeloma\|Relapsing Chronic Myelogenous Leukemia\|Secondary Myelodysplastic Syndromes\|Small Intestine Lymphoma\|Splenic Marginal Zone Lymphoma\|Stage II Multiple Myeloma\|Stage III Adult Burkitt Lymphoma\|Stage III Adult Diffuse Large Cell Lymphoma\|Stage III Adult Diffuse Mixed Cell Lymphoma\|Stage III Adult Diffuse Small Cleaved Cell Lymphoma\|Stage III Adult Hodgkin Lymphoma\|Stage III Adult Immunoblastic Large Cell Lymphoma\|Stage III Adult Lymphoblastic Lymphoma\|Stage III Adult T-cell Leukemia+Lymphoma\|Stage III Childhood Hodgkin Lymphoma\|Stage III Chronic Lymphocytic Leukemia\|Stage III Cutaneous T-cell Non-Hodgkin Lymphoma\|Stage III Grade 1 Follicular Lymphoma\|Stage III Grade 2 Follicular Lymphoma\|Stage III Grade 3 Follicular Lymphoma\|Stage III Mantle Cell Lymphoma\|Stage III Marginal Zone Lymphoma\|Stage III Multiple Myeloma\|Stage III Mycosis Fungoides+Sezary Syndrome\|Stage III Small Lymphocytic Lymphoma\|Stage IV Adult Burkitt Lymphoma\|Stage IV Adult Diffuse Large Cell Lymphoma\|Stage IV Adult Diffuse Mixed Cell Lymphoma\|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma\|Stage IV Adult Hodgkin Lymphoma\|Stage IV Adult Immunoblastic Large Cell Lymphoma\|Stage IV Adult Lymphoblastic Lymphoma\|Stage IV Adult T-cell Leukemia+Lymphoma\|Stage IV Childhood Hodgkin Lymphoma\|Stage IV Chronic Lymphocytic Leukemia\|Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma\|Stage IV Grade 1 Follicular Lymphoma\|Stage IV Grade 2 Follicular Lymphoma\|Stage IV Grade 3 Follicular Lymphoma\|Stage IV Mantle Cell Lymphoma\|Stage IV Marginal Zone Lymphoma\|Stage IV Mycosis Fungoides+Sezary Syndrome\|Stage IV Small Lymphocytic Lymphoma\|Testicular Lymphoma\|Waldenström Macroglobulinemia	January 2002	Phase 2
NCT01858740	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)\|National Heart, Lung, and Blood Institute (NHLBI)	Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Acute Biphenotypic Leukemia\|Acute Leukemia of Ambiguous Lineage\|Acute Undifferentiated Leukemia\|Adult Acute Lymphoblastic Leukemia in Remission\|Adult Acute Myeloid Leukemia in Remission\|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Childhood Acute Lymphoblastic Leukemia in Remission\|Childhood Acute Myeloid Leukemia in Remission\|Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Myelodysplastic Syndrome With Excess Blasts-1\|Myelodysplastic Syndrome With Excess Blasts-2\|Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Childhood Acute Lymphoblastic Leukemia\|Recurrent Childhood Acute Myeloid Leukemia\|Refractory Adult Acute Lymphoblastic Leukemia\|Refractory Childhood Acute Lymphoblastic Leukemia	December 17, 2013	Phase 2
NCT00429416	Sidney Kimmel Cancer Center at Thomas Jefferson University\|Thomas Jefferson University	Hematologic Malignancies	March 2004	Phase 1\|Phase 2
NCT00801931	Columbia University	Leukemia\|Lymphoma\|Neuroblastoma\|Immunodeficiencies\|Anemia	September 6, 2007	Phase 1\|Phase 2
NCT00358657	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)\|National Heart, Lung, and Blood Institute (NHLBI)	Immunodeficiency Syndrome\|Severe Aplastic Anemia\|Genetic Disorder	May 24, 2006	Phase 2
NCT00622895	Fred Hutchinson Cancer Center\|National Institute of Allergy and Infectious Diseases (NIAID)	Systemic Scleroderma\|Severe Systemic Sclerosis	September 1, 2006	Phase 1\|Phase 2
NCT00506129	M.D. Anderson Cancer Center	Lymphoma\|Disorder Related to Bone Marrow Transplantation	September 2003	Phase 2
NCT00281918	Hoffmann-La Roche\|German CLL Study Group	Leukemia	July 2003	Phase 3
NCT03126864	M.D. Anderson Cancer Center\|Intrexon Corporation	Hematopoietic+Lymphoid Cancer\|Acute Myeloid Leukemia	August 4, 2017	Phase 1
NCT01322776	Sun Yat-sen University\|Fudan University\|Zhejiang University\|West China Hospital\|Ruijin Hospital\|Tianjin Medical University Cancer Institute and Hospital\|Peking University Cancer Hospital & Institute\|Jiangsu Cancer Institute & Hospital	Mantle Cell Lymphoma Recurrent	March 2011	Phase 1\|Phase 2
NCT04558736	St. Jude Children´s Research Hospital	Aplastic Anemia\|Bone Marrow Failure Syndrome	January 21, 2021	Phase 2
NCT01953900	Baylor College of Medicine\|National Cancer Institute (NCI)\|Center for Cell and Gene Therapy, Baylor College of Medicine\|The Methodist Hospital Research Institute	Osteosarcoma\|Neuroblastoma	April 2014	Phase 1
NCT01020734	Asan Medical Center	Leukemia	May 2011	Phase 2
NCT00220311	Genzyme, a Sanofi Company\|Sanofi	Leukemia, Lymphocytic, Chronic, B-Cell	November 2000	Phase 4
NCT02588612	GlaxoSmithKline	Neoplasms	February 1, 2016	Phase 1
NCT02833805	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Severe Aplastic Anemia\|Aplastic Anemia\|Bone Marrow Failure\|Immunosuppression	September 2016	Phase 2
NCT00387959	Memorial Sloan Kettering Cancer Center\|National Cancer Institute (NCI)	Leukemia\|Lymphoma	July 2006	Phase 2
NCT04706936	Second Affiliated Hospital, School of Medicine, Zhejiang University\|Carbiogene Therapeutics Co. Ltd.	Relapsed or Refractory Multiple Myeloma	April 1, 2021	Phase 1
NCT00769522	German CLL Study Group\|Roche Pharma AG\|Mundipharma Pte Ltd.	Chronic Lymphocytic Leukemia	October 2, 2008	Phase 3
NCT00630253	Masonic Cancer Center, University of Minnesota	Fanconi Anemia	February 17, 2000	Phase 1\|Phase 2
NCT03613532	Jacqueline Garcia, MD\|National Institutes of Health (NIH)\|Dana-Farber Cancer Institute	Acute Myeloid Leukemia (AML)\|Myelodysplastic Syndrome (MDS)\|Chronic Myelomonocytic Leukemia (CMML)\|MDS+Myeloproliferative Neoplasm-unclassifiable (MDS+MPN-unclassifiable)\|Hematopoietic Stem Cell Transplant	October 24, 2018	Phase 1
NCT00448357	UNC Lineberger Comprehensive Cancer Center\|National Cancer Institute (NCI)\|Otsuka America Pharmaceutical	Chronic Myeloproliferative Disorders\|Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes	October 2005	Phase 1\|Phase 2
NCT03594162	UNC Lineberger Comprehensive Cancer Center\|Bellicum Pharmaceuticals	Acute Lymphoblastic Leukemia\|Immune System Diseases\|Immunoproliferative Disorders
NCT00381550	National Cancer Institute (NCI)	Accelerated Phase Chronic Myelogenous Leukemia\|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative\|Blastic Phase Chronic Myelogenous Leukemia\|Chronic Eosinophilic Leukemia\|Chronic Myelomonocytic Leukemia\|Essential Thrombocythemia\|Philadelphia Chromosome Negative Chronic Myelogenous Leukemia\|Polycythemia Vera\|Primary Myelofibrosis\|Relapsing Chronic Myelogenous Leukemia	August 2006	Phase 2
NCT01495572	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Metastatic Melanoma\|Skin Cancer	December 2011	Phase 2
NCT02933775	RenJi Hospital\|CARsgen Therapeutics Co., Ltd.	CD19 Positive Malignant B-cell Leukemia and Lymphoma	October 2016	Phase 1
NCT04898894	St. Jude Children´s Research Hospital\|Karyopharm Therapeutics Inc\|AbbVie\|Gateway for Cancer Research	Acute Leukemia of Ambiguous Lineage in Relapse\|Acute Myeloid Leukemia, in Relapse\|Refractory Acute Leukemia of Ambiguous Lineage\|Refractory Acute Myeloid Leukemia	November 15, 2021	Phase 1
NCT00564200	PETHEMA Foundation	Multiple Myeloma	November 2007	Phase 2
NCT03860844	Sanofi	Acute Lymphoblastic Leukemia\|Acute Myeloid Leukemia	August 6, 2019	Phase 2
NCT00385788	M.D. Anderson Cancer Center	Hodgkin´s Disease	July 2005	Phase 2
NCT00382694	Nordic Myeloma Study Group	Multiple Myeloma	May 2005	Phase 2
NCT00670410	Columbia University	Neuroblastoma	November 2003	Phase 1
NCT00047060	National Heart, Lung, and Blood Institute (NHLBI)\|National Institutes of Health Clinical Center (CC)	Mycosis Fungoides\|Sezary Syndrome	July 30, 2002	Phase 1\|Phase 2
NCT00577278	City of Hope Medical Center\|National Cancer Institute (NCI)	Graft Versus Host Disease\|Leukemia\|Lymphoma	October 3, 2007	Phase 2
NCT00054236	Case Comprehensive Cancer Center	Chronic Myeloproliferative Disorders\|Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Diseases	May 2002	Phase 1
NCT00738829	Arbeitsgemeinschaft medikamentoese Tumortherapie\|Celgene Corporation\|Roche Pharma AG	Leukemia, Lymphocytic, Chronic, B-Cell	October 2008	Phase 1\|Phase 2
NCT01464359	Masonic Cancer Center, University of Minnesota	Acute Myelogenous Leukemia\|Refractory Acute Myelogenous Leukemia	October 2011	Phase 2
NCT05478837	University of California, San Francisco\|The V Foundation\|Parker Institute for Cancer Immunotherapy	Diffuse Midline Glioma, H3 K27M-Mutant	January 1, 2023	Phase 1
NCT00276848	German CLL Study Group	Chronic Lymphocytic Leukemia	July 1999	Phase 3
NCT00003829	Alliance for Clinical Trials in Oncology\|National Cancer Institute (NCI)	Leukemia	August 1999	Phase 2
NCT01124526	Asociacion Espanola de Hematologia y Hemoterapia	Non Hodgkin Lymphoma	September 2004	Phase 4
NCT04823091	Wuhan Union Hospital, China\|Beijing GoBroad Hospital Management Co.,Ltd\|Shanghai YaKe Biotechnology Ltd.	T-Cell Lymphocytic Leukemia\|T-Cell Chronic Lymphocytic Leukemia\|T Cell Non-Hodgkin Lymphoma	April 15, 2021	Phase 1
NCT01271010	Hoffmann-La Roche	Lymphocytic Leukemia, Chronic	June 17, 2011	Phase 4
NCT00038844	M.D. Anderson Cancer Center	Lymphoma\|Leukemia	June 2001	Not Applicable
NCT00060424	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	B-Cell Prolymphocytic Leukemia\|Chronic Lymphocytic Leukemia\|Prolymphocytic Leukemia\|Recurrent Chronic Lymphocytic Leukemia\|Recurrent Small Lymphocytic Lymphoma\|Refractory Chronic Lymphocytic Leukemia\|T-Cell Prolymphocytic Leukemia	March 2003	Phase 2
NCT04205838	Jonsson Comprehensive Cancer Center	Diffuse Large B-Cell Lymphoma, Not Otherwise Specified\|High Grade B-Cell Lymphoma\|Progressive Disease\|Recurrent Diffuse Large B-Cell Lymphoma\|Recurrent High Grade B-Cell Lymphoma\|Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma\|Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma\|Refractory Diffuse Large B-Cell Lymphoma\|Refractory High Grade B-Cell Lymphoma\|Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma\|Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma	March 4, 2020	Phase 2
NCT05601830	Institute of Hematology & Blood Diseases Hospital	Minimal Residual Disease	October 28, 2022	Phase 1
NCT02118311	Masonic Cancer Center, University of Minnesota\|National Institutes of Health (NIH)\|National Cancer Institute (NCI)	Hematologic Malignancies	June 2016	Phase 2
NCT01652014	University of Medicine and Dentistry of New Jersey\|National Cancer Institute (NCI)\|Rutgers, The State University of New Jersey	Accelerated Phase Chronic Myelogenous Leukemia\|Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome\|Adult Acute Lymphoblastic Leukemia in Remission\|Adult Acute Myeloid Leukemia in Remission\|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities\|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)\|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)\|Adult Nasal Type Extranodal NK+T-cell Lymphoma\|Anaplastic Large Cell Lymphoma\|Angioimmunoblastic T-cell Lymphoma\|Blastic Phase Chronic Myelogenous Leukemia\|Cutaneous B-cell Non-Hodgkin Lymphoma\|de Novo Myelodysplastic Syndromes\|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue\|Hepatosplenic T-cell Lymphoma\|Intraocular Lymphoma\|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable\|Nodal Marginal Zone B-cell Lymphoma\|Noncutaneous Extranodal Lymphoma\|Peripheral T-cell Lymphoma\|Post-transplant Lymphoproliferative Disorder\|Previously Treated Myelodysplastic Syndromes\|Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Adult Burkitt Lymphoma\|Recurrent Adult Diffuse Large Cell Lymphoma\|Recurrent Adult Diffuse Mixed Cell Lymphoma\|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma\|Recurrent Adult Grade III Lymphomatoid Granulomatosis\|Recurrent Adult Hodgkin Lymphoma\|Recurrent Adult Immunoblastic Large Cell Lymphoma\|Recurrent Adult Lymphoblastic Lymphoma\|Recurrent Adult T-cell Leukemia+Lymphoma\|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma\|Recurrent Grade 1 Follicular Lymphoma\|Recurrent Grade 2 Follicular Lymphoma\|Recurrent Grade 3 Follicular Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Marginal Zone Lymphoma\|Recurrent Mycosis Fungoides+Sezary Syndrome\|Recurrent Small Lymphocytic Lymphoma\|Refractory Chronic Lymphocytic Leukemia\|Refractory Hairy Cell Leukemia\|Refractory Multiple Myeloma\|Relapsing Chronic Myelogenous Leukemia\|Secondary Acute Myeloid Leukemia\|Secondary Myelodysplastic Syndromes\|Small Intestine Lymphoma\|Splenic Marginal Zone Lymphoma\|T-cell Large Granular Lymphocyte Leukemia\|Testicular Lymphoma\|Waldenström Macroglobulinemia	January 2014	Phase 2
NCT05436418	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Peripheral Blood Stem Cell Transplantation\|Hematopoietic Stem Cell Transplantation	November 18, 2022	Phase 1\|Phase 2
NCT00074269	University of California, San Diego\|National Cancer Institute (NCI)	Breast Cancer	July 2003	Phase 2
NCT00041288	University of Texas Southwestern Medical Center	Leukemia\|Lymphoma	October 2001	Phase 2
NCT00578643	Baylor College of Medicine	Chronic Granulomatous Disease	March 2004	Phase 2
NCT04162756	Kite, A Gilead Company\|Gilead Sciences	Relapse+Refractory Mantle Cell Lymphoma
NCT03919526	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	MRD-positive\|Acute Lymphoblastic Leukemia	August 11, 2019	Phase 1
NCT02251821	Fred Hutchinson Cancer Center\|Incyte Corporation\|National Cancer Institute (NCI)	Primary Myelofibrosis\|Secondary Myelofibrosis	October 20, 2014	Phase 2
NCT00454480	The University of New South Wales\|National Cancer Institute (NCI)	Leukemia\|Myelodysplastic Syndromes	August 2006	Phase 2\|Phase 3
NCT04030195	Precision BioSciences, Inc.	Non-Hodgkin´s Lymphoma, Relapsed\|Chronic Lymphoid Leukemia in Relapse\|Non-Hodgkin´s Lymphoma Refractory\|Chronic Lymphocytic Leukemia\|Lymphoma, Non-Hodgkin\|Leukemia, Lymphocytic, Chronic\|B-cell Chronic Lymphocytic Leukemia\|B-cell Non Hodgkin Lymphoma\|Small Lymphocytic Lymphoma	March 24, 2020	Phase 1\|Phase 2
NCT01453101	Hackensack Meridian Health	Multiple Myeloma	June 9, 2010	Phase 2
NCT05244070	Bristol-Myers Squibb	Leukemia, Lymphocytic, Chronic, B-Cell\|Lymphoma	September 14, 2022	Phase 1
NCT00282282	Dana-Farber Cancer Institute\|Brigham and Women´s Hospital	Graft Versus Host Disease\|GVHD	January 2006	Phase 2
NCT02880293	Memorial Sloan Kettering Cancer Center	Hematologic Malignancy	August 23, 2016	Not Applicable
NCT03434769	Benjamin Tomlinson\|Case Comprehensive Cancer Center	Non-Hodgkin Lymphoma	July 9, 2018	Phase 1
NCT02859402	Keimyung University Dongsan Medical Center\|Otsuka Pharmaceutical Co., Ltd.	T-cell Non-Hodgkin Lymphoma\|Lymphoma, Extranodal NK-T-Cell	December 2016	Phase 2
NCT00874315	Nationwide Children´s Hospital	Neuroblastoma	September 2008	Phase 2
NCT03778619	GC Cell Corporation	Relapsed Non Hodgkin Lymphoma\|Refractory Non-Hodgkin Lymphoma	November 28, 2018	Phase 1\|Phase 2
NCT00425802	Memorial Sloan Kettering Cancer Center\|National Cancer Institute (NCI)	Leukemia\|Lymphoma	November 28, 2006	Phase 2
NCT02577094	Nantes University Hospital\|Gilead Sciences\|Institut Cancerologie de l´Ouest	Lymphocyte B CD22 Positive Acute Lymphoblastic Leukemia		Phase 1\|Phase 2
NCT01292603	Hoffmann-La Roche	Lymphocytic Leukemia, Chronic	April 18, 2011	Phase 1
NCT05257083	European Myeloma Network\|Janssen Research & Development, LLC	Multiple Myeloma	December 2022	Phase 3
NCT04767308	Huazhong University of Science and Technology\|Shanghai IASO Biotechnology Co., Ltd	CD5&addition; Relapsed+Refractory Hematopoietic Malignancies\|Chronic Lymphocytic Leukemia (CLL)\|Mantle Cell Lymphoma (MCL)\|Diffuse Large B-cell Lymphoma (DLBCL)\|Follicular Lymphoma (FL)\|Peripheral T-cell Lymphomas (PTCL)	March 2021	Early Phase 1
NCT04539366	National Cancer Institute (NCI)	Recurrent Neuroblastoma\|Recurrent Osteosarcoma\|Refractory Neuroblastoma\|Refractory Osteosarcoma	June 11, 2021	Phase 1
NCT01457131	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Metastatic Cancer\|Metastatic Melanoma\|Metastatic Renal Cancer	October 6, 2011	Phase 1
NCT05476770	Therapeutic Advances in Childhood Leukemia Consortium	Hematologic Malignancy\|AML\|ALL\|BPDCN\|MDS\|Lymphoblastic Lymphoma\|Lymphoma, B-Cell\|Lymphoma, T-Cell\|Hodgkin Lymphoma\|Mixed Phenotype Acute Leukemia\|Acute Undifferentiated Leukemia	November 11, 2022	Phase 1
NCT02280811	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Vaginal Cancer\|Cervical Cancer\|Anal Cancer\|Penile Cancer\|Oropharyngeal Cancer	October 14, 2014	Phase 1\|Phase 2
NCT00255710	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins\|National Cancer Institute (NCI)	Chronic Myeloproliferative Disorders\|Graft Versus Host Disease\|Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Diseases	July 2002	Phase 1
NCT01664910	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Hematopoietic and Lymphoid Cell Neoplasm	October 29, 2012	Phase 1\|Phase 2
NCT02660281	University of Rochester	Hematological Disease\|Immune Deficiencies\|Solid Tumors\|Myelofibrosis\|Multiple Myeloma\|Lymphoma	October 2015	Phase 1
NCT00295971	University of California, San Francisco\|National Cancer Institute (NCI)	Congenital Amegakaryocytic Thrombocytopenia\|Leukemia\|Myelodysplastic Syndromes\|Severe Congenital Neutropenia	April 2005	Phase 1
NCT01342289	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Hodgkin´s Lymphoma\|Leukemia\|Myelodysplastic Syndrome(MDS)\|Multiple Myeloma\|Non Hodgkin´s Lymphoma	August 2011	Phase 1
NCT03093168	The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine\|Hrain Biotechnology Co., Ltd.\|First Affiliated Hospital of Wenzhou Medical University\|Shanghai Changzheng Hospital	Multiple Myeloma	February 15, 2017	Phase 1
NCT05624554	Merck Sharp & Dohme LLC	Chronic Lymphocytic Leukemia\|Small Lymphocytic Leukemia	December 22, 2022	Phase 3
NCT03793478	Daiichi Sankyo, Inc.\|Innovative Therapies For Children with Cancer Consortium\|Children´s Oncology Group	Acute Myeloid Leukemia	August 15, 2018	Phase 1\|Phase 2
NCT00091143	Providence Cancer Center, Earle A. Chiles Research Institute\|National Cancer Institute (NCI)	Melanoma (Skin)	July 2004	Phase 1
NCT00003659	Memorial Sloan Kettering Cancer Center\|National Cancer Institute (NCI)	Leukemia	September 1998	Phase 2
NCT00140569	Lymphoma Study Association	Follicular Lymphoma	January 1994	Phase 3
NCT00529880	Cooperative Study Group A for Hematology	Acute Myeloid Leukemia	December 2004	Phase 2
NCT01619761	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Acute Biphenotypic Leukemia\|Acute Lymphoblastic Leukemia in Remission\|Acute Myeloid Leukemia in Remission\|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|DS Stage II Plasma Cell Myeloma\|DS Stage III Plasma Cell Myeloma\|High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements\|ISS Stage II Plasma Cell Myeloma\|ISS Stage III Plasma Cell Myeloma\|Myelodysplastic Syndrome\|Recurrent Acute Lymphoblastic Leukemia\|Recurrent Acute Myeloid Leukemia\|Recurrent Chronic Lymphocytic Leukemia\|Recurrent Hodgkin Lymphoma\|Recurrent Non-Hodgkin Lymphoma\|Recurrent Small Lymphocytic Lymphoma\|Refractory Acute Lymphoblastic Leukemia\|Refractory Chronic Lymphocytic Leukemia\|Refractory Hodgkin Lymphoma\|Refractory Non-Hodgkin Lymphoma\|Refractory Small Lymphocytic Lymphoma\|Secondary Acute Myeloid Leukemia\|Therapy-Related Acute Myeloid Leukemia\|Therapy-Related Myelodysplastic Syndrome	May 3, 2013	Phase 1
NCT00871689	Masonic Cancer Center, University of Minnesota	Leukemia	January 2009	Phase 2
NCT01804634	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Refractory and+or Relapsed Metastatic Solid Tumors	March 27, 2013	Phase 2
NCT02379520	Baylor College of Medicine\|Center for Cell and Gene Therapy, Baylor College of Medicine\|The Methodist Hospital Research Institute	Human Papillomavirus-Related Carcinoma\|Human Papillomavirus Positive Oropharyngeal Carcinoma\|Human Papillomavirus Positive Cervical Carcinoma\|Human Papillomavirus Positive Anal Carcinoma\|Human Papillomavirus Positive Vulvar Carcinoma\|Human Papillomavirus Positive Penile Carcinoma	September 2015	Phase 1
NCT00448019	M.D. Anderson Cancer Center\|Genentech, Inc.	Chronic Lymphocytic Leukemia	February 2007	Phase 2
NCT02390739	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Metastatic Thyroid Cancer	March 2, 2015	Phase 1\|Phase 2
NCT01905943	Hoffmann-La Roche	Chronic Lymphocytic Leukemia	November 4, 2013	Phase 3
NCT01088048	Gilead Sciences	Indolent Non-Hodgkin´s Lymphoma\|Chronic Lymphocytic Leukemia\|Mantle Cell Lymphoma	March 25, 2010	Phase 1
NCT00119730	Dana-Farber Cancer Institute\|Massachusetts General Hospital\|Biogen	Mantle Cell Lymphoma	February 2005	Phase 2
NCT00907036	Cancer Research UK\|National Cancer Institute (NCI)	Lymphoma	July 2009	Phase 2
NCT00427336	M.D. Anderson Cancer Center	Aplastic Anemia	December 2000	Not Applicable
NCT05293509	M.D. Anderson Cancer Center	Stem Cell Transplantation	September 30, 2022	Phase 2
NCT01585415	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Metastatic Cancer\|Melanoma	April 9, 2012	Phase 1
NCT04262843	City of Hope Medical Center\|National Cancer Institute (NCI)	Acute Lymphoblastic Leukemia\|Acute Myeloid Leukemia\|High Risk Myelodysplastic Syndrome\|Myelodysplastic Syndrome	February 7, 2020	Phase 2
NCT04264039	Xinqiao Hospital of Chongqing\|Gracell Biotechnology Shanghai Co., Ltd.\|920th Hospital of Joint Logistics Support Force of People´s Liberation Army of China\|The Second Affiliated Hospital of Chongqing Medical University\|The Affiliated Hospital Of Guizhou Medical University\|Central South University\|The First Affiliated Hospital of Kunming Medical College\|The General Hospital of Western Theater Command\|Second Affiliated Hospital of Xi´an Jiaotong University\|Nanfang Hospital of Southern Medical University\|Fujian Medical University Union Hospital\|The First Affiliated Hospital of Anhui Medical University\|Tang-Du Hospital	B-cell Acute Lymphoblastic Leukemia\|B-cell Lymphoma	April 1, 2020	Early Phase 1
NCT03983850	National Cancer Institute (NCI)\|National Institute of Neurological Disorders and Stroke (NINDS)\|National Institutes of Health Clinical Center (CC)	Graft Versus Host Disease\|Hematologic Neoplasms	July 9, 2019	Phase 1\|Phase 2
NCT03247088	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Recurrent Acute Myeloid Leukemia\|Refractory Acute Myeloid Leukemia	July 30, 2017	Phase 1\|Phase 2
NCT02287311	Baylor College of Medicine\|Center for Cell and Gene Therapy, Baylor College of Medicine\|The Methodist Hospital Research Institute	Hodgkin Disease\|Non-Hodgkin Lymphoma\|Severe Chronic Active Epstein Barr Virus\|T+NK-lymphoproliferative Disease\|Nasopharyngeal Carcinoma\|Smooth Muscle Tumor	February 2015	Phase 1
NCT00450983	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)\|National Institute of Allergy and Infectious Diseases (NIAID)	Graft Versus Host Disease\|Leukemia\|Myelodysplastic Syndromes	December 2006	Phase 2
NCT01540812	PETHEMA Foundation	Acute Lymphoblastic Leukemia	February 2012
NCT00228852	Emory University	T-Cell Immune Deficiency Diseases\|Severe Combined Immunodeficiency		Phase 1\|Phase 2
NCT02348216	Kite, A Gilead Company\|Gilead Sciences	Refractory Diffuse Large B Cell Lymphoma (DLBCL)\|Relapsed Diffuse Large B-Cell Lymphoma\|Transformed Follicular Lymphoma (TFL)\|Primary Mediastinal B-cell Lymphoma (PMBCL)\|High Grade B-cell Lymphoma (HGBCL)	April 21, 2015	Phase 1\|Phase 2
NCT00801489	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11\|Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11\|Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1\|de Novo Myelodysplastic Syndrome\|High Risk Myelodysplastic Syndrome\|Inv(16)\|Myelodysplastic Syndrome With Excess Blasts\|t(16;16)\|t(8;21)\|Untreated Adult Acute Myeloid Leukemia	April 4, 2007	Phase 2
NCT03159702	Medical College of Wisconsin	Hematological Malignancy\|Multiple Myeloma	December 8, 2017	Phase 2
NCT02858310	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Papillomavirus Infections\|Cervical Intraepithelial Neoplasia\|Carcinoma In Situ\|Vulvar Neoplasms\|Vulvar Diseases	January 27, 2017	Phase 1\|Phase 2
NCT00566696	St. Jude Children´s Research Hospital	Leukemia, Acute Lymphocytic (ALL)\|Leukemia, Myeloid, Acute(AML)\|Leukemia, Myeloid, Chronic(CML)\|Juvenile Myelomonocytic Leukemia (JMML)\|Hemoglobinuria, Paroxysmal Nocturnal (PNH)\|Hodgkin Lymphoma\|Lymphoma, Non-Hodgkin (NHL)\|Myelodysplastic Syndrome (MDS)	December 14, 2007	Phase 2
NCT04809766	Fred Hutchinson Cancer Center\|Lonza Walkersville, Inc.	Metastatic Pancreatic Ductal Adenocarcinoma\|Stage IV Pancreatic Cancer AJCC v8	December 14, 2021	Phase 1
NCT02133196	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Advanced Non-Small Cell Lung Cancer\|Squamous Cell Carcinoma\|Advanced NSCLC\|Adenosquamous Carcinoma\|Adenocarcinoma	October 23, 2014	Phase 2
NCT01652092	Masonic Cancer Center, University of Minnesota	SCID\|Omenn´s Syndrome\|Reticular Dysgenesis\|Wiskott-Aldrich Syndrome\|Bare Lymphocyte Syndrome\|Common Variable Immunodeficiency\|Chronic Granulomatous Disease\|CD40 Ligand Deficiency\|Hyper IgM Syndrome\|X-linked Lymphoproliferative Disease\|Hemophagocytic Lymphohistiocytosis\|Griscelli Syndrome\|Chediak-Higashi Syndrome\|Langerhan´s Cell Histiocytosis	September 4, 2012	Not Applicable
NCT03992326	Centre Hospitalier Universitaire Vaudois	Solid Tumor, Adult	September 1, 2019	Phase 1
NCT04195633	Fred Hutchinson Cancer Center\|medac GmbH	Acute Leukemia\|Acute Lymphoblastic Leukemia\|Acute Myeloid Leukemia\|Adult Diffuse Large Cell Lymphoma\|Anaplastic Large Cell Lymphoma\|Burkitt Lymphoma\|Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Chronic Myelomonocytic Leukemia\|Hodgkin Lymphoma\|Lymphoblastic Lymphoma\|Lymphoplasmacytic Lymphoma\|Mantle Cell Lymphoma\|Mixed Phenotype Acute Leukemia\|Myelodysplastic Syndrome\|Prolymphocytic Leukemia\|Refractory Chronic Lymphocytic Leukemia\|Refractory Follicular Lymphoma\|Refractory Marginal Zone Lymphoma\|Refractory Small Lymphocytic Lymphoma	January 25, 2021	Phase 2
NCT02652468	University of Wisconsin, Madison	Lymphoma	March 10, 2016	Not Applicable
NCT01191957	Gruppo Italiano Trapianto di Midollo Osseo	Acute Myeloid Leukemia (AML)	January 2008	Phase 3
NCT02440464	National Heart, Lung, and Blood Institute (NHLBI)\|Blood and Marrow Transplant Clinical Trials Network\|National Cancer Institute (NCI)\|National Marrow Donor Program	Multiple Myeloma	August 2015	Phase 2
NCT01218867	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Metastatic Cancer\|Metastatic Melanoma\|Renal Cancer	November 10, 2010	Phase 1\|Phase 2
NCT00034528	National Institute of Allergy and Infectious Diseases (NIAID)	Hemoglobinopathies\|Anemia, Sickle Cell\|Hemoglobin SC Disease\|Thalassemia\|Thalassemia Major	September 2001	Phase 2
NCT02926053	Inge Marie Svane\|Herlev Hospital	Metastatic Renal Cell Carcinoma	December 2016	Phase 1
NCT00009984	National Cancer Institute (NCI)	Recurrent Small Lymphocytic Lymphoma\|Refractory Chronic Lymphocytic Leukemia	March 2002	Phase 2
NCT04959175	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Hematologic Neoplasms	September 23, 2021	Phase 1\|Phase 2
NCT05531708	Shanghai Pudong Hospital\|UTC Therapeutics Inc.	Mesothelin-positive Advanced Refractory Solid Tumors	April 2, 2021	Phase 1
NCT02446964	City of Hope Medical Center\|National Cancer Institute (NCI)	Adult Acute Lymphoblastic Leukemia in Complete Remission\|Acute Myeloid Leukemia in Remission\|Previously Treated Myelodysplastic Syndrome\|Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Childhood Acute Lymphoblastic Leukemia\|Recurrent Childhood Acute Myeloid Leukemia\|Childhood Acute Lymphoblastic Leukemia in Complete Remission	June 25, 2015	Phase 1
NCT00860457	Georgetown University\|Celgene Corporation	Chronic Lymphocytic Leukemia	February 2008	Phase 2
NCT03412877	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Endocrine Tumors\|Non-Small Cell Lung Cancer\|Ovarian Cancer\|Breast Cancer\|Gastrointestinal+Genitourinary Cancers\|Neuroendocrine Tumors\|Multiple Myeloma	September 6, 2018	Phase 2
NCT03591510	Novartis Pharmaceuticals\|Novartis	FLT3-mutated Acute Myeloid Leukemia	March 13, 2019	Phase 2
NCT02776202	National Guard Health Affairs	Sickle Cell Disease	May 2016	Phase 2
NCT04982354	Baptist Health South Florida\|Jazz Pharmaceuticals	Acute Myeloid Leukemia	July 5, 2022	Phase 1\|Phase 2
NCT05320380	LLS PedAL Initiative, LLC\|Children´s Oncology Group\|ImmunoGen, Inc.\|National Cancer Institute (NCI)	Recurrent Acute Myeloid Leukemia\|Recurrent B Acute Lymphoblastic Leukemia\|Recurrent Mixed Phenotype Acute Leukemia\|Recurrent T Acute Lymphoblastic Leukemia\|Refractory Acute Myeloid Leukemia\|Refractory B Acute Lymphoblastic Leukemia\|Refractory Mixed Phenotype Acute Leukemia\|Refractory T Acute Lymphoblastic Leukemia	December 20, 2022	Phase 1\|Phase 2
NCT00578292	Baylor College of Medicine	Thalassemia	February 2004	Not Applicable
NCT05084027	First Affiliated Hospital of Zhejiang University\|Sir Run Run Shaw Hospital\|Second Affiliated Hospital, School of Medicine, Zhejiang University\|Zhejiang Provincial People´s Hospital\|The Affiliated People´s Hospital of Ningbo University\|First Affiliated Hospital of Wenzhou Medical University\|Ningbo Hospital of Zhejiang University\|The First Affiliated Hospital of Zhejiang Chinese Medical University	Hematologic Malignancy\|Older Patients\|Allogeneic Hematopoietic Stem Cell Transplantation	October 7, 2021	Phase 2
NCT00006233	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Melanoma (Skin)	January 2000	Phase 2
NCT03624036	Kite, A Gilead Company\|Gilead Sciences	Relapsed+Refractory Chronic Lymphocytic Leukemia and Relapsed+Refractory Small Lymphocytic Lymphoma	November 15, 2018	Phase 1
NCT00084695	Milton S. Hershey Medical Center\|National Cancer Institute (NCI)	Childhood Langerhans Cell Histiocytosis\|Fanconi Anemia\|Leukemia\|Lymphoma\|Myelodysplastic Syndromes\|Neuroblastoma\|Sarcoma\|Unspecified Childhood Solid Tumor, Protocol Specific	September 2003	Phase 2
NCT03643276	Martin Schrappe\|Deutsche Krebshilfe e.V., Bonn (Germany)\|University Hospital Schleswig-Holstein	Acute Lymphoblastic Leukemia, Pediatric	July 15, 2018	Phase 3
NCT02581007	Northside Hospital, Inc.\|Blood and Marrow Transplant Group of Georgia	Chronic Myelogenous Leukemia\|Acute Myelogenous Leukemia\|Myelodysplastic Syndrome\|Acute Lymphocytic Leukemia\|Chronic Lymphocytic Leukemia\|Hodgkin´s Lymphoma\|Non-Hodgkin´s Lymphoma\|Myelofibrosis\|CMML\|Multiple Myeloma	October 26, 2015	Phase 2
NCT00916045	King´s College Hospital NHS Trust	Leukemia, Myeloid, Acute\|Myelodysplastic Syndromes\|Leukemia, Lymphoblastic, Acute\|Lymphoma, Non-Hodgkin\|Hodgkin Disease\|Chronic Lymphocytic Leukemia	September 2009	Phase 2
NCT04989335	Sheba Medical Center\|Race Oncology Ltd	Myelogenous Leukemia, Acute	August 2, 2021	Phase 2
NCT00361140	H. Lee Moffitt Cancer Center and Research Institute	Myelodysplastic Syndromes\|Myeloproliferative Disorders\|Leukemia, Lymphocytic\|Myeloma\|Lymphoma	August 2005	Phase 4
NCT05451849	TCR2 Therapeutics	Mesothelioma\|Mesotheliomas Pleural\|Mesothelioma, Malignant\|Mesothelioma Peritoneum\|Ovarian Cancer\|Ovarian Serous Adenocarcinoma\|Pancreatic Cancer\|Pancreatic Adenocarcinoma\|Colorectal Cancer\|Triple Negative Breast Cancer\|TNBC - Triple-Negative Breast Cancer\|Ovarian Adenocarcinoma\|Pancreatic Neoplasms\|Colorectal Neoplasms\|Ovarian Neoplasms	June 21, 2022	Phase 1\|Phase 2
NCT01666080	Masonic Cancer Center, University of Minnesota	Hematologic Disorders\|Hemoglobinopathies\|Immunodeficiencies	August 2012	Not Applicable
NCT03233854	Crystal Mackall, MD\|California Institute for Regenerative Medicine (CIRM)\|Stanford University	B Acute Lymphoblastic Leukemia\|CD19 Positive\|Minimal Residual Disease\|Philadelphia Chromosome Positive	September 1, 2017	Phase 1
NCT00278265	German CLL Study Group	T-Cell Large Granular Lymphocytic Leukemia	June 2005	Phase 2
NCT00845104	Fred Hutchinson Cancer Research Center+University of Washington Cancer Consortium\|Fred Hutchinson Cancer Center	B-cell Chronic Lymphocytic Leukemia\|Refractory Chronic Lymphocytic Leukemia	January 2009	Phase 2
NCT04119024	Jonsson Comprehensive Cancer Center\|City of Hope National Medical Center	Clinical Stage IV Cutaneous Melanoma AJCC v8\|IL13RA2 Positive\|Metastatic Melanoma\|Cutaneous Melanoma, Stage III\|Cutaneous Melanoma, Stage IV	November 27, 2019	Phase 1
NCT02410551	M.D. Anderson Cancer Center\|CTI BioPharma	Myeloproliferative Diseases	June 15, 2015	Phase 2
NCT00281879	OHSU Knight Cancer Institute\|National Cancer Institute (NCI)	Chronic Myeloproliferative Disorders\|Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Neoplasms\|Unusual Cancers of Childhood	February 2006	Phase 2
NCT02498912	Memorial Sloan Kettering Cancer Center\|Stanford University\|Juno Therapeutics, Inc.	Solid Tumors	August 2015	Phase 1
NCT00545714	Hoffmann-La Roche	Leukemia, Lymphocytic, Chronic, B-Cell	November 21, 2007	Phase 2
NCT04196413	Crystal Mackall, MD\|CureSearch\|Stanford University	Glioma of Spinal Cord\|Glioma of Brainstem	June 4, 2020	Phase 1
NCT00076752	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Lupus Erythematosus, Systemic	January 30, 2004	Phase 2
NCT00278213	German CLL Study Group	Prolymphocytic Leukemia	September 2002	Phase 2
NCT00004255	Chimeric Therapies\|National Cancer Institute (NCI)	Graft Versus Host Disease\|Leukemia\|Myelodysplastic Syndromes	March 2000	Phase 2\|Phase 3
NCT01962636	Masonic Cancer Center, University of Minnesota	Acute Myeloid Leukemia (AML)\|Acute Lymphocytic Leukemia (ALL)\|Chronic Myelogenous Leukemia\|Plasma Cell Leukemia\|Myelofibrosis\|Myelodysplasia\|Chronic Lymphocytic Leukemia\|Small Lymphocytic Lymphoma\|Marginal Zone B-Cell Lymphoma\|Follicular Lymphoma\|Lymphoplasmacytic Lymphoma\|Mantle-Cell Lymphoma\|Prolymphocytic Leukemia\|Diffuse Large B Cell Lymphoma\|Lymphoblastic Lymphoma\|Burkitt´s Lymphoma\|Non-Hodgkin Lymphoma\|Multiple Myeloma	December 2016	Not Applicable
NCT05508009	Alice Bertaina\|Stanford University	SIOD With CKD Stage 3 Through 5\|Cystinosis With CKD Stage 3 Through 5\|FSGS With CKD Stage 3 Through 5\|SLE Nephritis With CKD Stage 3 Through 5	October 2022	Phase 1\|Phase 2
NCT03914885	UNC Lineberger Comprehensive Cancer Center	Hodgkin Lymphoma, Adult
NCT03303950	University of Utah	Anemia\|ASXL1 Gene Mutation\|EZH2 Gene Mutation\|IDH1 Gene Mutation\|IDH2 Gene Mutation\|Plasma Cell Myeloma\|Primary Myelofibrosis\|Recurrent Plasma Cell Myeloma\|Secondary Myelofibrosis\|Thrombocytopenia	March 30, 2018	Phase 2
NCT00008177	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Adult Acute Myeloid Leukemia in Remission\|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities\|Adult Acute Myeloid Leukemia With Del(5q)\|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)\|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)\|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)\|Chronic Myelomonocytic Leukemia\|de Novo Myelodysplastic Syndromes\|Previously Treated Myelodysplastic Syndromes\|Recurrent Adult Acute Myeloid Leukemia\|Refractory Anemia With Excess Blasts\|Refractory Anemia With Excess Blasts in Transformation\|Refractory Anemia With Ringed Sideroblasts\|Refractory Cytopenia With Multilineage Dysplasia\|Secondary Myelodysplastic Syndromes\|Untreated Adult Acute Myeloid Leukemia	July 27, 1999	Phase 1
NCT01145209	National Heart, Lung, and Blood Institute (NHLBI)\|University of Virginia\|GlaxoSmithKline\|National Institutes of Health Clinical Center (CC)	Small Lymphocytic Lymphoma\|CLL (Chronic Lymphocytic Leukemia)	July 1, 2010	Phase 2
NCT00825149	Hoffmann-La Roche	Non-Hodgkin´s Lymphoma	February 2009	Phase 1
NCT02533401	Hoffmann-La Roche	Lymphocytic Leukemia, Chronic	February 2006	Phase 2
NCT03530085	Nanfang Hospital of Southern Medical University\|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University\|Guangzhou First People´s Hospital\|Peking University People´s Hospital\|Third Affiliated Hospital, Sun Yat-Sen University\|Zhujiang Hospital	Acute Myeloid Leukemia\|Allogeneic Hematopoietic Stem Cell Transplantation\|Conditioning\|Elderly	June 15, 2018	Phase 2\|Phase 3
NCT00608374	Taunton and Somerset Hospital\|National Cancer Institute (NCI)	Lymphoma	June 2006	Phase 3
NCT00185445	Genzyme, a Sanofi Company\|Sanofi	Non Hodgkin Lymphoma	June 2004	Phase 2
NCT00410163	GlaxoSmithKline	Leukaemia, Lymphocytic, Chronic	January 2007	Phase 2
NCT02799147	St. Petersburg State Pavlov Medical University	Leukemia, Acute Lymphoblastic\|Acute Myeloid Leukemia\|Mixed-Lineage Acute Leukemias	June 2016	Phase 1\|Phase 2
NCT03128034	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Acute Lymphoblastic Leukemia\|Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome\|Acute Myeloid Leukemia\|Chronic Myelomonocytic Leukemia\|Myelodysplastic Syndrome With Excess Blasts\|Recurrent Acute Myeloid Leukemia\|Refractory Acute Lymphoblastic Leukemia\|Recurrent Acute Lymphoblastic Leukemia\|Recurrent Mixed Phenotype Acute Leukemia\|Refractory Acute Myeloid Leukemia\|Refractory Mixed Phenotype Acute Leukemia\|Mixed Phenotype Acute Leukemia	October 24, 2017	Phase 1\|Phase 2
NCT02614066	Kite, A Gilead Company\|Gilead Sciences	Relapsed+Refractory B-precursor Acute Lymphoblastic Leukemia	March 7, 2016	Phase 1\|Phase 2
NCT00005863	Medical Research Council\|National Cancer Institute (NCI)	Leukemia\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Neoplasms	August 1998	Phase 3
NCT04784052	Rajni Agarwal\|Stanford University	Fanconi Anemia	December 7, 2021	Phase 1\|Phase 2
NCT04171843	Precision BioSciences, Inc.	Relapsed+Refractory Multiple Myeloma	April 30, 2020	Phase 1\|Phase 2
NCT00119392	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	B-cell Chronic Lymphocytic Leukemia\|Nodal Marginal Zone B-cell Lymphoma\|Recurrent Adult Burkitt Lymphoma\|Recurrent Adult Diffuse Large Cell Lymphoma\|Recurrent Adult Diffuse Mixed Cell Lymphoma\|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma\|Recurrent Adult Grade III Lymphomatoid Granulomatosis\|Recurrent Adult Immunoblastic Large Cell Lymphoma\|Recurrent Adult Lymphoblastic Lymphoma\|Recurrent Grade 1 Follicular Lymphoma\|Recurrent Grade 2 Follicular Lymphoma\|Recurrent Grade 3 Follicular Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Marginal Zone Lymphoma\|Recurrent Small Lymphocytic Lymphoma\|Splenic Marginal Zone Lymphoma\|Waldenström Macroglobulinemia	June 2004	Phase 2
NCT02111850	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Cervical Cancer\|Renal Cancer\|Urothelial Cancer\|Melanoma\|Breast Cancer	February 7, 2014	Phase 1\|Phase 2
NCT00020176	National Cancer Institute (NCI)	Breast Cancer	June 2000	Phase 2
NCT00309842	Masonic Cancer Center, University of Minnesota	Acute Myeloid Leukemia\|Acute Lymphocytic Leukemia\|Chronic Myelogenous Leukemia\|Myelofibrosis\|MDS\|Refractory Anemia\|Chronic Lymphocytic Leukemia\|Prolymphocytic Leukemia\|Non-Hodgkin´s Lymphoma\|Leukemia\|Lymphoma\|Multiple Myeloma\|Myelodysplastic Syndromes	July 28, 2005	Phase 2
NCT01339910	Medical College of Wisconsin\|National Heart, Lung, and Blood Institute (NHLBI)\|National Cancer Institute (NCI)\|Blood and Marrow Transplant Clinical Trials Network\|National Marrow Donor Program	Leukemia, Myelocytic, Acute	June 2011	Phase 3
NCT02960646	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Acute Lymphoblastic Leukemia\|Acute Myeloid Leukemia\|Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome\|Aplastic Anemia\|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Chronic Myelomonocytic Leukemia\|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Lymphoblastic Lymphoma\|Myelodysplastic Syndrome\|Myeloproliferative Neoplasm\|Plasma Cell Myeloma\|Recurrent Chronic Lymphocytic Leukemia+Small Lymphocytic Lymphoma\|Recurrent Hodgkin Lymphoma\|Recurrent Non-Hodgkin Lymphoma\|Recurrent Plasma Cell Myeloma\|Therapy-Related Myelodysplastic Syndrome	January 18, 2017	Phase 1
NCT01527045	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)\|National Heart, Lung, and Blood Institute (NHLBI)	Aggressive Non-Hodgkin Lymphoma\|Blasts Under 5 Percent of Bone Marrow Nucleated Cells\|Chronic Lymphocytic Leukemia\|Loss of Chromosome 17p\|Myelodysplastic+Myeloproliferative Neoplasm\|Non-Hodgkin Lymphoma\|Prolymphocytic Leukemia\|Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Aggressive Adult Non-Hodgkin Lymphoma\|Recurrent Childhood Acute Lymphoblastic Leukemia\|Recurrent Childhood Acute Myeloid Leukemia\|Recurrent Chronic Lymphocytic Leukemia\|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Recurrent Diffuse Large B-Cell Lymphoma\|Recurrent Hodgkin Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Non-Hodgkin Lymphoma\|Recurrent Plasma Cell Myeloma\|Recurrent Small Lymphocytic Lymphoma\|Waldenstrom Macroglobulinemia	September 25, 2012	Phase 2
NCT03841110	Fate Therapeutics	Advanced Solid Tumors\|Lymphoma\|Gastric Cancer\|Colorectal Cancer\|Head and Neck Cancer\|Squamous Cell Carcinoma\|EGFR Positive Solid Tumor\|HER2-positive Breast Cancer\|Hepatocellular Carcinoma\|Small Cell Lung Cancer\|Renal Cell Carcinoma\|Pancreas Cancer\|Melanoma\|NSCLC\|Urothelial Carcinoma\|Cervical Cancer\|Microsatellite Instability\|Merkel Cell Carcinoma	February 15, 2019	Phase 1
NCT03907852	TCR2 Therapeutics\|Bristol-Myers Squibb	Mesothelioma\|Mesothelioma, Malignant\|Mesothelioma; Pleura\|Mesotheliomas Pleural\|Mesothelioma Peritoneum\|Cholangiocarcinoma\|Cholangiocarcinoma Recurrent\|Ovarian Cancer\|Non Small Cell Lung Cancer\|Non Small Cell Lung Cancer Metastatic\|High Grade Ovarian Serous Adenocarcinoma	April 15, 2019	Phase 1\|Phase 2
NCT00787761	Northside Hospital, Inc.\|Blood and Marrow Transplant Group of Georgia	Myeloproliferative Disorders\|Kidney Cancer\|Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Diseases	April 2007	Phase 2
NCT00004218	Leukemia Research Fund\|Medical Research Council\|National Cancer Institute (NCI)	Leukemia	October 1999	Phase 3
NCT00098670	National Cancer Institute (NCI)	B-cell Chronic Lymphocytic Leukemia\|Stage I Chronic Lymphocytic Leukemia\|Stage II Chronic Lymphocytic Leukemia\|Stage III Chronic Lymphocytic Leukemia\|Stage IV Chronic Lymphocytic Leukemia	October 2004	Phase 2
NCT05155215	Beijing Immunochina Medical Science & Technology Co., Ltd.	Lymphoma\|Lymphoma, Mantle-Cell\|Neoplasms by Histologic Type\|Neoplasms\|Lymphoproliferative Disorders	December 31, 2021	Phase 1\|Phase 2
NCT00068315	National Cancer Institute (NCI)	Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue\|Hematopoietic+Lymphoid Cancer\|Nodal Marginal Zone B-cell Lymphoma\|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma\|Recurrent Grade 1 Follicular Lymphoma\|Recurrent Grade 2 Follicular Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Marginal Zone Lymphoma\|Recurrent Small Lymphocytic Lymphoma\|Refractory Chronic Lymphocytic Leukemia\|Splenic Marginal Zone Lymphoma\|Waldenström Macroglobulinemia	July 2003	Phase 1
NCT04264078	Xinqiao Hospital of Chongqing\|Gracell Biotechnology Shanghai Co., Ltd.\|920th Hospital of Joint Logistics Support Force of People´s Liberation Army of China\|The Second Affiliated Hospital of Chongqing Medical University\|The Affiliated Hospital Of Guizhou Medical University\|Central South University\|The First Affiliated Hospital of Kunming Medical College\|The General Hospital of Western Theater Command\|Second Affiliated Hospital of Xi´an Jiaotong University\|Nanfang Hospital of Southern Medical University\|Fujian Medical University Union Hospital\|The First Affiliated Hospital of Anhui Medical University\|Tang-Du Hospital	T-cell Leukemia\|T-cell Lymphoma	March 1, 2021	Early Phase 1
NCT00619645	University of California, Davis	Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes	June 2007	Phase 2
NCT03448393	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Acute Lymphoid Leukemia\|B-Cell Leukemia\|Leukemia, Lymphocytic, B Cell\|B-Cell Lymphoma\|Lymphoma, Non-Hodgkin	March 26, 2018	Phase 1
NCT02083250	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Acute Lymphoblastic Leukemia in Remission\|Acute Myeloid Leukemia in Remission\|Allogeneic Hematopoietic Stem Cell Transplantation Recipient\|Myelodysplastic Syndrome\|Previously Treated Myelodysplastic Syndrome\|Recurrent Acute Lymphoblastic Leukemia\|Recurrent Acute Myeloid Leukemia	March 6, 2014	Phase 1
NCT04551885	Fate Therapeutics	Solid Tumor, Adult	September 7, 2020	Phase 1
NCT00958854	Cancer Research UK\|National Cancer Institute (NCI)	Lymphoma	January 2006	Phase 2
NCT00714259	University of Alabama at Birmingham	Multiple Myeloma\|CLL + SLL\|Non Hodgkin´s Lymphoma\|Waldenstroms\|Mantle Cell Lymphoma	July 2008	Phase 2\|Phase 3
NCT02333838	Assistance Publique - Hôpitaux de Paris	Leukemia, Myeloid	May 2015	Phase 2
NCT02652455	H. Lee Moffitt Cancer Center and Research Institute\|Bristol-Myers Squibb\|Prometheus Inc.\|Iovance Biotherapeutics, Inc.	Melanoma (Skin)\|Skin Cancer	March 8, 2016	Early Phase 1
NCT03813147	National Cancer Institute (NCI)\|Children´s Oncology Group	Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome\|Recurrent Acute Myeloid Leukemia\|Recurrent Myelodysplastic Syndrome\|Refractory Acute Myeloid Leukemia\|Refractory Myelodysplastic Syndrome	May 1, 2019	Phase 1
NCT00577161	CTI BioPharma	Non-Hodgkin´s Lymphoma	September 2007	Phase 3
NCT01478074	Altor BioScience\|M.D. Anderson Cancer Center	Acute Myeloid Leukemia	November 2011	Phase 1
NCT00429572	M.D. Anderson Cancer Center	Breast Cancer	January 1998	Phase 2
NCT04561557	Tongji Hospital\|Nanjing IASO Biotherapeutics Co.,Ltd	Autoimmune Diseases\|Autoimmune Diseases of the Nervous System\|Neuromyelitis Optica Spectrum Disorder\|Myasthenia Gravis\|Chronic Inflammatory Demyelinating Polyradiculoneuropathy\|Immune-Mediated Necrotizing Myopathy	September 22, 2020	Early Phase 1
NCT00509496	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Skin Cancer\|Melanoma	June 2007	Phase 2
NCT05000450	Allogene Therapeutics	Relapsed+Refractory Multiple Myeloma	June 6, 2021	Phase 1\|Phase 2
NCT00096018	Roswell Park Cancer Institute	Leukemia	May 2002	Phase 1\|Phase 2
NCT05470283	M.D. Anderson Cancer Center	Tumor\|Metastatic Melanoma\|Melanoma	September 7, 2022	Phase 1
NCT04339777	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Lymphoproliferative Disorders\|Autoimmune Lymphoproliferative\|Immune System Diseases\|Common Variable Immunodeficiency\|Primary T-cell Immunodeficiency Disorders	September 22, 2020	Phase 2
NCT01861106	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	GATA2\|Immunodeficiency\|MDS	July 24, 2013	Phase 2
NCT01625351	St. Jude Children´s Research Hospital\|CURE Childhood Cancer, Inc.	Ewing Sarcoma\|Gastrointestinal Tumor\|Germ Cell Tumor\|Hepatic Tumor\|Lymphoma\|Wilms Tumor\|Rhabdoid Tumor\|Clear Cell Carcinoma\|Renal Cell Carcinoma\|Melanoma\|Neuroblastoma\|Rhabdomyosarcoma\|Non-rhabdomyosarcoma	August 20, 2012	Phase 1
NCT01493453	Professor Robert Hawkins\|The Christie NHS Foundation Trust	CD19 Positive Non-Hodgkin Lymphoma	March 2008	Phase 1
NCT03761056	Kite, A Gilead Company\|Gilead Sciences	B-cell Lymphoma	January 29, 2019	Phase 2
NCT03335241	Sun Yat-sen University	Ovarian Cancer	March 1, 2017	Phase 2
NCT02750254	Washington University School of Medicine	Acute Myeloid Leukemia\|Myelodysplastic Syndrome\|Acute Lymphocytic Leukemia	June 27, 2016	Phase 1
NCT00566332	French Study Group on Chronic Lymphoid Leukemia\|Lymphoma Study Association\|French Innovative Leukemia Organisation\|Département de Biostatistiques et Informatique Médicale DBIM	Waldenström Macroglobulinemia\|Lymphoplasmacytic Lymphoma\|Splenic Marginal Zone Lymphoma	June 2001	Phase 3
NCT03602157	UNC Lineberger Comprehensive Cancer Center\|University Cancer Research Fund at Lineberger Comprehensive Cancer Center\|Stand Up To Cancer	Lymphoma\|Immune System Diseases\|Immunoproliferative Disorders\|Lymphatic Diseases\|Lymphoproliferative Disorders\|Neoplasms\|Cutaneous Lymphoma\|Cutaneous Anaplastic Large Cell Lymphoma\|Mycosis Fungoides\|Sezary Syndrome\|Lymphomatoid Papulosis\|Cutaneous T Cell Lymphoma\|Gray Zone Lymphoma	December 12, 2018	Phase 1
NCT00198991	Goethe University\|Deutsche Krebshilfe e.V., Bonn (Germany)\|German Federal Ministry of Education and Research	Adult Acute Lymphocytic Leukemia	April 2003	Phase 4
NCT02456350	Shenzhen Second People´s Hospital\|Shenzhen Institute for Innovation and Translational Medicine	Chronic Lymphocytic Leukemia\|Acute Lymphocytic Leukemia\|Lymphoma	April 2015	Phase 1
NCT00036738	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Adult Acute Lymphoblastic Leukemia in Remission\|Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1\|Blastic Phase\|Childhood Acute Lymphoblastic Leukemia in Remission\|Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1\|Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Chronic Phase of Disease\|Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent Childhood Acute Lymphoblastic Leukemia\|Recurrent Disease	July 13, 2001	Phase 2
NCT03609814	University of California, San Francisco	Hematologic Malignancies\|Nonmalignant Diseases\|Immunodeficiencies\|Hemoglobinopathies\|Genetic Inborn Errors of Metabolism\|Fanconi´s Anemia\|Thalassemia\|Sickle Cell Disease	January 26, 2016
NCT00478244	Masonic Cancer Center, University of Minnesota	Epidermolysis Bullosa	April 2007	Not Applicable
NCT00017108	European Organisation for Research and Treatment of Cancer - EORTC\|National Cancer Institute (NCI)	Leukemia	March 2001	Phase 3
NCT02220985	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)\|National Heart, Lung, and Blood Institute (NHLBI)	Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Acute Biphenotypic Leukemia\|Acute Leukemia of Ambiguous Lineage\|Acute Undifferentiated Leukemia\|Allogeneic Hematopoietic Stem Cell Transplant Recipient\|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Blastic Plasmacytoid Dendritic Cell Neoplasm\|Childhood Acute Lymphoblastic Leukemia in Remission\|Childhood Acute Myeloid Leukemia in Remission\|Donor\|Lymphoblastic Lymphoma\|Myelodysplastic Syndrome With Excess Blasts\|Myelodysplastic Syndrome With Excess Blasts-1\|Myelodysplastic Syndrome With Excess Blasts-2\|Recurrent Acute Lymphoblastic Leukemia\|Recurrent Acute Myeloid Leukemia\|Recurrent Childhood Acute Lymphoblastic Leukemia\|Recurrent Childhood Acute Myeloid Leukemia\|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive\|Refractory Acute Lymphoblastic Leukemia\|Refractory Acute Myeloid Leukemia\|Acute Lymphoblastic Leukemia in Remission\|Acute Myeloid Leukemia in Remission	February 3, 2015	Phase 2
NCT00278512	Northwestern University	Vasculitis	August 2003	Phase 1
NCT02757885	Emory University	Sickle Cell Disease	April 2016	Phase 2
NCT00802113	Columbia University	Non-Hodgkin´s Lymphoma\|Hodgkins Disease	June 2003	Phase 1\|Phase 2
NCT03721068	UNC Lineberger Comprehensive Cancer Center\|United States Department of Defense\|Bellicum Pharmaceuticals\|University Cancer Research Fund at Lineberger Comprehensive Cancer Center	Neuroblastoma\|Osteosarcoma	February 19, 2019	Phase 1
NCT03494569	City of Hope Medical Center\|National Cancer Institute (NCI)	Acute Lymphoblastic Leukemia\|Acute Lymphoblastic Leukemia in Remission\|Acute Myeloid Leukemia\|Acute Myeloid Leukemia in Remission\|Hematopoietic Cell Transplantation Recipient\|Minimal Residual Disease\|Myelodysplastic Syndrome\|Secondary Acute Myeloid Leukemia	July 6, 2018	Phase 1
NCT04789408	Kite, A Gilead Company\|Gilead Sciences	Acute Myeloid Leukemia	July 19, 2021	Phase 1
NCT00027560	Memorial Sloan Kettering Cancer Center\|National Cancer Institute (NCI)	Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Neoplasms	July 2001	Phase 2
NCT00950846	Baylor College of Medicine\|Center for Cell and Gene Therapy, Baylor College of Medicine	Congenital Pediatric Disorders	September 2009	Not Applicable
NCT01256398	National Cancer Institute (NCI)	Acute Lymphoblastic Leukemia\|Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1	December 14, 2010	Phase 2
NCT04608487	Dana-Farber Cancer Institute\|Kite, A Gilead Company	Lymphoma\|Lymphoma Cns	December 4, 2020	Phase 1
NCT01263704	Hoffmann-La Roche	Lymphocytic Leukemia, Chronic	July 17, 2011	Phase 2
NCT01962415	Paul Szabolcs\|University of Pittsburgh	Primary Immunodeficiency (PID)\|Congenital Bone Marrow Failure Syndromes\|Inherited Metabolic Disorders (IMD)\|Hereditary Anemias\|Inflammatory Conditions	February 4, 2014	Phase 2
NCT00143065	Ohio State University Comprehensive Cancer Center	Lymphoma, Small Lymphocytic\|Lymphocytic Leukemia, Chronic	August 2005	Phase 2
NCT01471067	M.D. Anderson Cancer Center\|American Stem Cell, Inc.\|National Cancer Institute (NCI)	Blood And Marrow Transplantation\|Leukemia\|Lymphoma\|Transplantation Infection\|Transplantation, Bone Marrow	July 13, 2012	Phase 1
NCT02992743	GlaxoSmithKline	Neoplasms	December 6, 2016	Phase 2
NCT02869217	University Health Network, Toronto\|Takara Bio Inc.	NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive Patients\|Synovial Sarcoma\|Melanoma\|Esophageal Cancer\|Ovarian Cancer\|Lung Cancer\|Bladder Cancer\|Liver Cancer	September 2016	Phase 1
NCT03322735	Henan Cancer Hospital\|The Pregene (ShenZhen) Biotechnology Company, Ltd.	Multiple Myeloma	December 8, 2017	Phase 1\|Phase 2
NCT04521946	M.D. Anderson Cancer Center	Anaplastic Ependymoma\|Atypical Teratoid+Rhabdoid Tumor\|Central Nervous System Germ Cell Tumor\|Choroid Plexus Carcinoma\|Intracranial Myeloid Sarcoma\|Malignant Brain Neoplasm\|Malignant Glioma\|Medulloblastoma\|Primitive Neuroectodermal Tumor\|Recurrent Anaplastic Ependymoma\|Recurrent Atypical Teratoid+Rhabdoid Tumor\|Recurrent Malignant Brain Neoplasm\|Recurrent Malignant Glioma\|Recurrent Medulloblastoma\|Recurrent Primitive Neuroectodermal Tumor	January 14, 2021	Phase 1
NCT00313508	H. Lee Moffitt Cancer Center and Research Institute\|National Cancer Institute (NCI)	Intraocular Melanoma\|Melanoma (Skin)	February 2006	Phase 1
NCT00924001	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Melanoma\|Malignant Melanoma\|Melanoma, Experimental	August 2007	Phase 1\|Phase 2
NCT01534143	Barbara Ann Karmanos Cancer Institute\|National Cancer Institute (NCI)	Refractory Multiple Myeloma\|Stage I Multiple Myeloma\|Stage II Multiple Myeloma\|Stage III Multiple Myeloma	February 2012	Phase 2
NCT00472849	M.D. Anderson Cancer Center\|Sanofi	Richter´s Transformation\|Leukemia	May 2007	Phase 1\|Phase 2
NCT04093596	Allogene Therapeutics	Relapsed+Refractory Multiple Myeloma	September 23, 2019	Phase 1
NCT00005941	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Cervical Cancer\|Vaginal Cancer	November 1999	Phase 2
NCT00262782	German CLL Study Group	Chronic Lymphocytic Leukemia	April 1997	Phase 3
NCT02702960	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins\|Fibrolamellar Cancer Foundation	Fibrolamellar Hepatocellular Carcinoma\|Hepatocellular Carcinoma (Fibrolamellar Variant)\|Hepatocellular Carcinoma	March 2016	Phase 2
NCT02215967	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Myeloma, Plasma-Cell\|Myeloma-Multiple	August 12, 2014	Phase 1
NCT00423826	Barbara Ann Karmanos Cancer Institute\|National Cancer Institute (NCI)	Leukemia\|Lymphoma\|Multiple Myeloma and Plasma Cell Neoplasm\|Myelodysplastic Syndromes\|Precancerous Condition\|Secondary Myelofibrosis	January 2007
NCT02282904	National Institute of Allergy and Infectious Diseases (NIAID)\|National Institutes of Health Clinical Center (CC)	Chronic Granulomatous Disease	October 23, 2014	Phase 1\|Phase 2
NCT02918292	Medical College of Wisconsin\|National Heart, Lung, and Blood Institute (NHLBI)\|National Cancer Institute (NCI)\|Blood and Marrow Transplant Clinical Trials Network\|National Marrow Donor Program	Severe Aplastic Anemia	July 3, 2017	Phase 2
NCT03697824	GlaxoSmithKline\|Merck Sharp & Dohme LLC	Neoplasms	February 25, 2019	Phase 2
NCT03342196	Case Comprehensive Cancer Center	Leukemia	March 21, 2018	Phase 2
NCT01176006	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	DOCK8 Deficiency	October 5, 2010	Phase 2
NCT04416984	Allogene Therapeutics	Relapsed+Refractory Large B Cell Lymphoma	May 21, 2020	Phase 1\|Phase 2
NCT00547196	City of Hope Medical Center\|National Cancer Institute (NCI)	Leukemia\|Lymphoma\|Myelodysplastic Syndromes	August 16, 2005	Not Applicable
NCT00301860	University of California, San Francisco\|National Cancer Institute (NCI)	Leukemia\|Lymphoma	January 2003	Not Applicable
NCT03168438	GlaxoSmithKline\|Merck Sharp & Dohme LLC	Neoplasms	August 18, 2017	Phase 1
NCT02894645	National University Hospital, Singapore	Acute Lymphoblastic Leukemia (ALL)	October 2008	Phase 4
NCT03164057	St. Jude Children´s Research Hospital	Acute Myeloid Leukemia\|Myelodysplastic Syndromes	June 15, 2017	Phase 2
NCT00641095	University College, London\|Cancer Research UK	Lymphoma	December 7, 2006	Phase 2\|Phase 3
NCT00019838	National Cancer Institute (NCI)	Leukemia\|Lymphoma	July 1999	Phase 1
NCT01186458	Hoosier Cancer Research Network\|Genentech, Inc.\|Millennium Pharmaceuticals, Inc.	Lymphoma, Non-Hodgkin	October 2010	Phase 2
NCT01877837	Hackensack Meridian Health	Sickle Cell Disease	June 2011	Phase 3
NCT04232085	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Primary Immune Deficiency Disorder\|Immune Deficiency Disease\|Bone Marrow Failure	February 12, 2020	Phase 2
NCT01592981	University College, London	Waldenstrom´s Macroglobulinaemia	January 2013	Phase 2
NCT00303719	Masonic Cancer Center, University of Minnesota	Kidney Cancer\|Leukemia\|Lymphoma\|Multiple Myeloma\|Plasma Cell Neoplasm\|Myelodysplastic Syndromes	March 26, 2002	Phase 2
NCT00337246	Cancer Research UK\|National Cancer Institute (NCI)	Leukemia	July 2005	Phase 2
NCT02111863	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Melanoma\|Skin Cancer	February 21, 2014	Phase 2
NCT02926586	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	Acute Myeloid Leukemia\|Core-Binding Factor	January 1, 2017	Phase 4
NCT00899431	M.D. Anderson Cancer Center\|Celgene Corporation	Chronic Lymphocytic Leukemia	May 6, 2009	Phase 2
NCT03666000	Precision BioSciences, Inc.	Non-Hodgkin Lymphoma\|B-cell Acute Lymphoblastic Leukemia	March 11, 2019	Phase 1\|Phase 2
NCT05069935	Fate Therapeutics	Solid Tumor, Adult	October 15, 2021	Phase 1
NCT00112567	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Leukemia\|Myelodysplastic Syndromes	April 2003	Phase 1\|Phase 2
NCT00346359	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Chronic Myeloproliferative Disorders\|Graft Versus Host Disease\|Leukemia\|Myelodysplastic Syndromes\|Myelodysplastic+Myeloproliferative Diseases	March 2006	Phase 2
NCT00510887	Duke University\|Millennium Pharmaceuticals, Inc.	Lymphoma, Follicular	January 2007	Phase 2
NCT00031655	Fred Hutchinson Cancer Research Center+University of Washington Cancer Consortium\|National Cancer Institute (NCI)\|Fred Hutchinson Cancer Center	Adult Acute Lymphoblastic Leukemia in Remission\|Childhood Acute Lymphoblastic Leukemia in Remission\|Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent Childhood Acute Lymphoblastic Leukemia	September 2001	Phase 2
NCT00324623	Prof. Serge Leyvraz\|Centre Hospitalier Universitaire Vaudois	Melanoma (Skin)	September 2005	Phase 1
NCT00006251	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Acute Undifferentiated Leukemia\|Adult Nasal Type Extranodal NK+T-cell Lymphoma\|Anaplastic Large Cell Lymphoma\|Angioimmunoblastic T-cell Lymphoma\|Childhood Burkitt Lymphoma\|Childhood Diffuse Large Cell Lymphoma\|Childhood Grade III Lymphomatoid Granulomatosis\|Childhood Immunoblastic Large Cell Lymphoma\|Childhood Myelodysplastic Syndromes\|Childhood Nasal Type Extranodal NK+T-cell Lymphoma\|Chronic Myelomonocytic Leukemia\|Cutaneous B-cell Non-Hodgkin Lymphoma\|de Novo Myelodysplastic Syndromes\|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue\|Hepatosplenic T-cell Lymphoma\|Intraocular Lymphoma\|Juvenile Myelomonocytic Leukemia\|Mast Cell Leukemia\|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable\|Myeloid+NK-cell Acute Leukemia\|Nodal Marginal Zone B-cell Lymphoma\|Noncutaneous Extranodal Lymphoma\|Peripheral T-cell Lymphoma\|Post-transplant Lymphoproliferative Disorder\|Previously Treated Myelodysplastic Syndromes\|Primary Systemic Amyloidosis\|Recurrent Adult Acute Lymphoblastic Leukemia\|Recurrent Adult Acute Myeloid Leukemia\|Recurrent Adult Burkitt Lymphoma\|Recurrent Adult Diffuse Large Cell Lymphoma\|Recurrent Adult Diffuse Mixed Cell Lymphoma\|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma\|Recurrent Adult Grade III Lymphomatoid Granulomatosis\|Recurrent Adult Hodgkin Lymphoma\|Recurrent Adult Immunoblastic Large Cell Lymphoma\|Recurrent Adult Lymphoblastic Lymphoma\|Recurrent Adult T-cell Leukemia+Lymphoma\|Recurrent Childhood Acute Lymphoblastic Leukemia\|Recurrent Childhood Acute Myeloid Leukemia\|Recurrent Childhood Anaplastic Large Cell Lymphoma\|Recurrent Childhood Grade III Lymphomatoid Granulomatosis\|Recurrent Childhood Large Cell Lymphoma\|Recurrent Childhood Lymphoblastic Lymphoma\|Recurrent Childhood Small Noncleaved Cell Lymphoma\|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma\|Recurrent Grade 1 Follicular Lymphoma\|Recurrent Grade 2 Follicular Lymphoma\|Recurrent Grade 3 Follicular Lymphoma\|Recurrent Mantle Cell Lymphoma\|Recurrent Marginal Zone Lymphoma\|Recurrent Mycosis Fungoides+Sezary Syndrome\|Recurrent Renal Cell Cancer\|Recurrent Small Lymphocytic Lymphoma\|Recurrent+Refractory Childhood Hodgkin Lymphoma\|Refractory Chronic Lymphocytic Leukemia\|Refractory Hairy Cell Leukemia\|Refractory Multiple Myeloma\|Small Intestine Lymphoma\|Splenic Marginal Zone Lymphoma\|Stage II Multiple Myeloma\|Stage III Multiple Myeloma\|T-cell Large Granular Lymphocyte Leukemia\|Testicular Lymphoma\|Waldenström Macroglobulinemia	May 2000	Phase 1\|Phase 2
NCT01338987	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Myelodysplastic Syndrome\|Acute Lymphocytic Leukemia\|Acute Myelogenous Leukemia\|Chronic Myelogenous Leukemia\|Chronic Myelomonocytic Leukemia	April 19, 2011	Phase 2
NCT04904588	Center for International Blood and Marrow Transplant Research\|National Marrow Donor Program	Acute Lymphoblastic Leukemia\|Acute Myelogenous Leukemia\|Mixed Phenotype Acute Leukemia\|Acute Leukemia\|Myelodysplastic Syndromes\|Chronic Myelogenous Leukemia\|Chronic Lymphocytic Leukemia\|Lymphoma	September 30, 2021	Phase 2
NCT03716856	First Affiliated Hospital of Zhejiang University\|CARsgen Therapeutics Co., Ltd.	Refractory or Relapsed Multiple Myeloma	March 23, 2018	Phase 1
NCT01807182	Fred Hutchinson Cancer Center\|National Cancer Institute (NCI)	Stage III Cutaneous Melanoma AJCC v7\|Stage IIIA Cutaneous Melanoma AJCC v7\|Stage IIIB Cutaneous Melanoma AJCC v7\|Stage IIIC Cutaneous Melanoma AJCC v7\|Stage IV Cutaneous Melanoma AJCC v6 and v7\|Metastatic Melanoma	August 20, 2013	Phase 2
NCT02724904	Massachusetts General Hospital\|Adienne SA\|Dana-Farber Cancer Institute	Lymphoma	May 2017	Phase 1\|Phase 2
NCT03166397	Sheba Medical Center	Malignant Melanoma Stage IV	June 5, 2017	Phase 2
NCT00091611	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Kidney Neoplasms	September 2004	Phase 1
NCT04859946	M.D. Anderson Cancer Center\|Incyte Corporation	Hematologic and Lymphocytic Disorder	January 11, 2022	Phase 1
NCT02771197	Northside Hospital, Inc.\|Merck Sharp & Dohme LLC	Acute Myeloid Leukemia	September 28, 2016	Phase 2
NCT00775931	Masonic Cancer Center, University of Minnesota	Severe Osteopetrosis	August 2008	Phase 2\|Phase 3
NCT02443831	University College, London	Acute Lymphoblastic Leukemia\|Burkitt Lymphoma	April 2016	Phase 1
NCT00429026	M.D. Anderson Cancer Center	Renal Cell Cancer	January 2004	Phase 2
NCT00004862	National Cancer Institute (NCI)	Leukemia	October 1999	Phase 1
NCT05449899	Nanfang Hospital of Southern Medical University\|Peking University People´s Hospital\|Institute of Hematology and Blood Diseases Hospital\|Guangzhou First People´s Hospital\|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University\|First People´s Hospital of Chenzhou\|The Seventh Affiliated Hospital of Sun Yat-sen University	Secondary Acute Myeloid Leukemia Evolving From MDS\|Allogeneic Hematopoietic Stem Cell Transplantation\|Conditioning	July 2022	Phase 2\|Phase 3
NCT04432506	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Hematopoietic and Lymphoid Cell Neoplasm\|Recurrent Diffuse Large B-Cell Lymphoma\|Recurrent High Grade B-Cell Lymphoma\|Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma\|Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma\|Refractory Diffuse Large B-Cell Lymphoma\|Refractory High Grade B-Cell Lymphoma\|Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma\|Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma	July 27, 2020	Phase 2
NCT00902044	Baylor College of Medicine\|Center for Cell and Gene Therapy, Baylor College of Medicine\|The Methodist Hospital Research Institute\|Cancer Prevention Research Institute of Texas	Sarcoma	February 11, 2010	Phase 1
NCT00258427	Masonic Cancer Center, University of Minnesota	Fanconi Anemia	March 26, 2002	Phase 2
NCT00923390	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Renal Cancer\|Kidney Cancer	March 2, 2009	Phase 1
NCT02497404	Weill Medical College of Cornell University	Leukemia, Erythroblastic, Acute\|Myelodysplastic Syndromes	February 13, 2015	Phase 2
NCT02676323	St. Jude Children´s Research Hospital	Acute Myeloid Leukemia\|Myelodysplastic Syndrome	May 3, 2016	Phase 1
NCT05618925	ImmunityBio, Inc.	NonHodgkin´s Lymphoma Refractory	November 15, 2022	Phase 1
NCT01019876	Columbia University	Bone Marrow Failure\|Osteopetrosis\|Fanconi Anemia\|Severe Combined Immunodeficiency	June 2002	Phase 2\|Phase 3
NCT00290641	Masonic Cancer Center, University of Minnesota\|National Cancer Institute (NCI)	Chronic Myeloproliferative Disorders\|Leukemia\|Lymphoma\|Myelodysplastic Syndromes	April 2001	Not Applicable
NCT05334329	City of Hope Medical Center\|National Cancer Institute (NCI)\|CytoImmune Therapeutics	Advanced Lung Non-Small Cell Carcinoma\|Metastatic Lung Non-Small Cell Carcinoma\|Recurrent Lung Non-Small Cell Carcinoma\|Refractory Lung Non-Small Cell Carcinoma\|Stage III Lung Cancer AJCC v8\|Stage IIIA Lung Cancer AJCC v8\|Stage IIIB Lung Cancer AJCC v8\|Stage IIIC Lung Cancer AJCC v8\|Stage IV Lung Cancer AJCC v8\|Stage IVA Lung Cancer AJCC v8\|Stage IVB Lung Cancer AJCC v8	July 20, 2022	Phase 1
NCT00923195	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Melanoma\|Skin Cancer	December 2008	Phase 2
NCT03263936	Therapeutic Advances in Childhood Leukemia Consortium	Acute Myelogenous Leukemia	July 11, 2017	Phase 1
NCT04318678	St. Jude Children´s Research Hospital	AML\|B-ALL\|T-ALL\|BPDCN\|MDS	May 27, 2020	Phase 1
NCT00924170	National Cancer Institute (NCI)\|National Institutes of Health Clinical Center (CC)	Adult T-Cell Leukemia (ATL)	October 31, 2008	Phase 1\|Phase 2
NCT05092451	M.D. Anderson Cancer Center	B-Cell Lymphoma\|Myelodysplastic Syndromes (MDS)\|Acute Myeloid Leukemia (AML)	November 1, 2022	Phase 1\|Phase 2
NCT00946023	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Lymphoma\|B-cell Lymphoma\|Non Hodgkin Lymphoma\|Chronic Lymphocytic Leukemia	July 2009	Phase 2
NCT02680951	Emory University	Acute Myeloid Leukemia	December 2015	Phase 1
NCT05008536	Xinqiao Hospital of Chongqing\|Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.	Multiple Myeloma, Refractory	October 1, 2021	Early Phase 1
NCT00595127	Memorial Sloan Kettering Cancer Center\|National Cancer Institute (NCI)\|Miltenyi Biotec, Inc.	Fanconi Anemia	June 2001	Not Applicable

Appearance

Solid

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Solvent & Solubility

In Vitro:

DMSO : ≥ 100 mg/mL ( 273.82 mM )

H ₂ O : 5 mg/mL ( 13.69 mM ; Need ultrasonic)

* "≥" means soluble, but saturation unknown.

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	2.7382 mL	13.6908 mL	27.3815 mL
5 mM	0.5476 mL	2.7382 mL	5.4763 mL
10 mM	0.2738 mL	1.3691 mL	2.7382 mL

* Please refer to the solubility information to select the appropriate solvent.

In Vivo:

1.

Add each solvent one by one: phosphate buffer saline

Solubility: 20 mg/mL (54.76 mM); Clear solution; Need ultrasonic
2.

Add each solvent one by one: PBS

Solubility: 18.33 mg/mL (50.19 mM); Clear solution; Need ultrasonic
3.

Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

Solubility: ≥ 2.5 mg/mL (6.85 mM); Clear solution
4.

Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

Solubility: ≥ 2.5 mg/mL (6.85 mM); Clear solution
5.

Add each solvent one by one: 10% DMSO >> 90% corn oil

Solubility: ≥ 2.5 mg/mL (6.85 mM); Clear solution

* All of the co-solvents are available by MCE.

References

[1] Sorscher EJ, et al. In vivo antitumor activity of intratumoral fludarabine phosphate in refractory tumors expressing E. coli purine nucleoside phosphorylase. Cancer Chemother Pharmacol. 2012 Aug;70(2):321-9.
[2] Kikuchi E, et al. Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts. Cancer Gene Th

Synonyms

9H-Purin-6-amine, 2-fluoro-9-(5-O-phosphono-β-D-arabinofuranosyl)-

2-Fluoro-9-(5-O-phosphono-β-D-arabinofuranosyl)-9H-purin-6-amine

Fludarabine phosphate

NSC 312887

NSC 328002

Fludara

Fludarabine 5′-monophosphate

2-Fluoroadenine arabinoside 5′-monophosphate

FAMP

Fludura

2-F-ara-AMP

Fludarabine 5′-dihydrogen phosphate

Request a Quote

Please fill in your details below to request a COA for our product. We will send the COA to the provided email address promptly.

Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.

Information

Shipping
Privacy notice
Terms of Service
About us
Contact us

Customer service

Search
Custom Synthesis

My account

My account
Orders
Addresses
Shopping cart